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Abstract 
Computer aided diagnosis within neuroimaging must rely on advanced image 
processing techniques to detect and quantify subtle signal changes that may be 
surrogate indicators of disease state. This the sis proposes two such novel 
methodologies that are both based on large volumes of interest, are data drive n, and 
use cross-sectional scans: appearance-based classification (ABC) and voxel-based 
classification (VBC). 
The concept of appearance in ABC represents the union of intensity and shape 
information extracted from magne tic resonance images (MRI). The classification 
method relies on a linear modeling of appearance features via principal components 
analysis, and comparison of the distribution of projection coordinates for the 
populations under study within a reference multidimensional appearance 
eigenspace. Classification is achieved using forward, stepwise linear discriminant 
analyses, in multiple cross-validated trials. In this work, the ABC methodology is 
shown to accurately lateralize the seizure focus in temporal lobe epilepsy (TLE), 
differentiate normal aging individuals from patients with either Alzheimer's 
dementia (AD) or Mild Cognitive Impairment (MCI), and finally predict the 
progression of MCI patients to AD. These applications demonstrated that the ABC 
technique is robust to different signal changes due to two distinct pathologies, to low 
xii 
resolution data and motion artifacts, and to possible differences inherent to multi-
site acquisition. 
The VBC technique relies on voxel-based morphometry to identify regions of grey 
and white matter concentration differences between co-registered cohorts of 
individuals, and then on linear modeling of variables extracted from these regions. 
Classification is achieved using linear discriminant analyses within a multivariate 
space composed of voxel-based morphometry measures related to grey and white 
matter concentration, along with clinical variables of interest. VBC is shown to 
increase the accuracy of prediction of one-year clinical status from three to four out 
of five TLE patients having undergone selective amygdalo-hippocampectomy. 
These two techniques are shown to have the necessary potential to solve current 
problems in neurological research, assist clinical physicians with their decision-
making process and influence positively patient management. 
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Abrégé 
Les systèmes experts d'aide au diagnostic en neuroimagerie doivent composer avec 
des techniques avancées de traitement de l'image pour détecter et quantifier des 
differences subtiles dans le signal, qui peuvent être des indicateurs indirects de l'état 
de la maladie. Cette thèse propose deux nouvelles méthodes à cet effet, toutes deux 
basées sur de larges volumes d'intérêt contenant les données intrinsèques, et qui 
font usage d'un seul volume d'acquisition: la classification basée sur l'apparence 
(CBA), et la classification basée sur les voxels (CBV). 
Le concept d'apparence en CBA représente l'union de l'information d'intensité et 
de forme, informations continues dans les images obtenues par résonance 
magnétique (IRM). La méthode de classification se base sur un modèle linéaire de 
vecteurs d'apparence via une analyse par composantes principales, et la comparaison 
des distributions de coordonnées de projection - pour les groupes sous étude - dans 
un espace référentiel multidimensionnel d'apparence. La classification elle-même 
est obtenue grâce à des analyses discriminantes linéaires graduées, dans de multiples 
essais de validation. Dans ce travail, il est démontré que la méthode CBA parvient à 
classifier de façon précise le foyer épileptogène en épilepsie du lobe temporal, de 
différencier le vieillissement normal de la maladie d'Alzheimer et du déficit 
cognitive léger, ainsi que de prédire la progression vers la démence d'Alzheimer 
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pour les patients atteints d'un déficit cognitif léger. Ces applications démontrent 
que la technique CBA est robuste face à des changements de signaux dus aux deux 
pathologies distinctes, à des données à basse résolution et porteuses de défauts reliés 
au mouvement, et potentiellement aux différences inhérentes dans des acquisitions 
multi-sites. 
La technique CBV se fonde sur la morphométrie par voxel pour identifier les 
régions de différence en concentration de matière grise et matière blanche entre les 
images recalées de deux groupes d'individus. Suit la modélisation linéaire de 
variables mesurées dans ces régions, incluant des variables cliniques d'intérêt. La 
classification est effectuée à l'aide d'analyses discriminantes linéaires à l'intérieur 
d'un espace multivarié, formé des mesures reliées à la concentration de matière 
grise ou blanche et des variables cliniques. Il est démontré que CBV permet 
d'augmenter la précision de la prédiction du résultat post-opératoire pour des 
patients souffrant d'épilepsie du lobe temporal et ayant subit une résection du 
complexe amygdalo-hippocampique, et ce dans une proportion de trois à quatre 
patients sur cinq. 
Ces deux techniques ont donc le potentiel nécessaire pour résoudre des problèmes 
actuels en recherche neurologique, d'assister les spécialistes dans leur processus 
décisionnel et d'influencer de façon positive la gestion des patients. 
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Original contributions 
The central purpose of this work was to develop automated aid to diagnosis 
methodologies for neurological diseases, and to test and validate the se techniques 
with real-life data sets. More specifically, the following original contributions are 
claimed. 
Main contributions: 
1) Created an appearance-based classification (ABC) methodology using MR 
images for the purpose of aid to diagnosis in neurological diseases; 
2) Determined that ABC can accurately lateralize the seizure focus in intractable 
temporal lobe epilepsy (TLE); 
3) Determined that ABC can accurately discriminate normal aging from 
Alzheimer's dementia (AD) and mild cognitive impairment (MCI); 
4) Determined that ABC can accurately predict progression to AD on average 2.6 
years before clinical diagnostic, in a given cohort of amnestic MCI patients; 
5) Created a voxel-based morphometry classification (VBC) methodology using 
MR images for the purpose of aid to diagnosis in neurological diseases; 
16 
6) Determined that VBC can improve the accuracy of predicting one-year post-
operative clinical status in patients having undergone selective amygdalo-
hippocampectomy (SAR) for intractable TLE; 
7) Proposed and verified experimentally that the cumulative microscopic effect of 
AD and TLE influence the T1w MR signal and can be estimated by appearance-
based models; 
8) Proposed and verified experimentally that large, nonspecific volumes of interest 
centered on the medial temporal lobes (MTL) contain addition al discrimina tory 
information when compared to hippocampal and/or amydgala volumetry, in the 
tested TLE and AD applications. 
Secondary contributions: 
9) Defined a class of appearance parameters composed of a combination of T1-
weighted MR intensity and shape measures; 
10) Extended 2D appearance-based segmentation approaches into a 3D 
classification methodology; 
11) Evaluated that assessing shape changes in the right medial temporal lobe is 
essential for accurate lateralization of the seizure focus in TLE; 
12) Determined that there are extra-hippocampal areas of grey and white matter 
concentration changes that are related to one-year SAR outcome; 
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13) Determined that shape characteristics within the MIL are critical in the 
differentiation of AD and MCI from normal aging; 
14) Determined that ABC is sufficiently robust ta reject site acquisition differences 
in a classification task; 
15) Determining that I1-weighted intensity characteristics within the right MIL are 
cri tic al in predicting MCI progression ta AD; 
16) Vsed a novel visualization ta 01 ta demonstrate the regions of intensity changes 
in the right MIL that are linked ta progression of MCI ta AD; 
17) Created a pipeline for the rapid, reproducible and automated processing of MR 
images across multiple datasets. 
Disclaimer 
A V.S. patent application has been submitted on parts of this work for protection of 
intellectual property ("Systems and Methods of Classification Vtilizing Intensity and 
Spatial Data", Co-inventors D.L. Collins, Ph.D., S. Duchesne, ing., M.Sc., V.S. 
Patent Pending, No 10/990396). 
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Chapter 1 
Introduction 
Neuroimaging techniques, in partieular structural or anatomical magnetie resonance 
imaging (MRI), allow the visualization and quantification of pathologically induced 
brain changes in the living subject; it then becomes possible to employ metrics 
capturing these changes as surrogate measures of the state of the disease. These 
techniques can help to achieve earlier diagnosis, characterize the time-course of the 
illness and generally increase therapy efficacy. 
Many neurological diseases exhibit pathologically specifie discrimina tory 
information in the form of local intensity variations and shape changes when 
observed on MRI. Such diseases include for example schizophrenia, Alzheimer's 
dementia (AD) or epilepsy with a seizure focus that can be lateralized to one of the 
medial temporal lobes (MTL). 
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The purpose of this thesis is to develop and validate, using real data, novel 
automated image processing techniques that would exploit these intensity and shape 
changes, in order to ultimately answer important clinical problems in neurology. For 
this the sis, the image input data will be limited to structural MRI, whose availability 
is constantly increasing in major Canadian centers. As such, the techniques 
presented will allow for automated, reproducible, and robust analysis of images as an 
aid to diagnosis and eventually assist clinieians in their decision process regarding 
patient management and care. 
Thesis overview 
This the sis is organized into eight major sections. Chapter 2, containing the 
background about basie and advanced MRI techniques necessary to the 
understanding of the novel methodologies, follows this introduction. Chapter 3 
includes a detailed overview of the two methodologies that have been developed and 
validated in this thesis: (a) appearance-based classification (ABC), based on multi-
dimensional analysis of intensity and shape measures from large, non-specifie 
Volumes of Interest; and (b) voxel-based classification (VBC), based on individual-
to-group comparison of regional variations in grey and white matter concentrations, 
targeted using between-group voxel-based morphometry. 
Following Chapter 3, four separate manuscripts, each preceded by a preface, form 
additional chapters. Bach manuscript consists in the validation of one of the 
23 
aforementioned methodologies with real data, the idea being that, for each of two 
diseases, one article attempts to aid the immediate diagnostic, while the second 
endeavors the prediction of future clinical status. 
ln the first article, published in Neurolmage, a study is performed to lateralize the 
seizure focus in temporal lobe epilepsy (TLE) patients. The second article, to be 
submitted to NeuroSurgery, recounts our attempt at predicting surgical outcome 
(clinical status at one-year foIlow-up) for a sub-group of the same TLE cohort. 
The third article, to be submitted to Alzheimer's and Dementia, is concemed with 
improving the diagnosis of normal aging individuals vs. patients with either 
Alzheimer's dementia (AD) or mild cognitive impairment (MCI). FinaIly, the la st 
article, to be submitted to Lancet NeuroJogy, details our work in predicting the 
future clinical status and progression of MCI patients to AD. 
The thesis concludes with a last chapter containing a general discussion and 
suggestions for future research. References for aIl chapters, as weIl as recurring 
abbreviations, have been collected in a single list at the end of the the sis for brevity. 
24 
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Chapter 2 
Background 
In Canada, for the year 2001, approximately 647000 individuals over 15 years of age 
received a magne tic resonance scan, 12% of those for neurological or brain-related 
issues (CIHI 2003). As of 2003, there were 147 magnetic resonance (MR) scanners 
in the country, most of them acquired and installed within the past 5 years (CIHI 
2003). With no si de effects, high-resolution and high contrast between soft tissues, 
MRI is a modality that has dramatically improved the ability to perform in vivo 
analysis and diagnosis, particularly in neurology and neurosurgery. 
The burden of interpretation of MRI rests on the many radiologists working in 
various hospitals and clinical centers. Most medical problems find their solution 
through the experienced judgment and careful observation that these professionals 
bring to the task; in sorne instances however, advanced image processing techniques 
are necessary to help them reach a confident decision. Qualitative analysis often 
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leads to many more quantitative questions (Which of these two hippocampi is 
smallest? What is the size of this multiple sclerosis plaque 7), while the biggest 
problem remains to answer accurately the most fundamental clinical question: does 
the patient have, or not, the disease? In these instances, computerized systems offer 
an automate d, unbiased and objective assessment of the images that hopefully can 
provide factual evidence supporting the diagnosis. 
In order to understand the advanced image processing techniques presented in this 
work, one needs to summarize the context for their evolution, the raw data that will 
be used as input, and sorne of the previous techniques and procedures on which they 
are based. The purpose of this chapter is to fulfill this need. It is composed of four 
sections, beginning with an overview of nuclear magnetic resonance (NMR), 
continuing with a more in-depth description of basic MR signaIs, and moves on to 
basic and more advanced processing techniques that are used to maximize the 
information content of the MR images. This summary of the path from initial data 
to processed output is done with the goal of highlighting the usefulness of each step 
in the context of clinical aid to diagnosis. The chapter closes with two case studies on 
TLE and AD, which are the two main applicative are as of this thesis. 
Nuclear Magnetic Resonance 
The process of Nuclear Magnetic Resonances (NMR) centers on the interaction of 
an atomic nucleus with a magne tic field. Spin, a fundamental property of the nuclei 
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that de scribes its angular momentum, must be half-integer in order for the nucleus 
to experience resonance. This implies therefore that nuclei such as carbon-13, 
nitrogen-15, fluorine-19, sodium-23, phosphorus-31 and, of course, the hydrogen 
nucleus, can be used for NMR. The latter is the most relevant nuclei for in-vivo 
medical imaging, because it is present in large concentrations in water and fat, which 
are major constituents of human tissue. 
In the presence of an external magnetic field Ba in the z-direction, the magnetic 
moment of the spinning nucleus combines with B(b and the nucleus experiences a 
torque. This will flip the nucleus in one of two states: a low energy state, aligned with 
B(b and a high energy state, away from B(Jo Bulk magnetization refers to the total 
alignment of multiple nuclei in a sample; the low energy state will slightly dominate 
the high energy one, and the sample becomes magnetized; it is expressed as a vector 
M, aligned with Ba .. 
If one were to apply a transverse magnetic field Bl to the magnetized sample, with 
energy corresponding to the difference between low and high states, then sorne 
nuclei in the sample would flip and bulk magnetization would be reduced. The 
vector Mwould be seen to tilt away from the direction of B(b and spiral towards the 
"transverse" or perpendicular plane. As soon as Mhas a compone nt in the 
transverse plane (Mxy), it will generate a detectable signal (Tofts 2003). 
When BI is removed, the absorbed energy in the system will dissipate in order for the 
system to return, or "relax", to the previous state of equilibrium. This dissipation 
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occurs by a number of processes, known collectively as relaxation mechanisms (Tofts 
2003), whose exponential decay are governed by various time constants T. 
Longitudinal, or Tl-relaxation, refers to energy transfer from the spins to the 
surrounding lattice, and therefore describes the return to equilibrium of the 
longitudinal compone nt M z of the bulk magnetization vector M Transverse, or T2-
relaxation, refers to spin-spin interactions, and explains the changes in the 
perpendicular component to the background field. 
First level: MR data analysis 
MR signaIs, acquired as a function of the relaxation mechanisms described above, 
are indicative of the biological composition of the tissue and of its physiological 
status; changes can be correlated with the pathology of interest. The first level of 
MR data analysis usually consists in the radiological interpretation of the images or 
the analysis of the measured signal with minimal processing (usually only performed 
to correct for acquisition-specific distortions). 
Tl imaging 
In normal tissues Tl values are related to macromolecular concentration, water 
binding and water content (Tofts 2003). This is the reason for the basic Tl contrast 
in the brain: the fat in myelin causes white matter (WM) to have a shorter Tl value 
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than grey matter (GM), and in tum GM has a shorter value than cerebro-spinal fluid 
(CSF) (see Figure l) 
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Figure 1 - Approach to magnetic equilibrium of an initially unmagnetized sample. 
In this graph, a value of 1.0 for Mo represents equilibrium magnetization, and the 
time is shown in seconds (Source: 
http://airto.bmap.ucla.eduIBMCweb/Course Work/M285/MRIlMRBasics.html) 
In practice Tl-weighted images have become the standard for anatomical MRI, 
offering the best possible means of assessing GM and WM boundaries and therefore 
allowing the parcellation or segmentation of the brain into different morphological 
reglOns. 
Pathologies that affect the water distribution will change the Tl signal. For instance, 
edema around tumors or in inflammatory acute multiple sclerosis (MS) lesions lead 
to an increase in Tl (Tofts 2003). Tl changes in TLE and AD will be addressed 
specifically later in this chapter. 
30 
T2 imaging 
Transverse relaxation relates to the spin-spin interactions of the decaying transverse 
magnetization and is found to be a function of the tissue and/or the local magnetic 
environment of the nuc1ei (Tofts 2003). As such this opens a window to the 
microscopie environment of the hydrogen nuc1ei under investigation, and allows for 
a differentiation in tissue types, in health or in disease. T2 relaxation, like Tl, is 
strongly correlated to the bulk water content in the cells however, contrary to Tl, 
fatty tissue will have a longer T2 signal. The contrast in T2-weighted images of the 
brain is therefore reversed from that of a Tl-weighted image: CSF appears bright, 
and WMdark. 
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Figure 2 - Decay of transverse component of MR signal 
This graph shows the magnitude of the MR signal as it decays over time from its 
initial maximum (Source: 
airto.bmap.ucla.eduIBMCweb/CourseWorkIM285IMRIlMRBasics.html) 
In the normal brain, heterogeneity in T2 values is attributed to variations in water 
content, cytoarchitecture, iron concentration, degree of myelination and increased 
vascularity (Tofts 2003). Abnormalities identified on T2-weighted images reflect 
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altered tissue water content, which can be associated with axonalloss, gliosis, 
demyelination and edema, which are seen in or around MS lesions (Larsson, Barker 
et al. 1998)(Larsson et al 1989). In TLE, increases in T2-weighted signal intensity 
have been reported in hippocampal sclerosis, related to the gliosis in the dentate 
gyrus (Briellmann, Kalnins et al. 2002). T2 is not a good indicator of AD (Laakso, 
Partanen et al. 1996). 
Figure 3 - T2 imaging in TLE 
Coronal T2 maps calculated from 23 images of a control subject. Pixel intensity 
represents T2 relaxation time calculated by fitting a single exponential to 
corresponding pixels from each constituent image. The white squares within the 
hippocampal head (panels 1 and 2), body (panels 3-5), and tail (panel 6) represent 
the region of interest for the T2 relaxation time measurements. Significantly higher 
T2 relaxation time was found in TLE patients when compared to NC. 
Source: (Bernasconi, Bernasconi et al. 2000) 
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Figure 4 - T2-weighted imaging in AD 
This coronal T2-weighted image shows extensive white matter hyperintensity and 
severe medial temporal lobe atrophy, which is suggestive of combination between 
degenerative and vascular brain pathology. 
Source: (Bastos Leite, Scheltens et al. 2004) 
Proton densi ty imaging 
Proton density (PD) refers to the overall concentration of MRI-visible protons 
(hydrogen nuclei) in tissue. As discussed previously, most of the hydrogen nuclei are 
located in water, and virtually all tissue water is visible. There is also a large pool of 
non-aqueous protons (30% of protons in white matter) that is MRI-invisible (Tofts 
2003). 
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Increases in PD correspond largely to edema and are seen in longitudinal 
examination of MS plaques (Narayanan, Fu et al. 1997). Changes in PD often 
correlate closely with Tl changes. 
Figure 5 - PD imaging 
Axial proton density MRI showing white matter lesions: (A) normal control; (B) 
patient with vascular dementia (extensive frontal, occipital and parietal 
hyperintensities); (C) patient with pathologically confirmed dementia with Lewy 
bodies (primarily frontal and parietal abnormalities); (D) patient with 
pathologically confirmed AD (frontal, parietal and occipital changes) 
Source: (Barber, Scheltens et al. 1999) 
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Diffusion Imaging 
Free water will diffuse isotropically, that is equally in all directions, due to Brownian 
motion. Barriers, such as cell membranes in biological tissue, will hinder this 
diffusion and make the process anisotropic. The higher the anisotropy, the more 
restricted the water pool; anisotropy can serve therefore indirectly to measure 
cellular membrane integrity. Diffusion imaging measures the microscopic 
translational motion of hydrogen nuclei in water molecules and from this we can 
infer the degree of anisotropy via the apparent diffusion coefficient (ADC). In 
heaIthy tissue, myelin will have high anisotropy, particularly in large fiber bundles or 
tracts (such as the corpus callosum), whereas in CSF, diffusion will be nearly 
isotropic. 
Decreases in anisotropy in disease are indicative of the destruction of tissue, such as 
in demyelination in MS (Cassol, Ranjeva et al. 2004). Further, by measuring the 
diffusion behavior in a range of directions (the diffusion tensor) we obtain a 
measure that is independent of the orientation of the subject in the scanner (Tofts 
2003). By following the direction of maximum diffusion, we can identify the 
connectivity of major nerve fiber bundles, a process known as tractography. 
Decreased anisotropy in the hippocampi in both AD and MCI when compared to 
normal aging have been reported (Kantarci, Jack et al. 2001), with other differences 
elsewhere in the brain between AD and normal aging (see Figure 6). The reliability 
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for individu al prognosis is pOOf however, as there is considerable overlap between 
the anisotropy values of the three groups. 
Figure 6 - Diffusion imaging in AD 
Apparent diffusion coefficient (average) map, with regions of interest drawn on the 
anterior cingulated WM, thalamic, temporal stem and hippocampi. AD patients 
exhibit decreased anisotropy in these areas wh en compared to normal aging. 
Source (Kantarci, Jack et al. 2001) 
Magnetization Transfer Imaging 
Magnetization transfer imaging (MTI) enables the properties of protons bound to 
macromolecules to be probed (Tofts 2003). These bound protons (the 30% MRI-
invisible protons referred to in the Proton Density Imaging section above) compose 
a different pool than the free water protons observed so far via Tl, T2, PD or DTI; 
they are largely located in fat and proteins, and therefore in myelinated white matter. 
The magnetization transfer ratio (MTR) between free and bound protons gives an 
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indication of the quantity of bound protons present in tissue. CSF being essentially 
free water, its MTR will be close to zero, whereas MTR in WM will be high. 
MTR is reduced in many pathologies, in part due to demyelination, such as the 
corpus callosum of AD patients (Hanyu, Asano et al. 1999). There are also 
notice able changes in MTR in MCI patients (Kabani, SIed et al. 2002). MTR 
measurements were initially thought to be useful for lateralization of seizure focus in 
TLE (Tofts, Sisodiya et al. 1995), but more extensive research refuted that claim (Li, 
Narayanan et al. 2000). 
MR Spectroscopy 
Hydrogen is, by far, the most commonly observed nuclei in MRI however, as 
mentioned previously, any half-integer spin nuclei can theoretically be observed. 
Bulk magnetization actually results in a spectrum with peaks corresponding to 
various other chemical compounds or metabolites that resonate at different 
frequencies. Magnetic Resonance Spectroscopy (MRS) is concerned with the 
understanding and tracking of resonant peaks from other molecules; the major 
difficulty of course consisting in the identification of spectral peaks corresponding to 
a given molecule. Once identified, the resulting specificity is high however, and 
absolute concentration measurements become possible. 
Various chemicals involved in brain morphological and physiological processes have 
been identified. These include N-acetyl-aspartate (NAA), thought to give an 
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indication of neuronal density, choline-containing compounds, creatine, myo-inositol, 
glutamate and glutamine, lactate and lipids (Tofts 2003). 
Of aIl the compounds studied by Kantarci et a1., (Kantarci, Smith et al. 2002), the 
NANMyo-inositol ratio may be the most efficient predictor of memory and 
cognitive function in patients with MCI and AD. MRS has also been shown to be 
sensitive in detecting hippocampal sclerosis in TLE (Li, Caramanos et al. 2000)( see 
Figure 7). 
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Figure 7 - MRS imaging in TLE 
Follow-up temporal lobe 'H-MRS imaging of a 26-year-old patient with newly 
diagnosed TLE, 7 months after complete seizure control by carbamazepine, still 
shows low NAAlCr values in both temporal regions 
Source: (Bernasconi, Antel et al. 2001) 
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Functional MR imaging 
Functional MRI (fMRI) shows the location and sometimes magnitude of increased 
neuronal activation arising from specifie tasks (e.g. visual, motor or cognitive). 
Whereas aIl previous MR signaIs are directly related to the concentration of nuclei 
in the tissue, albeit in a macroscopic fashion, fMRI is an indirect measure of 
physiological response to an activation paradigm. As its name implies, it is a 
functional modality and should therefore be compared to other such imaging 
techniques, such as nuclear radiation (e.g. gamma cameras, positron emission 
tomography (PET) and single photon emission computed tomography (SPECT» or 
electro-magnetic imaging (e.g. electro-encephalography (EEG) and magneto-
encephalography (MEG». AlI functional modalities, when compared to structural 
imaging such as x-ray based computed tomography (CT) or high resolution MRI, 
offer limited spatial resolution. Yet, their informational content is of paramount 
importance, as it enables a window into the time-dependent physiological processes 
in health and in disease. 
There are several ways of detecting the increased metabolic demand associated with 
activity using MRI, the most common being the blood oxygen de pende nt (BOLD) 
signal (Logothetis and Pfeuffer 2004). When nerve cells are active they consume 
oxygen, supplied by local capillaries and carried by hemoglobin. A hemodynamic 
response occurs a few seconds after a burst of neuronal activity. The difference in 
the level of blood oxygenation, related to the fluctuations in diamagnetic oxygenated 
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hemoglobin and paramagnetic deoxygenated hemoglobin, results in a contrast (the 
BOLD signal) that can be used for imaging purposes. 
Aside from acquisition parameters, the relevance of the neuropsychological 
activation paradigm must also be considered when evaluating results from fMRI. If 
the test has poor specificity/sensitivity, then the acquisition will not compensate for 
this poor design. It must also be closely coordinated with the acquisition sequence. 
FM RI has been used extensively in many areas of the neurosciences; for example, 
localization of language regions for surgical planning (Poliakov, Hinshaw et al. 1999), 
and assessment of differences in cognitive abilities between normal aging and AD 
(Johnson, Saykin et al. 2000) and MCI (see Figure 8). 
Figure 8 - tMRI in AD 
Areas of significance where age-matched controls are significantly more active than 
patients with MCI on the two comparisons: (A) novel items: the hippocampus is 
significantly more active in controls th an MCI and (D) previously learned items: the 
posterior cingulate and precuneus are more active in controls during recognition. 
Source: (Johnson, Schmitz et al. 2005) 
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Second level: MR data-derived features analysis 
While the radiological analysis of MR data does give a number of answers to clinical 
questions, it is generally not sufficient when dealing with complex problems, such as 
assessing the rate of atrophy for structures in AD, or measuring the reduction in 
plaque size in MS through time during treatment. Further processing must be done 
to the original data, to put images in correspondence, and pinpoint subtle elements 
of interest on the images. 
Texture 
The concept of texture in medical imaging refers to the relationship between 
neighboring pixels (in 2D) or voxels (3D), under the hypothesis that sorne of the 
tissue characteristic giving rise to the signal within that image element will be related 
to its surrounding. Extracting local neighborhood intensity co-occurrences via n-th 
order statistics therefore serves to highlight changes in this interdependence, ideally 
related to the cumulative effect of microscopic pathological disturbances. Texture in 
MR images may de pend, to varying degrees, on local water content, on the nature, 
concentration and distribution of prote in and lipid molecules, on the chemical 
constituents and structure of molecules other than water, and substances which 
affect the local magne tic field, on perfusion, diffusion and flow and on the presence 
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of contrast agents (Tofts 2003). Different image resolutions will also restrain the 
comparative ability of texture metrics across subjects or groups. The most widely 
used texture metrics are derived from the spatial gray-Ievel dependence matrix, 
often referred to as the co-occurrence matrix, which can be computed in 3D 
(Kovalev, Kruggel et al. 2001). 
Neurodegenerative diseases of the brain, such as AD, are characterized by complex 
microscopic processes which result in cell death and physiological changes to brain 
tissue. It has been suggested that this may result in detectable changes in the 2D/3D 
macroscopic texture visible in MR (Freeborough and Fox 1998). First-order texture 
measures also show promise for assisting in locating focal cortical dysplasia in extra-
temporal epilepsy (Bernasconi, Antel et al. 2001; Srivastava, Maes et al. 2005). 
GM/WM/CSF classification 
At current imaging resolutions ( -1mm3), within-brain voxels in MRI may broadly be 
thought as composed of either one of three classes: white matter (WM), grey matter 
(GM), or cerebro-spinal fluid (CSF). The GM is primarily composed of neuronal 
bodies, while the WM consists essentially of closely packed axonal tracts, heavily 
myelinated, forming cortico-cortical or cortico- sub-cortical connections. It is readily 
acknowledged that the actual in vivo cellular arrangement is not as clearly defined, 
as within any given voxel, a large number of axons and cell bodies co-exist; however, 
the overall signal being an average of each tissue contributions within that volume 
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element, the majority of voxels will have a signal heavily weighted towards either 
GM, WM, or CSF. For sorne boundary voxels (especially the GM/WM interfaces), 
the difficulty remains to separate or assign them a particular label, due to partial 
volume effects (i.e. proportions of different tissue classes within a single volume 
element). 
At present however, this trichotomous view of brain tissue serves many purposes, 
and therefore much work has been dedicated to the separation of images into those 
major classes, a process referred to as tissue classification or segmentation. 
Tissue classification techniques have typically used either multi-modality images, in 
an effort to parcellate the multi-spectral intensity space into three distinctive classes, 
and/or used a priori information about the known spatial distribution of 
GM/WM/CSF in control subjects. This task is made even more complicated by the 
fact that the spatial distribution of GM/WM/CSF is highly variable, no two brains 
being topologically alike; and further, GM and WM intensities do vary across a 
single brain, in part due to the acquisition or improper correction of its bias, and 
otherwise because of the heterogeneousness of tissue within volume elements 
throughout the brain. The reader is referred to (Pham, Xu et al. 2000) for a 
comprehensive review of segmentation algorithms. 
In and of itself, the assignment of classes to tissue does not necessarily lead to a 
useful measurement that can aid the diagnosis; further analysis of the tissue maps 
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however does so, such as brain matter volumetry, ratio maps, and voxel-based 
morphometry (VBM), discussed in the next section. 
Figure 9 - GM average map for TLE subjects with left hippocampal atrophy. 
This transverse image shows the average, smoothed distribution of GM in a group of 
47 TLE patients with left hippocampal atrophy. In such an image voxels take a value 
between 0 (no GM present on average) and 1 (GM present in aIl cases). 
Registration 
Registration is the process by which two or more images are put in correspondence, 
i.e. aligned with respect to each other; when successful, it allows the comparison of 
spatial elements - and the signal within - on a point-by-point basis between the two 
or more Images. 
Scans from a single subject can be registered, either cross-sectionally across different 
modalities (intra-subject, inter-modality)( e.g. Tl and T2 images acquired in a single 
session) or longitudinally (intra-subject, intra-modality)(multiple images acquired at 
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different time points in the course of health or disease). Inter-subject registration 
allows image data from a group of subjects to be pooled. This is done for the 
purpose of group comparisons, or in order to compare scans from an individual to 
those of a group. Again, this can be performed cross-sectionally or longitudinaIly, 
within or across modalities. For a thorough review of image registration algorithms, 
the reader is referred to articles by Maintz et al. and Hill et al. (Maintz and 
Viergever 1998; Hill, Batchelor et al. 2001). 
Whether or not registration is successful is not in itself indicative of a particular 
pathological state. Rather, the strength of co-registered images resides in the ability 
to perform intra-subject or inter-subject comparisons, in a mono- or multi-modality 
fashion. Further, there is much information embedded in the registration process 
itself, which can be exploited using deformation-based morphometry (see next 
section). 
Registration is necessary step and a key enabling methodology in the study of health 
and disease. The co-registration possibilities are too numerous to discuss here: given 
Nindependently acquired modalities (T1w, T2w, PD, DTI, MTR, MRS, fMRI, 
SPECT, PET (one tracer each!), EEG, MEG, CT), one quickly reaches an 
astounding number of bi-modality combinations (in this case, 66). Of course, not aIl 
possibilities are necessarily relevant, as the informational value of certain modalities 
overlap. 
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Third level: MR model-based analysis 
Even data-driven techniques don't necessary get to the essence of the most often 
asked clinical question: does the subject have, or not, the disease? This often 
requires sorne form of meta or higher-order analysis before it can be distilled into a 
binary output suitable for clinical consumption. The following model-based 
techniques stand at the top of the image processing food chain, and typically result 
in a dichotomous output that can aid the diagnosis. 
Volumetry 
Volumetry, essentially the measurement of the volume of a particular bounded 
structure of interest (Figure 10), is the primary indicator of structure integrity. Due 
to its prevalence in the medicalliterature and its acceptance as a gold standard in 
many reports, it will be studied here in greater detail. 
Volumetry relies on accurate segmentation of the structures of interest, which is 
either performed manually or automatically; the two approaches will be discussed. 
While undeniably useful for understanding disease-driven changes in the chosen 
structure ( s), volumetry suffer from significant drawbacks related to its reliance on 
segmentation; the most important ones being lack of knowledge about interrelations 
between neighboring tissues, and the incapacity at spatially locating the detected 
volume change. 
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Figure 10 - Hippocampal and amygdala volumetry 
This image shows manually determined labels for the amygdala (yellow), 
hippocampal head (red), body (green) and tail (blue). This separation allows the 
analysis of sub-components of the He however, precise inter-individual boundaries 
are hard to define and assess with reliability. 
Source: N. Bernasconi 
Manual segmentation 
Manual segmentation techniques involve contour delineation of structures by one or 
more trained neuroanatomists. Stereology, Le. the technique of proper sampling 
based on the Cavalieri princip le (Cavalieri 1635), had been the preferred approach 
to calculating volumes before the advent of high-resolution images, where volumes 
can be reliably estimated directly from the (often isotropic) voxel count and slice 
thickness. 
While expert human intervention remains the most accurate segmentation technique 
and is considered the gold standard in many studies, serious drawbacks undermine 
its usefulness in a number of situations. The main difficulty resides in the subjective 
interpretation of anatomical variations. In the case of HC and AG for example, 
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differences in border definitions amongst research groups - and for that matter, 
amongst investigators of a same group - have hindered the comparison of results. 
The reported intra-class inter-rater overlap coefficients in a segmentation study of 
the HC are in the range K= 0.83-0.94 (Pruessner, Li et al.). Commonality in the 
definition of segmentation protocols is needed if results are to be compared. 
Secondly, research groups use different software packages to trace the targeted 
structure. Most employ 2D visualization tools for brain images, without the 
possibility of adjusting resolution or image contrast. A common 2D error is inter-
slice misregistration, which leads to non-smooth 3D surfaces. On the other hand, 
scalable 3D imaging is available, allowing for precise display and enlargement of 
regions of interest in coronal, sagittal and transverse orientation (Pruessner, Li et 
al.). Finally, manual processing is time-consuming, as the specialist must delineate 
the structures on a slice-by-slice basis. Taking the HC as an example, its longe st axis 
of 4-5 cm generates in the order of 40-50 slices with isotropie Imnf voxels. Hogan 
(Hogan, Mark et al. 2000) reports a total segmentation time of 2 hours per He. This 
result has been corroborated by Pruessner et al. (Pruessner, Li et al.) in their manual 
segmentation study. 
Automated segmentation 
Computer-based segmentation can be roughly divided in two broad approaches, 
based on the reliance or not on a priori information. 
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Forward segmentation approaches use a pre-defined template to match the 
new volume to achieve segmentation. In most cases experts are required to 
initialize the segmentation process by choosing landmarks. The matching 
process can be done in the way of an initial contour which will be propagated 
through sorne form of elastic matching onto the image until a proximity 
criteria is maximized. An example of this technique is the High-Dimensional 
Brain Mapping technique using fluid transformations, proposed by 
Christensen (Christensen, Joshi et aL). Other techniques, such as the Active 
Shape Model of Cootes and Taylor (Cootes, Taylor et aL), will rely on the 
placement of landmarks on the image to derive a model that is then globally 
deformed to match sorne intensity features of the new image. 
Backwards segmentation, on the other hand, can be thought as a reversion of 
the original paradigm. In those cases the new image is registered through 
various means unto a reference volume; atlases that have been previously 
defined on the reference volume can be propagated back unto the new 
subject, using the inverse transformation matrix. This paradigm can be 
observed in Thirion's demons (Thirion) and Collins' ANIMAL (Collins, 
Holmes et al.) algorithms. 
While objective and repeatable, automated segmentation of structures is not yet 
perfectly accurate, as evidenced by the reduced overlap with expert-based manual 
segmentation (Duchesne, Pruessner et al. 2002). 
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Morphometry 
Voxel-based morphometry 
Voxel-based morphometry (VBM) consists in the statistical analysis of generalized 
linear model (GLM) results performed on a voxel-by-voxel basis on combined 
cohorts of co-registered subject imaging data. The procedure has been used 
extensively for the study of GM or WM concentration volumes across subjects, and 
originates from the study of longitudinal activation maps in fMRI. In fact, one of the 
most popular standard software package for VBM is that of Ashburner et aL, 
(Ashburner and Friston 2000), which consists in an adaptation of their statistical 
parame tric mapping (SPM) technique, initially designed for functional activation 
(fMRI, PET) analysis. The method used in this thesis, called fMRIStat, was 
developed by Worsley et al. (Worsley, Marrett et al. 1996) for the same purpose. 
The standard approach involves co-registering images in a linear and/or non-linear 
fashion to improve the spatial co-location of brain structures; then tissue (GM, WM) 
are segmented into maps, spatially smoothed to form so-called "concentration" 
maps, with the understanding that they do not represent an absolute measurement 
of cell body counts or axonal densities, but rather an approximation of the likelihood 
of finding GM or WM in that area. Parameters of a generallinear model are 
estimated at each voxel, across subjects, possibly with addition al co-variates if 
applicable (e.g. age, sex). Voxels with statistically significant differences are 
identified based on a threshold corrected for multiple comparisons. Rather th an 
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using Bonferroni correction, fMRIStat relies on Gaussian Random Field theory for 
this correction (Worsley, Marrett et al. 1996). The final result is a volume containing 
only those voxels (or peaks) in which there are statistically significant differences 
between the tissue concentrations for the groups under study (see Figure 11). 
VBM's detection accuracy is limited by sources of spatially dependent and 
independent noise that compromise the statistical results. Misregistration is a key 
factor which has been discussed (Ashburner and Friston; Bookstein; Davatzikos 
2004) and addressed using linear and nonlinear registration in recent VBM 
implementations (Ashburner and Friston 2000); fMRIStat allows users to decide 
which degree of normalization should take place. 
Smoothing is generally used as a panacea to account for local misregistrations in the 
analysis, reduce noise in the input data and make the GM!WM concentrations 
normally distributed. This in turn improves the detection of regions of differences 
but cornes at the cost of decreasing localization accuracy. The size of the smoothing 
kernel should be matched to the expected difference between groups (Ashburner 
and Friston 2000). 
In order to report ensembles, or clusters, of differing voxels, as opposed to peaks, 
the issue of data nonisotropy must be successfully resolved (Worsley, Andermann et 
aL). Concentration volumes of GM / WM are highly nonisotropic since the noise 
compone nt has nonconstant smoothness. One needs to correct the image and make 
the data isotropic in a statistical sense (Worsley, Andermann et al.) before assessing 
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results. Whereas many studies do not explicitly mention such correction, one must 
take care to incorporate a methodology of the kind proposed by Salmond (Salmond, 
Ashburner et al. 2002) or Worsley (Worsley, Andermann et al.) before reporting 
c1uster statistics. These authors overcome nonisotropy by measuring c1uster size in 
resels - resolution elements - rather than voxels. This is shown below, where the total 
c1uster size S equals the summation of resels at these voxels i , part of c1uster cl, 
above the c1uster t-statistics threshold. Unitless resels are calculated by taking the 
ratio of the voxel volume dx dy dz in mnt over the cubed effective smoothing kernel 
full-width at half-maximum (FWHM) at that point, also in mnt (Worsley, 
Andermann et aL): 
s= 2 dxdydz 
iEcl FWHM; 
Deformation-based morphometry 
The term "deformation-based morphometry" will be used to refer to various 
techniques that have emerged in the literature whose common trait is the 
exploitation of the information contained within the high-dimensional, dense 
deformation field obtained by nonlinear registration of brain images. 
Assessment of shape differences across individuals used to be do ne via the analysis 
and tracking of landmarks (Bookstein 1984) , but those are difficult to identify 
reliably and consistently across the human brain. In essence, by calculating the 
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registration vectors required to align every point in an image with those of a 
common reference (Figure 12), the deformation field contains continuo us 
landmarks, and thus captures individu al brain shape characteristics that can be 
compared within a group in the reference space. 
Three morphometry techniques will be discussed: deformation, tensor, and surface-
based morphometry. 
Figure 11 - VBM in TLE 
Statistically significant peaks of gray matter decrease in patients with left and right 
temporal lobe epilepsy (L-TLE and R-TLE) in temporolimbic and frontal areas 
superimposed on the ICBM 152 average template of healthy controls for anatomical 
reference. 
Source (Bernasconi, Duchesne et al. 2004) 
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Figure 12 - Deformation field 
Computation of the nonlinear transformation required to align two images results in 
a dense deformation field, assessed at every voxel, capturing individual brain shape 
differences. 
Source: D.L. Collins 
- Deformation-based morphometry - When comparing groups, deformation-based 
morphometry uses registration-derived deformation fields to identify differences in 
the relative positions of structures within the subjects' brains. The 3D vector 
transformations can be analyzed as a multivariate statistical inference problem and 
solved using Hotelling's P statistic (Thompson and Toga 1997); the result can be 
turned into a probabilistic atlas of deformations for a group of individuals. 
Ashburner and Friston (Ashburner and Friston 2000) point out that such statistics 
based on the displacement field do not directly localize regions within different 
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structures, but rather identify brain structures that have translated to different 
positions. 
- Tensor-based morphometry - In those methods differences in the local shape of 
brain structures are derived from a tensor field (Chung, Worsley et al. 2001; Shen 
and Davatzikos 2003). By definition, the Jacobian of the deformation is the volume 
of the unit-cube after the deformation (Chung, Worsley et al. 2001). Assuming that 
one can find the deformation field at any voxel, volume change can thus be detected 
at a voxellevel. In tensor-based morphometry (Ashburner and Friston 2000), the 
nine components of the Jacobian form scalar fields used to measure the second-
order morphological variabilities. The advantage of this technique over the classical 
MRI-based volumetry is that it does not require a prioriknowledge of the region of 
interest to perform the morphological analysis. Moreover, the deformation-based 
volumetry improves the power of detecting the regions of volume change within the 
limits of the accuracy of the registration algorithm (Chung, Worsley et al. 2001). To 
detect statistically significant local volume change, the Trandom field with its P 
value of the maximum field can be used (Chung, Worsley et al. 2001). 
- Surface-based morphometry - Finally, the anatomical variations associated with 
the deformation of a surface can be statistically quantified; studies have looked at 
individu al structure surfaces (Csernansky, Wang et al. 2000; Wang, Joshi et al.; 
Csernansky, Schindler et al. 2004), and others have applied this idea to the whole 
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cortex, modeled as a continuous sheet (MacDonald, Kabani et al. 2000; Chung, 
Worsley et al. 2003; Lerch, Pruessner et al. 2005). 
High-dimensional classification 
Only recently have classification methods emerged that use high-dimensional 
information (e.g. multiple 3D image features), typically reduced to a lower 
dimensional domain. 
Techniques proposed by Golland et al. (Golland, Grimson et al. 2005) and Joshi et 
al. (Joshi, Pizer et al. 2002) rely on shape characteristics of single objects. So far 
the se methods have shown value with discrete structures, easily identifiable, and with 
simple topologies: the hippocampus (Joshi, Pizer et al. 2002), hippocampus and the 
corpus callosum (Golland, Grimson et al. 2005), and the thalamus (Csernansky, 
Schindler et al. 2004). Those method become limited by much the same 
considerations as volumetry: 1) they do not represent interactions between 
neighboring, and biomechanically dependent, tissue; and 2) they are prone to being 
misled by segmentation errors and inter/intra-rater variability, due to inconsistent 
formulation of the anatomical boundary, reduced contrast (which happens 
frequently in multiple pathologies), and possibly poor segmentation technique. 
The approach taken by Lao et al. (Lao, Shen et al. 2004 )as well as Liu et al. (Liu, 
Teverovskiy et al. 2004) most closely resembles the methodologies proposed in this 
thesis. They both rely on information from a wide image are a, as opposed to a 
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specific structure; they extract information directly from image parameters, and 
attempt the classification on the reduction parameters. 
Lao et al. use wavelet decomposition of mass-preserved GM, WM and CSF 3D 
concentration maps as input to a Support Vector Machine classifier. Liu et al. uses 
2D texture features on selected slices fed to a linear discriminant classifier. 
Other techniques 
New methods continuously emerge as more interdisciplinary collaborations exploit 
various elements of mathematical and computer vision theories, and older ones are 
continuously improved and brought in to aid the diagnosis of various neurological 
diseases. Those include medial sheets models (Joshi, Pizer et al.; Styner and Gerig; 
Bouix, Pruessner et al. 2005), 2D-cortical flattening (Drury, Van Essen et aL 1996; 
Fischl, Sereno et aL 1999; Van Essen, Drury et al. 2001), and sulci/gyri mapping. The 
latter attempts to capture the normal topological variability in sulcal and gyral 
patterns in the human cortex, considered by many to be one of the biggest challenges 
facing neurological imaging in the current era. Manual extraction of common 
topologies (Ono, Kubik et al. 1990) , along with automated techniques (Thompson, 
Schwartz et al. 1996; Le Goualher, Barillot et al. 1997; Lohmann and von Cramon 
2000; Cachia, Mangin et al. 2003; Mangin, Riviere et al. 2004) are trying to capture 
the full extent of normal variability (Dameron, Gibaud et al. 2004). 
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Case studies 
We will now turn our attention to outstanding problems within two neurological 
diseases who se characteristics make them ideal test cases to illustrate the capabilities 
of the methodologies developed in this thesis: temporal lobe epilepsy (TLE) and 
Alzheimer's dementia (AD). 
Case study: temporal lobe epilepsy 
Etiology and treatment 
Microscopically, the most commonly described findings in MTLE are neuronalloss 
and gliosis of the hippocampus (He) and the parahippocampal (PHe) region 
(Falconer, Serafetinides et al. 1964). The central goal of surgery in MTLE has been 
the removal of this affected tissue, in an attempt to remove the site of seizure 
generation and thus achieve seizure control. As the understanding of the disease and 
image-guidance improved (Olivier, Alonso-Vanegas et al. 1996), MTLE surgery has 
moved from complete to partiallobectomy (anterior temporallobectomy or ATL), 
to selective amygdalo-hippocampectomy (SAH) (Olivier 2000). The latter approach 
consists in the resection of the amygdala (AG) and He complex, and often parts of 
the neighboring structures, such as the entorhinal cortex (Ee). Vickrey et al. 
(Vickrey, Hays et al. 1995) have assessed MTLE surgery success and demonstrated 
that surgery patients had greater de cline in average monthly seizure frequency and 
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took fewer antiepileptie medications, when compared to patients that had not 
received surgery. 
Imaging characteristics 
HC neuronalloss found in surgie al speeimens obtained from patients with 
pharmacologically intractable TLE has been shown to correlate with HC atrophy on 
volumetrie Magnetie Resonance Images (MRI) (Caseino, Jack et al. 1991). MRI 
studies in MTLE have also shown volume reduction ipsilateral to the side of the 
seizure focus in the PHC region (Bernasconi, Bernasconi et al. 2003); there is also 
evidence for extra-limbic and extra-temporal gray and white matter reductions in 
epilepsy patients when compared to controls (Woermann, Free et al. 1999; Keller, 
Mackay et al. 2002; Bernasconi, Duchesne et al. 2004). Nearly 80% of MTLE cases 
exhibit lateralized HC atrophy, strongly correlated with an ipsilateral seizure focus 
(see Figure 13), while approximately 5% of intractable TLE patients demonstrate 
bilateral atrophy without significant differences between hemispheres, and the 
remaining 15% of cases have non-atrophic HC (Bernasconi, Bernasconi et al. 2003). 
Outstanding challenges 
Lateralization of seizure focus in TLE 
Presurgical evaluation of patients with refractory epilepsy is a necessary step, whose 
main outcome is the localization of the resection target. This thesis addresses the 
problem of patients with seizure focus, or foei, within the medial temporal lobes; one 
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of these will be selected as the resection target, a process referred to as lateralization 
01 seizure locus. 
Figure 13 • Tl images of TLE 
(Top) Sagittal and coronal Tl MRI of normal control subject (Middle) 
Left hippocampal atrophy is readily noticed on these images (same orientation as 
above) of a TLE patient as a enlargement of the lateral ventricles, along with 
increased atrophy of the hippocampal head (red lin es intersection). (Bottom) On the 
other hand, around 15% of intractable TLE patients exhibit normal hippocampal 
volumes, therefore making lateralization impossible in those cases on the basis of 
He volumetry alone. This is exemplified in these Tlw MR images (same orientation 
as ab ove) of a TLE patient with hippocampal normal volume. 
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As mentioned, HC atrophy is strongly correlated with an ipsilateral seizure focus. 
Volumetry of the hippocampus has therefore been used in many centers for pre-
surgi cal evaluation however, it is a time-consuming, manual procedure requiring 
expert intervention, and subject to the drawbacks outlined in a preceding section. 
Further, approximately 20% of intractable TLE patients demonstrate either bilateral 
atrophy or normal volumes, making volumetry-based lateralization impossible in 
these cases. The alternative to HC volumetry is to proceed with surgically implante d, 
intra-cranial electro-encephalography (sEEG). While very sensitive, sEEG is a very 
invasive approach that is time and resource consuming, notwithstanding its impact 
on the patient's quality of life. 
Our goal is to lateralize the seizure focus in TLE patients with and without 
hippocampal atrophy on cross-sectional Tl-weighted MRI. The ability to perform 
accurate lateralization in a non-invasive manner could significantly alter CUITent 
clinical practice. This forms the subject of Chapter 4 of this thesis; the methodology 
that has been developed and used to achieve lateralization is appearance-based 
classification, and is described in Chapter 3 in greater details than found in the 
published manuscript. 
Prediction of outcome for TLB surgery 
While the goal of surgery is to eradicate seizures, approximately 20 to 30% of 
patients are not seizure-free following standard surgery (Antel, Li et al. 2002). 
Predicting surgical outcome in the treatment of medial temporal lobe epilepsy 
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(MTLE) remains an outstanding challenge. Since the advent of high-resolution 
neuroimaging, there have been numerous attempts at finding structural or functional 
markers that can be used as a predictive surrogate of surgical outcome, but no 
completely reliable indicator has been found to date. 
While the majority of patients undergoing surgery have positive outcome, it is 
difficult at present to de termine a priori if the procedure will be successful. MRI has 
been used to predict surgical outcome in ATL (Jack, Sharbrough et al. 1992); 
(Radhakrishnan, So et al. 1998) (Kobayashi, Lopes-Cendes et al. 2001) with an 
accuracy ranging from 62% to 96%(Gilliam, Faught et al. 2000). Fewer authors have 
attempted to predict surgical outcome for SAH based on MRI: Abosch et al. 
(Abosch, Bernasconi et al. 2002) have used MRI, and Antel et al. (Antel, Li et al. 
2002) have used MRI in combination with MR spectroscopy. The seizure-free 
classifier developed by Antel correctly predicted the surgical outcomes of 39 of 52 
(75%) of patients who became seizure free and 21 of 29 (72%) of patients who did 
not. 
There remains a need to increase the accuracy of non-invasive, pre-operative 
surgi cal outcome prediction in SAH. This represents the goal of the work presented 
in Chapter 5; more information on the necessary background is included in that 
chapter, and the voxel-based classification methodology used to achieve this goal is 
described in detail in Chapter 3. 
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Case study: Alzheimer's dementia and Mild 
Cognitive Impairment 
Etiology and treatment 
Alzheimer's dementia (AD) is a progressive neurodegenerative disorder associated 
with disruption of neuronal function and graduaI deterioration in cognition, function, 
and behavior (Khachaturian 1985) . The progression of AD is graduaI, and the 
average patient lives 8 to 10 years after onset of symptoms (Petrella, Coleman et al. 
2003). It is the most common cause of dementia in the elderly (65 years and older), 
responsible for 75% of aIl dementia cases (Group 2000; J. R. PetreIla 2003). As the 
globallife expectancy rises and populations age, the prevalence of AD is expected to 
triple over the next 50 years (Carr, Goate et al. 1997); improving care while reducing 
the socio-economic impact of AD is therefore an important and necessary topic of 
research. 
The etiology of AD can be summarized as neuronal dysfunction and eventualloss 
due to abnormal accumulation of Aj3 and Tau proteins (Thal, Rub et al. 2000; Thal, 
Rub et al. 2002; Giannakopoulos, Herrmann et al. 2003). Neuropathological studies 
in AD have shown in fact that brain degeneration occurs very early in the course of 
the disease, even before the first clinical signs, in certain regions such as the medial 
temporal lobe (MTL)(Cummings, Pike et al. 1996; Nagy, Hindley et al. 1999; Thal, 
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Rub et al. 2000; Thal, Rub et al. 2002; J. R. Petrella 2003). Microscopically the 
strongest predictor of premortem cognitive dysfunction appears to be the relative 
area of entorhinal cortex occupied by beta-amyloid deposition(Cummings, Pike et al. 
1996). To date however the diagnosis of clinically probable AD can be made with 
high accuracy in living subjects only once the stage of dementia has been reached, 
and requires clinical, neuropsychological and imaging assessments (Petrella, 
Coleman et al. 2003). It can only be confirmed by postmortem histopathology (Risse, 
Raskind et al. 1990). 
Imaging characteristics 
AD is associated with progressive cerebral atrophy, which can be seen on MRI with 
high resolution (Fox and Schott 2004)(see Figure 14). This atrophy is preferentially 
located in early AD in the temporal and limbic areas (hippocampus, temporal pole, 
insula, with co-occurring enlargment of the lateral ventricles), while in later disease 
stages, the rest of the cortex (frontal, occipital lobes) is affected, with relative sparing 
of the sensori-motor cortex (Karas, Burton et al. 2003; Thompson, Hayashi et al. 
2003; Thompson, Hayashi et al. 2004). 
Longitudinal analysis of MRI has been proposed to differentiate between aging, 
MCI, and AD (Fox and Freeborough 1997; Fox and Schott 2004) with high accuracy 
however, by its very nature such a method implies a delay between scans before any 
assessment can be made. Cross-sectional measurements of the hippocampus have 
achieved classification between controis and AD patients (90.7%), and between 
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individuals with MCI and AD patients (82.3%) (Pennanen, Kivipelto et al. 2004). 
Longitudinally-assessed MR-based atrophy rates of the hippocampus is also a 
reliable indicator of the state of the disease (Jack, Slomkowski et al. 2003). 
Figure 14 - Tl weighted images of AD patients 
Those images perpendicular to the long axis of the temporal lobe show the different 
degrees of medial tem porallobe atrophy (MT A), according to the visual rating scale 
proposed by ScheItens (A) absence of atrophy (MTA=O); (B) minimal atrophy 
(MTA=l); (C) mild atrophy in the right side (MTA = 2), severe atrophy on the left 
(MT A=4); (D) moderate atrophy (MTA=3); and (E) severe atrophy (MT A=4) 
(Source: (Bastos Leite, ScheItens et al. 2004) 
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Outstanding challenges 
Dillerentiation 01 AD and MCllrom normal aging 
The difficulties in early clinical detection lie for the most part in the similarities 
between cognitive impairment due to normal aging (NA) processes and the initial 
manifestations of AD (Chetelat and Baron 2003). The ability to differentiate AD 
from NA, in an objective, repeatable and accurate fashion, would act as a potent 
factor in the therapy management of these individuals. Additional background on 
this topic is included in Chapter 6, where the differentiation of AD and MCI from 
NA is attempted using the same appearance-based technique (described in Chapter 
3) that was used for lateralization of seizure focus in TLE in Chapter 4. 
Barly prediction 01 MCI progression to AD 
Mild cognitive impairment (MCI) is a condition referring to patients with significant 
but isolated memory impairment relative to subjects of identical age (Flicker, Ferris 
et al. 1991; Petersen, Doody et al. 2001). MCI individuals are considered an at-risk 
group for progression to Alzheimer's dementia (AD)(DeCarli 2003; Dubois and 
Albert 2004). Early prediction of progression to AD in MCI patients is therefore an 
important research goal that is met in Chapter 7, and which may have significant 
impact on the therapy course for these individuals. Again, further relevant material 
is included in the introduction of this manuscript, and the appearance-based 
classification methodology is described in the next chapter. 
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Chapter 3 
Methods 
ln this chapter, two novel image analysis techniques are introduced as the 
methodological contributions of this thesis. Their application to existing diagnostic 
problems in classification and prediction of neurological diseases will be discussed in 
subsequent chapters. 
There are three major design considerations underlining both techniques. The first 
decision is to move from structure-centric approaches to one based on a large 
volume of interest (VOl), hoping to inerease the informational value (see Figure 15). 
For example, in volumetrie studies of the He, between 3000 to 4000 voxels are 
compressed in a single scalar measurement, expressed in mnt. Even though essential 
information about disease processes can be gained through volumetrie studies (e.g. 
atrophy rates in AD), much information is lost in this process; the location of 
atrophy being a prime example in this case. In the methodologies being proposed 
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here, more voxels are processed and linearly modeled to yield additional important 
information towards our classification/prediction goal. 
Figure 15 - Structure-centric vs. volume of interest approaches 
Volumetry of individu al structures (e.g. hippocampus, in green) has been used 
extensively in the analysis of Medical images but otTers limited informational value. 
A large, non-specifie 3D volume of interest (shown here in blue) would contain 
additional information potentially useful for classification and prediction. 
The second design choiee is a move from a priori knowledge-based approaches to a 
completely data-driven technique. Our goal is not to preselect a structure for 
analysis but rather to investigate the relationship between voxels within the volume 
of interest, as they relate to the pathology. This is the common biologieal hypothesis 
underlying the two methods to be presented in this section: that differences in MRI 
signaIs are likely due to pathology-related microscopie and macroscopic changes or 
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alterations in the various tissues within these voxels. It is therefore a conscious 
decision to not presuppose the pathological effect on the signal intensity, or its affect 
on any structure. Again, we can contrast this choice with volumetry, which works on 
the basic assumption that sorne pathologies result in cumulative tissue loss, 
measurable as a dichotomous change in boundary voxels and therefore structure 
volume. It is likely however that these pathologies alter the signal intensity in an 
incremental fashion, and thus, by compressing continuous change into a single 
binary step, one reduces the dynamic range and gets low sensitivity. A data-driven 
approach, where image features are extracted without a priorihypothesis, allows the 
modeling of subtle signal changes that, arguably, may be harder to interpret 
biologically, but serve our ultimate purpose of classification and prediction of 
pathological effects by virtue of being potentially more sensitive. 
The third major consideration is to restrict the analysis to cross-sectional data, as 
opposed to seriaI or longitudinal studies. This stems from a clinical need in rapid 
assessment of pathological effects in patients, but implies that both methodologies 
will rely on individual-to-group comparisons for classification and prediction. This of 
course assumes that the disease effect within each group will be sufficiently 
homogeneous. One way to improve upon this homogeneity in the four applications 
presented in Chapters 4 to 7 was to carefully assign patients in cohorts with similar 
age and/or clinical condition. 
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It should be stated at this point that the first methodology (appearance-based 
classification) was sufficiently developed and its application satisfactorily proven in 
TLE and AD as to warrant protection for intellectual property, resulting in a patent 
application to the United States Patents and Trademarks Office on 19 Nov. 2004 (no 
10/990396). 
MRI acquisition and initial image processing 
Pre-operative 3D T1-weighted (T1w) MR images in aIl of the foIlowing studies were 
acquired on multiple 1.5T scanners with different sequences however, initial image 
processing steps were common to aIl datasets and will now be described. 
Global MRI scans were first corrected for intensity non-uniformity due to scanner 
variations (SIed, Zijdenbos et al. 1998), and then globally aligned using a 9-degrees 
of freedom (DF) linear registration (Collins, Neelin et al. 1994) into a standard 
reference space. Following registration the data was resampled onto a 1mm isotropic 
grid (Collins, Neelin et al. 1994). The reference image used for the linear 
registration and resampling was the ICBM 152 T1-weighted target, a voxel-by-voxel 
average of the 152 normal subjects previously registered in the Talairach-like 
stereotaxic space in the context of the ICBM project (Mazziotta, Toga et al. 1995). 
This standard pipeline has been in use at our Institute and is described elsewhere 
(Zijdenbos, Forghani et al. 2002)(see Figure 16). 
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Figure 16 - Initial image processing pipeline 
Appearance-based classification (ABC) 
Unear 
reg istrati on 
The first technique presented is based on the concept of appearance, which 
encompasses not only the shape of the structure or volume of interest, but also its 
grey-Ievel intensities. 
The field of appearance-based analysis in medical imaging owes much to the 
contemporary work of Cootes and colleagues, whose first seminal publication on the 
topic of point distribution models (PDM) dates back to 1991 (Cootes, Cooper et al. 
1991). This segmentation concept was extended to Active Shape Models (Cootes, 
Taylor et al. 1995), which creates a model of the shape of the structure of interest 
that describes both typical shape and typical variability, using statistical analyses of 
previous examples from a training set. Finally, Active Appearance Models (AAM) 
were introduced in 1998 (Cootes, Edwards et al. 1998) in part to further their 
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original method and make more use of the intensity information in the images. 
Knowledge about the shape is incorporated into the AAM via a PDM. The intensity 
under the landmarks in the PDM is sampled and used to generate a gray-level model. 
The two models-gray-Ievel and PDM-are concatenated, and a supermodel is 
created from principal components analysis (PCA). The resulting principal 
components that explain the most variation in the supermodel are then selected. 
Those principal components can be considered as eigenmodes of appearance 
variation, embedding shape and intensity variability. 
Their goal in developing the PDM, ASM and AAM was to match a full, 
photorealistic model directly on a new image instance by minimizing the difference 
between the image under interpretation and one synthesized by the model. We have 
retained the concept of appearance (intensity and shape) but have widen its 
applicability from segmentation (Duchesne, Pruessner et al. 2002) to classification. 
The method can be summarized as follows (see Figure 17) and is described later in 
subsequent paragraphs. First, from processed data (A) we generate a non-
pathological appearance eigenspace (B) from a large training group of young, 
neurologically healthy training subjects (N = 152). This multidimensional 
eigenspace is created by uniting results from four distinct PCA of (i) linearly 
registered intensity images of the left and right VOIs from Tlw MRI of these 
training subjects (C); and (ii) an approximation of the Jacobian of the deformation 
fields for the same VOIs (D), fields obtained via non-linear registration to a 
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common reference image. Secondly, VOIs from patients are projected in the 
multidimensional appearance eigenspace created (E). The normality of the 
distribution of the projected eigencoordinates is assessed using quantile plots and 
Shapiro-Wilke statistics. The last step (F) consists in linear discriminant analyses 
(LDA) in a leave-one-out, forward stepwise approach, using eigencoordinates in the 
reference appearance eigenspace to classify the patients. While the eigenspace may 
not be optimal to represent the patient population, it forms the basis for a 
comparative evaluation of the different groups that leads to their classification. 
The methodological details are elaborated in the following sections. The reader will 
note that sorne of this work was first presented by the author as preliminary works in 
progress in conference proceedings (Duchesne, Bernasconi et al. 2002; Duchesne, 
Bernasconi et al. 2003), and finally as a peer-reviewed article (Duchesne, Bernasconi 
et aL), which forms the next chapter of this thesis. 
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Figure 17 - ABC methodological pipeline 
Volume of interest 
As mentioned, the approach is not structure-centric, but rather based on a regional 
analysis within a 3D VOL Two VOIs were selected in fact, centered on the left 
(Figure 18) and right medial temporal lobe respectively, using Talairach-like MN! 
space coordinates (start coordinates x = [-53, + 2] for the left and right side, y = 
-53 and z = -52). Each VOl measured n = 55 X 82 X 80 = 360800 voxels. The 
VOl was selected so that its extent captured the hippocampus and neighboring MTL 
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structures, such as the parahippocampal gyrus, irrespective of normal inter- and 
intra-individual variability. 
Figure 18 - Intensity and shape features within the left VOl in ABC methodology 
(Left column) Transverse, coronal and sagittal whole-brain views for TLE subject 
#28 with LHA. (Middle column) Identical views through the VOl, as defined in MNI 
space on the left MTL (red boxes on whole-brain views). (Right column) Identical 
views trough the trace VOl for the same subject. Green voxels do not move. From 
green to white (maximum) via yellows and reds indicate increase or expansion. 
From green to black (minimum), via blues and purples indicate decrease or 
contraction. The direction of movement is defined as the deformation which the 
subject's VOl seen in (A), (C) and (E) must accomplish in order to align with the 
corresponding VOl extracted from the reference volume. Contraction represents 
atrophy in the case of tissue. Notice in the transverse view in (A) and (B) the 
contraction of the lateral ventricular space, necessary to correct its enlargement, 
also noticeable in (E) and (F), while in (C) and (D), the coronal view displays the 
superiocentral shift due to hippocampal atrophy. 
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Intensity data 
Two image features at each voxellocation were retained for modeling. The first 
feature used in our classifier is grey JeveJ intensity, denoted by script g. Scanner 
output volumes are preprocessed in the manner described in the preceding section 
on initial image processing, and VOIs were extracted based on stereotaxic 
coordinates. To further reduce positional variations, which would propagate as 
unwanted noise in the morphometric modelling, a second local affine transformation 
(DF = 12) is applied to co-register the individual subject's VOl with the 
corresponding VOlon the ICBM 152 target. Finally, VOl intensity mean is also 
linearly scaled to the reference target. The input to the intensity model therefore 
consists in the rasterized intensity data from the VOIs processed in this fashion 
(Figure 18). Using intensity features from MRI raises the question of calibration 
and normalization. Absolute intensities are rarely used in MRI, since they vary with 
machine calibration, shimming, and patient-induced variations. We have tried to 
limit those variations by (1) using the same scanner for every individual in the study; 
(2) ensuring that the same quality assurance procedures were followed for each 
acquisition; and (3) scanning the patients in random group order. 
Shape data 
The second feature is the trace, denoted by script t. The trace is the first-order 
approximation of the Jacobian of a non-linear registration-derived deformation field, 
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which maps a subject to our reference ICBM target, and thus forms an estimate of 
local volume change. 
Nonlinear registration attempts to match image features from a source volume to 
those of the reference image at a locallevel, typically in a hierarchical fashion, with 
the aim of reducing a specifie cost function. Whereas many nonlinear registration 
processes exist, the one chosen for this study was ANIMAL (Collins and Evans 
1997). This algorithm attempts to match image grey-Ievel intensity features at a local 
level (voxel) in successive blurring steps, by maximizing the cross-correlation 
function of voxel intensities between the source and reference images. The result is a 
dense deformation field capturing the displacements required to align aIl voxels 
within the subject VOl with those of the reference image. In our application, we 
estimate the nonlinear transformation between the VOl of an individual subject to 
the ICBM 152 target VOL Even though the method does not require that the same 
VOl be used for both trace and intensity input, we have used the same in the four 
studies proposed in this thesis. 
Our implementation of trace calculation was discussed in (Janke, de Zubicarayet al. 
2001) and follows the notation developed by (Chung, Worsley et al. 2001). If U is the 
displacement field which matches homologous points between two images, then the 
local volume change of the deformation in the neighborhood of any given voxel is 
determined by the Jacobian J(Chung, Worsley et al. 2001), which is defined as 
au J(x,t) = det(l +-) 
ax 
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where 1 denotes the identity matrix and au is the 3 X 3 displacement gradient 
ax 
matrix of U. For relatively small displacements (Le. for small rotations) 
J "",1+ tr(VU) 
as suggested by (Chung, Worsley et al. 2001). Rence the trace tr(VU) represents a 
crude yet indicative measure of local volume change. When the change is near zero 
in the neighborhood of x, the deformation is incompressible so there is no volume 
change. Rowever, if the trace is positive, the volume increases while when negative, 
the volume decreases after the deformation. 
It could be argued that the determinant should be used, rather than the trace; first, 
the determinant measures a biologically meaningful quantity, that is brain tissue 
volume change; second, the latter is the sum of the eigenvalues whereas the former 
is their product. In the case of brain deformations, the numerical difference between 
the two measurements would be small. Our computing the determinants for each 
reference MRI and comparing them with the trace volumes proved this fact. The 
average difference between trace and determinant shows a mean of 0.006 (indicative 
of no bias) and a standard error of 0.011, pointing to a limited variability between 
the two measures. The trace of the Jacobian was retained for our modeling since the 
calculation time was one to two orders of magnitude faster than the determinant at 
the time; it is proposed to move to determinant calculations as a marginally better 
approximation of local volume change in the future, and as a way of ensuring that 
one extracts biologically meaningful information from the data. 
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The input to the PCA therefore consists in rasterized vectors of calculated trace 
volumes, for which examples are shown in Figure 18. 
Multidimensional spaces 
Principal Components Analysis (PCA) is used to reduce the dimensionality of the 
input data (intensity g, trace t) and generate linear variation models based on the 
N=152 datasets from our ICBM normal control subjects. 
Each intensity or shape VOl can be represented by a single point in an n 
dimensional space (n-D), where n is the number ofvoxels in the VOL Thus the 
ensemble of reference intensity or shape VOIs gives a cloud of points in this 
multidimensional space. It is assumed that these points lie within sorne region of the 
space, which are called "Allowable Domains" (similar to "Allowable Shape 
Domains" in Cootes' work (Cootes, Edwards et al. 2001» and that the points give an 
indication of the form and size of this region. Every point within this n-D domain 
relates back to an intensity or shape VOl whose characteristics are broadly similar to 
that of those in the original reference set upon which the Domain has been defined. 
The following mathematical reasoning is aimed at constructing independent linear 
models for each intensity or shape Allowable Domains. As such, it is given in its 
general form, with a notation identical to that developed by Cootes et al. (Cootes, 
Edwards et al. 2001). 
Given a set of N reference examples Xi> the mean is calculated using: 
1 N 
x=-}:x. 
N· l ' ,-
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where Xi is the column vector of intensity or trace values for a given VOl instance, of 
dimension n. The principal axes of an ellipsoid fitted to the ensemble data can be 
calculated by applying PCA, where each Principal Compone nt (PC) axis yields a 
direction of a mode of co-variation, a way in which the intensity or shape instances 
tend to move together. 
For each example i in the reference set, the deviation dxi from the mean Xi is 
calculated, where 
-
dxi = Xi-X 
ln order to find the basis for this space, the n x n covariance matrix, S, is calculated 
using: 
1 N T 
s=- ~dx.dx. N~ , , 
i-I 
The principal axes of the hyper-ellipsoid, giving the modes of variation of the 
intensity or trace examples, are described by Pk (k= 1,2, . .. n), the unit eigenvectors of 
Ssuch that: 
where Àk is the k-th eigenvalue of S, Àk ~ Âk+l. 
The ensemble of PCS from the left and right VOl grey-Ievel intensity models defines 
an Allowable Grey Domain G as the space of aIl possible elements expressed by the 
intensity eigenvectors Ào. Likewise, an Allowable Trace Domain T is created as the 
space of aIl possible elements expressed by trace eigenvectors Àr for the left or right 
VOIs. 
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Within the se Domains, linear models allow any new vector instance x, be it trace or 
intensityvectors from the left or right VOl, to be approximated by x, the mean 
normalised input vector; PXl the set of orthogonal modes of variation; and BXl the set 
of parameters: 
Each mode of variation is orthogonal to others within the same feature model. 
Covariances between features are not excluded, but most of them should be 
accounted for in the forward stepwise discriminant process. 
The assumption is made that the form of these Domains in a high dimensional space 
is approximately ellipsoïdal (Cootes, Edwards et al. 2001). It can be shown that the 
eigenvectors of the covariance matrix corresponding to the large st eigenvalues 
de scribe the longest axes of the ellipsoid, and thus the most significant modes of 
variation in the variables used to de rive the covariance matrix (Cootes, Edwards et al. 
2001). Most of these variations can usually be explained by a smaller number of 
modes, J, where J < < n and J < p. This means that if the n dimensional ellipsoid is 
approximated by an J dimensional ellipsoid, then the original ellipsoid has a 
relatively small width along axes with indexes J + 1 and greater (Cootes, Edwards et 
al. 2001). 
One method for calculating J is to chose the smallest number of modes such that the 
SUffi of their variances explains a sufficiently large proportion of À, the total variance 
of aIl the variables, where 
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ln order to know the variance of each eigenvector, or how each PC contributes to 
the description of the total variance of the system, the ratio of relative importance of 
the eigenvalue Àt: associated with the eigenvector kis used: 
where Tk is the fraction relative importance for eigenvalue Àt:, over the sum of aIl 1.., 
and p is the total number of eigenvectors. IncidentaIly, p= N-I in this 
implementation, adapted from that described in Appendix A of Cootes et al.'s 
technical report (Cootes and Taylor 2000). This algorithm reduces the 
dimensionality of the matrices to be estimated and hence ensures that substantial 
changes in VOl size can be easily accommodated. 
Aiming for a given percentage F of explained variation, one wants the smallest f 
eigenvectors such that the following condition is satiseizure focusied: 
F li + T2 + ... + Tf >-100 
The choice of threshold F will be dependent on the total amount of variation that 
the model is asked to represent. We de fi ne a restricted version of the domains G 
and T as G* and T*, such that 
G*CG 
T*CT 
where the upper bound on the dimensionality of G or T is p, as defined above, while 
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the upper bound for G* or T* is f, set by choosing the threshold F. 
ln aIl applications of this methodology herein, we proceeded in selecting a total of 
538 eigenvectors out of a possible (152 -1) x 4 = 604 for the four models (left/right 
intensity/trace VOIs) built from our reference group, corresponding to F=99.7% of 
the per-model variance. 
Rasterized vectors of the processed VOl intensity and trace data for each study 
subject are projected into Domains G* and T*, and thus form the eigencoordinate 
vectors. While a number of possible features can be calculated based on the 
distribution of the projected data, our classifier is based on the position along the PC 
axes. The distribution of eigencoordinates along any principal compone nt for a given 
population should be normally distributed and this normality is assessed via quantile 
plots and Shapiro-Wilke statistics. Classification, based on linear discriminant 
analyses of the eigencoordinate distributions, will be discussed in a subsequent 
section in this chapter. 
Methodological considerations 
Representation - Our approach has been to create a model eigenspace based on 
subjects from the ICBM database, in which we projected our cohorts of patients. 
While such a space built from young, neurologically healthy individuals may not be 
optimal to represent the test populations, it should be noted that our primary goal 
was to find an independent basis for a comparative evaluation of our study cohorts 
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and its subsequent classification, but not the best mathematical representation. This 
is exemplified in Figure 19, where a cartoon-like representation of our training set is 
drawn, aligned and centered with the first two principal components since they were 
extracted from that data. Our goal is to use this space for the separation of 
pathology #1 subjects into two groups, la and lb. While the space may not be 
optimal for pathology 1, it forms a reference basis built from young, neurologically 
healthy individuals, that can also be used for other pathologies, such as pathology #2 
that may or may not overlap with pathology #1. 
Pc:l 
G.-..1A 
-----.. PCI 
..... 
Figure 19 - Cartoon-like representation of classification of patient groups. 
The reference set is represented by the green ellipse, aligned and centered with the 
first two principal components since the eigenspace originates from these data. Our 
goal however is to use the same space for the separation of many pathologies. For 
example, pathology #1, while not optimally represented by the eigenvectors of the 
reference space, can still be separated in two groups, lA and lB. The same can be 
said of a second pathology, which may or may not overlap with the previous one. 
Using a normative space built from young, neurologically healthy individuals should 
give the ability to perform classification studies in multiple pathologies. 
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Independence - As the reference set is composed of ICBM subjects that are separate 
from the trial subjects, there is no issue of over determination in the creation of the 
reference space. Further, by using cross-validation trials, separating trial subjects 
into training and test sets, we ensured that there was no over leaming in the 
classification stage while maximizing the amount of information available in the 
trials subjects. 
Automation - The methodology is formulated to be simple, flexible, and easily 
scalable, allowing a number of possible features to be used without extensive 
reengineering. We achieved substantial data reduction, starting from a model of 152 
reference images (152 X 2 VOIs X 360800 voxels = 1.1 X 107 points in MRI space) 
down to 538 eigencoordinate points in a predefined PC space. 
RA VENS-based classification - There are similarities and differences between the 
ABC methodology and the classification method proposed by Lao et al. (Lao, Shen 
et al. 2004). Both reduce a high-dimensional input vector and attempt the 
classification on the reduction parameters, albeit using a different technique (PCA 
for ABC; wavelet de composition for Lao et aL). As measured in Liu et al. (Liu, 
Teverovskiy et al. 2004), the strength of the classification does not reside in the 
optimality of the classification function but rather in the appropriate choice of 
features. It is there that the main difference between the two techniques resides. Lao 
et al. uses mass-preserved GM, WM and CSF maps, which are essentially trinarized 
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versions of the original intensity image, whereas the ABC technique makes use of 
the full dynamic range of the data, and therefore has access to addition al 
information. Further, the ABC technique explicitly models local volume changes, as 
opposed to its implicit effect in the mass-preserving framework of the RA YENS 
maps (Davatzikos, Genc et al. 2001). 
VBM-based classification (VBM) 
The second methodology that forms part of this the sis is based on the well-known 
statistical analysis approach called voxel-based morphometry (VBM). Previously 
used solely for the purpose of finding and locating group differences in anatomy, it is 
extended here to the classification of individual MRIs based on group patterns and 
therefore constitutes to our knowledge one of the only application of VBM for 
assessment of images from a single individual. 
Detection of concentration differences related to grouping 
variable 
The primary objective is to determine regions of gray and white matter 
concentration differences that are related to the grouping variable. To this end 
multiple between-group VBM studies are performed (Ashburner and Friston 2000), 
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on combined cohorts of co-registered subject image data. The software package used 
in this thesis is fMRIStat from Worsley et al. (Worsley, Marrett et al. 1996). 
The approach involves co-registering images in a linear fashion (affine registration, 9 
DF) to improve the spatial co-location of brain structures, with a common reference 
target of 152 young healthy volunteers, the so-called MN! brain or ICBM 152 
average (Mazziotta, Toga et al. 1995). Brain tissue is then segmented (GM, WM) in 
volumes (Zijdenbos and Dawant 1994) where each voxel is assigned to one class. 
GM!WM maps are then blurred using an isotropic Gaussian kernel of lOmm full-
width at half-maximum, under the assumption that this spatial kernel size matches 
the expected changes (Ashburner and Friston 2000). In those smoothed 
"concentration maps", each voxel takes on a value between (0,1) indicative ofthe 
presence or not of GM or WM in that voxel. An example average concentration map 
for a group of TLE patients with left hippocampal atrophy is shown in Figure 9. 
Parameters of a generallinear model are estimated at each voxel, across subjects, 
possibly with additional co-variates if applicable (e.g. age, sex). Voxels with 
statistically significant differences are identified based on a threshold corrected for 
multiple comparisons. Rather th an using Bonferroni correction, fMRIStat relies on 
Gaussian Random Field theory for this correction (Worsley, Marrett et al. 1996). 
The final result is a volume containing only those voxels (or peaks) in which there 
are statistically significant differences between the tissue concentrations for the 
groups under study (see Figure 11). 
87 
Significant clusters, formed by a sufficiently large number ("extent") of contiguous 
voxels above a given threshold t-value (not necessarily peak voxels under the 
previous threshold for statistical significance), are obtained following the procedure 
developed by Worsley et al. (Worsley, Andermann et al. 1999) to correct for data 
anisotropy. 
Similarity measures 
Our hypothesis for VBM-based classification is that areas of differences in GM or 
WM concentration related to the grouping variable, which have been extracted in 
the previous step, can be exploited for classification purposes. We thus proceed in 
defining a global region of interest as the ensemble of aIl voxels j above the cluster 
statistical significance threshold tin each of the four concentration difference maps 
(one each for the combination of increase/decrease in GM/WM concentrations). 
The first measure selected was the straightforward ca1culation of the total number of 
voxels jwithin the region, V, and the second feature was the mean GM or WM 
concentration of aIl region-of-interest voxels j. Thus, for subject i, with concentration 
map [GMti (for increases in grey matter concentration), the measure ~ was 
calculated as follows: 
_ 1 V 
GMi = - 2 [GMtu 
v"' J-
with similar measures derived for WM and the same for decreases in 
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concentration ([GM]+, [GMr , [GM]+, [WMr ). 
Other metrics are possible; we have proposed a "weighted" concentration measure 
(Duchesne, Bernasconi et al. 2004), consisting in multiplying the GM or WM value 
in the region of interest voxels by its t-statistic and taking the mean weighted 
concentration value. This measure was rejected experimentally, as it did not increase 
the accuracy of classification. 
Ideally there would be two groups of subjects, one to extract the global area of 
interest, and the second to test the classification. However, in cases where there is a 
limited number N of patients, one can proceed in a leave-one-out fashion where 
multiple VBM group comparison analyses are carried out, with each subject 
removed in turn from the group; the concentration difference maps are therefore 
independently assessed from that subject. The global region of interest can be 
calculated as defined above for each trial, and the number of voxels in the region, 
along with the mean G M/WM concentration within that region, measured on the 
subject's own MR image. This approach is repeated Ntimes, in order to estimate the 
classifier's accuracy. 
Classification 
The classification approach used for the applications presented in this the sis was 
similar for the two methodologies described above. Every experiment was 
dichotomous, and while many possible choices of classifier existed, linear 
89 
discriminant analyses (LDA) were chosen due to their simplicity and ease of 
implementation. 
Closely following the notation of Duda et al. (Duda, Hart et al. 2001), we defined 
two states of nature 001, 002 in our experiments (e.g. left MTL vs. right MTL seizure 
focus subjects, or AD and MCI patients vs. normal aging). In each case, the subjects 
being classified are part of the trial group, and not the same as the reference group 
used to compute the MR-based features defining the reference space. 
The prior probabilities p( 001), p( 002) are usually fixed at 0.5, and do not necessarily 
always represent the normal population incidence. Exceptions to this rule will be 
noted in the text, and consisted in adjusting the prior probabilities to reflect the 
composition of the trial groups. 
The design of our classifier is simple. For each variable, the LDA function can be 
expressed as follows: 
g(v) = w1v + wo 
where vis the feature vector (e.g. eigencoordinates, VBM-based measures), wis the 
weight vector and Wo the bias or threshold weight. For a two-category classifier we 
implement the following decision rule: decide 001 if g(v) > 0 and 002 if g(v) < O. 
There were two possible implementations for LDA: complete estimation and 
forward, stepwise analysis. 
Complete estimation - all variables were included in the model; 
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Forward, stepwise analysis -variables were entered stepwise into the analysis by 
Wilk's f.. method; that is, at each step the variable that resulted in the smallest 
Wilk's f.. for the discriminant function was selected for entry. Wilk's f.. shows the 
proportion of the total variance in the discriminant scores not explained by 
differences among groups. A small f.. value (near 0) indicates that the group's 
mean discriminant scores differ. A f.. of 1 occurs when the mean of the 
discriminant scores is the same in aIl groups and there is no between-groups 
variability; therefore, the larger f.. is, the less discriminating power is present. 
Classification experiments were computed using SYST AT 10.2 (SSI, Richmond, 
CA). 
Cross-validation trials 
The final reported result in each manuscript consisted in the mean accuracy of 
multiple cross-validated trials (Figure 20). In each of those trials, the study data is 
randomly split in two groups: the first group is the training set and is used to 
estimate the classification functions; the second group is the test set, classified using 
the functions derived from the training set. This procedure is repeated multiple 
times and the average proportion of correct classifications of the test set is an 
empirical measure for the success of the discrimination. The cross-validation 
experiments were completed using SYSTAT 10.2 (SSI, Richmond, CA). 
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Figure 20 - Cross-validation trials 
Cross validation trials proceed as follows. The study population is randomly split 
into a training and a test set, with the linear discriminant functions estimated on the 
training set. The test set is used to evaluate how good the classification is, and this 
process is repeated multiple times to get a good estimate of the overall accuracy for 
classification. 
Results will be given in terms of their sensitivity (the proportion of individuals with a 
true positive result), their specificity (the proportion of individuals with a true 
negative result) and their accuracy (the proportion of aIl subjects correctly classified), 
as described in Table 1 below. 
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Sensitivity 
Test result SN= TP TP+FN 
Specificity 
Group 1 Group 2 
SP= TN 
TN+FP 
{I.I Group 1 
..... 
TP FN Accuracy 
{I.I 
0 
= co Group 2 FP TN cu 
..... 
~ 
TP+TN A=-------
TP+FP+TN+FN 
Table 1- Sensitivity, specificity, and accuracy measurements 
(TP = true positive, TN = true negative, FP = false positive, FN = false negative) 
ln the following chapters, these methods will be used for classification and 
prediction purposes in two different pathologies. In Chapter 4, the ABC technique 
will be used to lateralize the seizure focus on Tlw images from TLE patients with 
and without hippocampal atrophy; in Chapter 6, the same methodology will be used 
to differentiate AD and MCI patients from normal aging individuals, and in Chapter 
7, to predict cognitive decline to AD in a cohort of MCI patients. Finally, the VBC 
methodology will be used in Chapter 5 for the prediction of surgical outcome in a 
cohort of TLE patients having undergone selective amygdalo-hippocampectomy. 
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Chapter 4 
Lateralization of seizure focus in TLE 
Foreword 
We will recall that the primary goal of pre-operative evaluation in intractable TLE is 
to confirm which of the two amygdalo-hippocampal complexes is most affected, and 
therefore becomes the resection targe t, a process commonly referred to as 
lateralization of seizure focus. Further, we will recollect that nearly 80% of TLE 
cases exhibit He atrophy (HA) predominantly in the left (L) or right (R) MTL, 
strongly correlated with an ipsilateral seizure focus. However, around 5% of 
intractable TLE patients demonstrate bilateral atrophy without significant 
differences between hemispheres, and the remaining 15% of cases have non-
atrophie He (hippocampal normal volume, or HNV). In the se latter two cases 
volume-based lateralization of seizure focus is at best equal to chance. 
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Our primary goal in the manuscript presented in this chapter was to verify that there 
existed appearance differences (intensity and shape) related to seizure focus 
localization. We purposefully moved away from a structure-centric approach to 
selecting a large, non-specifie VOl, centered on the MTL, and inclusive of the HC as 
weIl as the AG, the parahippocamapl (PHC) gyrus, other nearby gyri and ventricular 
areas. This choice was motivated by volumetry resuIts obtained in the same cohort of 
patients by one of our co-author (Bernasconi, Bernasconi et al. 2003), as weIl as 
results from our voxel-based morphometry (VBM) study, also within the same 
cohort (Bernasconi, Duchesne et al. 2004) (see Figure 11), aIl pointing to the 
existence of extra-hippocampal differences in patients with left or right seizure focus 
when compared to normal controls. 
At the same time, we wished to verify that these appearance differences could be 
used for the purpose of lateralization. We hypothesized that they could be modeled 
linearly with principal components, or at least sufficiently weIl estimated to allow for 
the correct classification of patients with or without HA into the proper lateralized 
group. The standard of comparison for this task was clinical evaluation, including 
extensive video-EEG recordings, and in sorne cases backed-up by surgically 
implanted EEG (sEEG). 
Our resuIts indicate that our assumptions were correct. We found differences in 
appearance parameters that were sufficient to achieve 100% accurate lateralization 
of seizure focus in patients with or without HA (HA vs HNV, LHA vs RHA, LNV vs 
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RNV); further, we found that the system was 96% accurate at lateralizing seizure 
focus even when given no a priori information about structure atrophy (L vs R). This 
is to be compared with He volumetry, which achieves 81 % accuracy at the same task 
in our cohort. 
Early forms of this work were printed as conference proceedings (Duchesne, 
Bernasconi et al. 2002; Duchesne, Bernasconi et al. 2003), before being published in 
the journal Neurolmage. 
The reader will notice that the Methods section of this manuscript, as well as the 
Discussion - Methodological Considerations, have already been addressed in the 
previous Methods chapter of this thesis; figures and figure captions have also been 
seen earlier. The reader may therefore choose to skip the Methods section of this 
chapter without loss of information. 
For the sake of brevity, keywords have not been included, and a list of common 
abbreviations can be found at the end of this thesis. 
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Abstract 
Classification of neurological diseases tends to concentrate on specifie structures 
such as the hippocampus (He). The hypothesis for the novel classification 
methodology presented in this work is that pathologies will impact large tissue areas 
with detectable variations of Tl-weighted MR signal intensity and registration 
metrics. The technique is applied to the lateralization of seizure focus in 127 patients 
with intractable temporal lobe epilepsy (TLE), in whieh the site of seizure onset was 
determined by comprehensive evaluation (69 with left MTL seizure focus (seizure 
focus) (group "L") and 58 with right seizure focus (group "R")). The method 
analyses large, non-specific Volumes of Interest (VOl) centered on the left and right 
medial temporal lobes (MTL) (55 x 82 x 80 voxels) of pre-processed scans in 
stereotaxic space. The VOIs are then linearly and nonlinearly registered to a 
reference target image. Principal Components Analyses of (i) the normalized 
intensity and (ii) the trace, a measure of local volume change, are used to generate a 
multidimensional reference space from a set of 152 neurologieally healthy subjects. 
Data from TLE patients are projected in this space, and leave-one-out, forward 
stepwise linear discriminant analysis of the eigencoordinate distributions is used to 
classify TLE patients. Following MRI volumetric analysis, 80 patients had He 
atrophy (group "HA") ipsilateral to the seizure focus (42 with le ft seizure focus 
or "LHA", and 38 with right or "RHA"), and the remaining 47 had normal He 
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volumes (group "HNV") (27 with left seizure focus or "LNV", and 20 with right 
seizure focus or "RNV"). The method was 100% accurate at separating "HA" 
vs "HNV", "LHA" vs "RHA", and "LNV" vs "RNV". It was also 96% accurate at 
separating "L" vs "R". 
Our results indicate that MR data projected in multidimensional feature domains 
can lateralize seizure focus in epilepsy patients with a high accuracy, irrespective of 
He volumes. This single scan, practical and objective method holds promise for the 
pre-surgical evaluation of TLE patients. 
Introduction 
Many neurological diseases exhibit pathologically-specific discriminatory 
information in the form of local intensity variations and shape changes when 
observed on magnetic resonance images (MRI). This is the case for schizophrenia, 
Alzheimer's dementia (AD) or epilepsy with a seizure focus that can be lateralized 
to one of the medial temporal lobes (MTL). MRI-based computer-aided diagnosis 
approaches have usually focused on those attributes. An example is the T1-weighted 
(T1w) signal intensity, that may serve as an indicator of disease progression since 
subtle changes may indicate an underlying pathological process before structure 
integrity is lost. This would be the case for tissue atrophy in AD or temporal lobe 
epilepsy (TLE) for example, where authors have used the signal intensity directly 
(Webb, Guimond et al. 1999; Duchesne, Bernasconi et al. 2002; Thomaz, Boardman 
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et al. 2004), while others performed texture analysis to show evidence of alterations 
that corroborate the hypothesis of tissue damage in conjunction with intensity 
information (Liu, Teverovskiyet al. 2004). Other techniques employ registration, a 
process where individual subject images are aligned into a reference space, to make 
spatial comparisons between cohorts at the voxellevel, such as in voxel-based 
morphometry (Ashburner and Friston 2000), deformation-based morphometry 
(Chung, Worsley et al. 2001; Chung, Worsley et al. 2003; Shen and Davatzikos 2003; 
Lao, Shen et al. 2004), or surface analysis of individual structures (Csernansky, 
Wang et al. 2000; Wang, Joshi et al. 2001; Csernansky, Schindler et al. 2004). 
Appearance-based approaches combine intensity and local shape information, but 
their application has been limited to segmentation (Cootes, Edwards et al. 2001; 
Duchesne, Pruessner et al. 2002). 
The most common neuroimaging technique for computer-aided diagnosis in 
pathologies such as AD or TLE has consisted in the study of individual structures, 
such as the hippocampus (HC), mostly via volumetry (Jack, Theodore et al. 1995) 
and now with newer methods based on shape characteristics, such as medial surfaces 
(Joshi, Pizer et al. 2002; Styner, Gerig et al. 2003; Bouix, Pruessner et al. 2005). 
While undeniably useful for understanding disease-driven change in the chosen 
structure ( s), these analyses suffer from significant drawbacks: they rely heavily on 
segmentation, a process with its own limitations, do not capture interrelations 
between neighboring tissues, critical in many pathologies, and usually require expert 
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knowledge, making them unsuitable for large scale studies. Finally, apart from 
appearance-based approaches, most of the techniques reviewed use either intensity 
or registration information, but rarely both. 
Lateralization of seizure focus in TLE 
We present intractable TLE as a pathology of interest whose characteristics make it 
an ideal test case for our proposed methodology. Microscopically, the most 
commonly described pathological findings in TLE are neuronalloss and gliosis of 
the HC and the parahippocampal region (Falconer, Serafetinides et al. 1964). As 
discussed, MR-based volumetry is a primary indicator of structure integrity 
(Bernasconi, Bernasconi et al. 2003), and hippocampal neuronalloss found in 
surgical specimens obtained from patients with pharmacologically intractable TLE 
has been shown to correlate with hippocampal atrophy on volumetric MRI (Caseino, 
Jack et al. 1991). Studies in TLE have also shown volume reduction ipsilateral to the 
side of the seizure focus in the parahippocampal region (Bernasconi, Bernasconi et 
al. 2003). The advent of high resolution MRI has, therefore, had a major impact on 
the presurgical evaluation of patients with refractory epilepsy. Nearly 80% of TLE 
cases exhibit lateralized HC atrophy (see Figure 21), strongly correlated with an 
ipsilateral seizure focus (Bernasconi, Bernasconi et al. 2003). HC volumetry is 
therefore used in many centers for the pre-surgical evaluation however, it is a time-
consuming, manual procedure requiring expert intervention, and subject to the 
drawbacks outlined above. Further, around 5% of intractable TLE patients 
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demonstrate bilateral atrophy without significant differences between hemispheres, 
and the remaining 15% of cases have nonatrophic He, making volume-based 
lateralization impossible. Finally, neuropathologieal studies have shown that more 
than one brain structure are affected in TLE, while voxel-based morphometry 
studies of MR images (Woermann, Free et al. 1999; Keller, Mackay et al. 2002; 
Bernasconi, Duchesne et al. 2004) have reported significant areas of grey matter and 
white matter concentration decrease throughout the medial temporal lobe as weIl as 
in extra-temporal lobe brain areas. 
Hypothesis and objective of research 
Our general hypothesis is that in the case of many neurologieal diseases, mieroscopie 
changes will impact the T1w MRI signal intensity suffieiently to be detected, while 
macroscopie alterations in structure shape will be notieed via registration-based 
metrics. Consequently, we are proposing in this article a classification methodology 
that moves away from the single structure-based paradigm by using (i) a large, non-
specifie Volume of Interest (VOl) containing sufficient discriminatory information, 
and (ii) by combining intensity and registration-based shape features. A preliminary 
implementation has been described in Duchesne et al. (Duchesne, Bernasconi et al. 
2003). From the preceding literature on TLE, we concluded that a single-structure 
approach for the lateralization of seizure focus was not adequate and that, in order 
to be succesful, classification should be based on the information contained in a VOl 
centered on the MTL, incorporating the HC along with other limbic structures. In 
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this paper, lateralization of seizure foeus in TLE is used as a test case for our 
proposed classification methodology. 
Figure 21 - Tl images in TLE 
(Top) Sagittal (x = 62) and coronal ( y = 117) T1-weighted (Tl w) magnetic resonance 
images (MRI) of normal control subject #18. (Middle) Hippocampal neuronalloss 
found in surgical specimens obtained from patients with pharmacologically 
intractable temporal lobe epilepsy (TLE) has been shown to correlate with 
hippocampal atrophy (HA) on volumetrie MRI (Cascino et al., 1991). For example, 
left HA is readily observed on these T1w MR images (same orientation as above) of 
patient #18 as an enlargement of the lateral ventricles, along with increased atrophy 
of the hippocampal head (red lines intersection). (Bottom) On the other hand, 
around 15% of intractable TLE patients exhibit normal hippocampal volumes, 
therefore making lateralization impossible in those cases on the basis of HC 
volumetry alone. This is exemplified in these T1w MR images (same orientation as 
above) ofHNV patient #1. 
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The objectives of this work are therefore to de scribe the methodology and 
demonstrate its usefulness by proceeding with the lateralization of seizure focus in 
TLE patients with and without hippocampal atrophy, based on their pre-operative 
Tlw MRIs. 
Methods 
Our method can be summarized as follows (see Figure 22). First, from processed 
data (A) we generate a non-pathological eigenspace (B) from a large training 
group of young, neurologically healthy training subjects (N = 152). This 
multidimensional eigenspace is created by uniting results from four distinct Principal 
Component analyses of (i) linearly registered intensity images of the left and right 
VOIs from TlwMRI of the se training subjects (C); and (ii) an approximation of the 
determinant of the Jacobian matrix of the deformation field for the same VOIs (D), 
where the deformation fields are obtained by non-linear registration to a common 
reference image. Secondly, VOIs from our patients are projected in the 
multidimensional eigenspace created (E). The normality of the distribution of the 
projected eigencoordinates is first assessed using quantile plots and Shapiro-Wilke 
statistics. The last step consists in linear discriminant analyses (LDA) in a leave-one-
out, forward stepwise approach, using eigencoordinates in the non-pathological 
eigenspaces to classify the patients. While the non-pathological eigenspace may not 
be optimal to represent the patient population, it forms the basis for a comparative 
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evaluation of the different groups that leads to their classification. The 
methodological details are elaborated in the following sections. 
Figure 22 - Classification methodology 
Our hypothesis for the proposed classification system is that pathologically-induced 
microscopie changes will impact the Tlw MR signal intensity, while macroscopic 
alterations in structure shape can be detected via image registration. In this 
methodology, two volumes of interest (VOl), centered on the left and right medial 
temporal lobes, are extracted from pre-processed data (A). At first, a large group of 
young, healthy control subjects' images (N = 152) is used to generate a normal, non-
pathological eigenspace (B) that will serve as a basis for comparison of the TLE 
study subjects. This multidimensionaI reference eigenspace is created by uniting 
results from four distinct Principal Component analyses of (i) linearly registered 
intensity images of the VOIs from Tlw MRI (C); and (ii) an approximation of the 
determinant of the Jacobian matrix of the deformation field within those VOIs (D). 
The data from the study subjects (Groups A and B) are projected in the reference 
space (E). Classification is based on leave-one-out, forward stepwise linear 
discriminant analyses of the eigencoordinate distributions (F). 
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Subjects 
The Ethics Committee of the Montreal Neurological Institute and Hospital 
approved the study and informed consent was obtained from aIl participants. A total 
of 279 subjects were inc1uded in this study. The training group consisted in 152 
young, neurologically healthy volunteers from the International Consortium for 
Brain Mapping project (Mazziotta, Toga et al. 1995), whose scans were used to 
create the non-pathological mode!. The test population consisted in 127 patients 
with pharmacologically intractable TLE. Seizure type and the site of seizure onset 
were determined by a comprehensive evaluation inc1uding detailed c1inical history, 
neurological examination, review of medical records and neuropsychological 
evaluation. The seizure focus was determined by predominantly ipsilateral interictal 
epileptic abnormalities (70% cutoff) and unequivocal unilateral seizure onset 
recorded during prolonged video-EEG monitoring in aIl patients. Based on these 
criteria, TLE patients were divided into those with a left-sided (group "L", n= 69 
[54%]) or a right-sided (group "R", n=58 [46%]) seizure focus. 
MRI acquisition and initial processing 
MRI data for our 279 subjects was collected with a T1-weighted MRI protocol on a 
1.5 T scanner (Philips Gyroscan, Best, Netherlands) using a fast gradient echo 
sequence (TR = 18ms, TE = lOms, 1 NEX pulse sequence, flip angle = 30°, matrix 
size=256 X 256, FOV = 256mm, slice thickness=lmm). Following acquisition, 
intensity inhomogeneities due to scanner variations were corrected (SIed, Zijdenbos 
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et al. 1998). A 9-degrees of freedom (DF) linear registration was then used for 
global alignment (Collins, Neelin et al. 1994) into a standard reference space. The 
data was finally resampled onto a 1mm isotropie grid (Collins, Neelin et al. 1994). 
The reference image used for the linear registration and resampling was the ICBM 
152 Tl w targe t, a voxel-by-voxel average of the 152 normal subjects previously 
registered in the Talairach-like stereotaxie space in the context of the ICBM project 
(Mazziotta, Toga et al. 1995). 
Input data for multi-dimensional space creation 
Two VOIs were selected for this study, centered on the left and right medial 
temporal lobe, using Talairach coordinates (start coordinates x = [-53, + 2] for the 
left and right side respectively, y = -53 and z = -52). Each VOl measured n = 55 
X 82 X 80 = 360800 voxels. The VOl was selected so that its extent captured the 
hippocampus and neighboring MTL structures, such as the parahippocampal gyrus, 
irrespective of normal inter- and intra-individual variability (see Figure 23). 
Two image features at each voxellocation were retained for modeling. The first 
feature used in our classifier is grey JeveJ intensity, denoted by script g. Scanner 
output volumes are preprocessed in the manner described in the preceding section, 
which includes intensity inhomogeneity correction and globallinear registration into 
Talairach space (DF = 9). The VOIs are then extracted based on their Talairach 
coordinates. To further reduce positional variations, which would propagate as 
unwanted noise in the morphometrie PCA modelling, a second local affine 
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transformation (DF = 12) is applied to co-register the individual subject's VOl with 
the corresponding VOlon the ICBM 152 target. Finally, VOl intensity mean is also 
linearly scaled to the reference target. 
Figure 23 - Intensity and shape features within the volume of interest 
(Left column) Transverse, coronal and sagittal whole-brain views for TLE subject 
#28 with LHA. (Middle column) Identical views through the Volume oflnterest 
(VOl), as defined in stereotaxie space on the left medial temporal lobe (red boxes on 
whole-brain views). (Right column) Identical views trough the trace VOl for the 
same subject. Green voxels do not move. From green to white (maximum) via 
yellows and reds indicate increase or expansion. From green to black (minimum), 
via blues and purples indicate decrease or contraction. The direction of movement is 
defined as the deformation which the subject's VOl seen in (A), (C) and (E) must 
accomplish in order to align with the corresponding VOl extracted from the 
reference volume. Contraction represents atrophy in the case of tissue. Notice in the 
transverse view in (A) and (B) the contraction of the lateral ventricular space, 
necessary to correct its enlargement, also noticeable in (E) and (F), while in (C) and 
(D), the coronal view displays the superiocentral shift due to hippocampal atrophy. 
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The input to the intensity model therefore consists in the rasterized intensity data 
from the VOIs processed in this fashion. The second feature is the trace, denoted by 
script t. The trace is the first-order approximation of the determinant of the 
Jacobian matrix of a non-linear registration-derived deformation field, whieh maps a 
subject to our reference ICBM target, and thus forms an estimate of local volume 
change. 
Nonlinear registration attempts to match image features from a source volume to 
those of the reference image at a locallevel, typically in a hierarchieal fashion, with 
the aim of reducing a specifie cost function. Whereas many nonlinear registration 
processes exist, the one chosen for this study was ANIMAL, developed by (Collins 
and Evans 1997). This algorithm attempts to match image grey-Ievel intensity 
features at a locallevel (voxel) in successive blurring steps, by maximizing the cross-
correlation function of voxel intensities between the source and reference images. 
The result is a dense deformation field capturing the displacements required to align 
the subject VOl with that of the reference image. In our application, we estimate the 
nonlinear transformation between the VOl of an individual subject to the ICBM 152 
target VOL Note that the trace input VOl for our subjects is the same as the one 
used for the intensity modeling. 
Our implementation of trace calculation was discussed in (Janke, de Zubicaray et al. 
2001) and follows the notation developed by (Chung, Worsley et al. 2001). If U is the 
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displacement field which matches homologous points between two images, then the 
local volume change of the deformation in the neighborhood of any given voxel is 
determined by the Jacobian J(Chung, Worsley et al. 2001), which is defined as 
au J(x,t) = det(I + -) 
ax 
where 1 denotes the identity matrix and au is the 3 X 3 displacement gradient 
ax 
matrix of U. For relatively small displacements, 
J ... 1+ tr(VU) 
as suggested by (Chung, Worsley et al. 2001). Rence the trace tr(VU) represents a 
crude yet indicative measure of local volume change. This is weIl suited to brain 
applications as the level of atrophy present between controls and patients is small yet 
significant and should therefore be apparent in the results of a local non-linear 
registration process. Examples are shown in Figure 23. The input to the trace PCA 
therefore consists in rasterized vectors of calculated trace volumes. 
Multidimensional spaces and classification 
Principal Components Analysis (PCA) is used to reduce the dimensionality of the 
input data (intensity g, trace t) and generate linear variation models based on the 
N=152 datasets from our ICBM normal control subjects. We use here the notation 
identical to (Cootes, Edwards et al. 2001): 
which allows any vector instance x, be it trace or intensity vectors from the left or 
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right VOl, to be approximated by x, the mean normalised input vector; PX' the set of 
orthogonal modes of variation; and BX' the set of parameters. The resulting four PC 
models were eachp=N-l (or 151-dimensional). 
The ensemble of Principal Components from the left and right VOl grey-level 
intensity models defines an Allowable Grey Domain G as the space of aIl possible 
elements expressed by the intensity eigenvectors "-o. Likewise, an Allowable Trace 
Domain T is created as the space of aIl possible elements expressed by trace 
eigenvectors Ivr for the le ft or right VOIs. It can be shown that the eigenvectors of 
the covariance matrix corresponding to the largest eigenvalues de scribe the longest 
axes of the ellipsoid, and thus the most significant modes of variation in the variables 
used to derive the covariance matrix (Cootes, Edwards et al. 2001). Most of the 
variation can usuaIly be explained by a smaller number of modes, 1, where 1 < < n 
and 1 < p. This me ans that if the 2n dimension al ellipsoid is approximated by a 1 
dimensional ellipsoid, then the original ellipsoid has a relatively small width along 
axes with indexes 1 + 1 and greater (Cootes, Edwards et al. 2001). 
The total variance of aIl the variables is equal to: 
whereas for 1 eigenvectors, explaining a sufficiently large proportion of f..., the sum of 
their variances, or how much the se principal directions contribute in the description 
of the total variance of the system, is ca1culated with the ratio of relative importance 
of the eigenvalue At associated with the eigenvector k 
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We proceeded in selecting eigenvectors for each of our four models (left/right 
intensity/trace VOIs), corresponding to a per-model variance ratio of l = 0.997 for 
our normative training group. Again, our goal was not to find the optimal space to 
represent the study subjects, but rather to have a common basis in which to compare 
study populations. This is exemplified in Figure 24, where a cartoon-like 
representation of our training set is drawn, aligned and centered with the first two 
principal components since they were extracted from that data. Our goal is to use 
this space for the separation of pathology #1 subjects into two groups, la and lb. 
While the space may not optimal for pathology 1, it forms a normative basis built 
from young, neurologically healthy individuals that can also be used for other 
pathologies, such as pathology #2 that may or may not overlap with pathology #1. 
The reader should also note that in this study we will not discuss the case of 
classifying normal control subjects from TLE patients on the basis of their MRI 
characteristics, as it offers no clinical value. 
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Figure 24 - Cartoon-like representation of classification of patient groups 
The reference set is represented by the green ellipse, aligned and centered with the 
first two principal components sin ce the eigenspace originates from these data. Our 
goal however is to use the same space for the separation of many pathologies. For 
example, pathology #1, while not optimally represented by the eigenvectors of the 
reference space, can still be separated in two groups, lA and lB. The same can be 
said of a second pathology, which may or may not overlap with the previous one. 
Using a normative space built from young, neurologically healthy individuals should 
give the ability to perform classification studies in multiple pathologies. 
Rasterized vectors of the processed VOl intensity and trace data for each study 
subject are projected into Domains Gand T, and thus form the eigencoordinate 
vectors. While a number of possible features can be calculated on the distribution of 
the projected data, our classifier is based on the position along the PC axes. The 
distribution of eigencoordinates along any principal component for a given 
population should be normally distributed and this normality is assessed via quantile 
plots and Shapiro-Wilke statistics. 
The classification is based on leave-one-out, forward stepwise linear discriminant 
analyses of eigencoordinates along the significant eigenvectors (SYSTAT 10.2, 
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Georgia, PA; P-to-enter < 0.0001). Results for classification are then compared to 
the pre-operative clinical evaluations in terms of accuracy. 
Results 
As mentioned earlier, the patient population consisted in 127 individuals with 
pharmacologically intractable epilepsy, 69 (54%) with a left MTL seizure focus 
(group "L") and 58 (46%) in the right (group "R"). MRI volumetrie analyses were 
performed on T1w MRI for aIl patients using a previously published protocol (rater: 
N.B.) (Bernasconi, Bernasconi et al. 2003). The He was determined atrophic if its 
volume fell below two standard deviations from the mean He volume of a matched 
group of control subjects. Eighty (80) patients (63%) had hippocampal atrophy 
(group "HA") ipsilateral to the seizure focus (42 with left seizure focus and HA or 
group "LHA", and 38 with right seizure focus and HA or group "RHA"). The 
remaining 47 patients (37%) had normal hippocampal volumes (group "HNV") as 
seen on MRI (27 with left seizure focus and HNV or group "LNV", and 20 with 
right seizure focus and HNV or group "RNV"). Table 2 contains demographic 
information on the different groups of TLE patients as weIl as the training set. 
By definition, He volumetry based on MR images was therefore 100% accurate in 
this cohort to lateralize seizure focus in those patients with HA, as the seizure focus 
was always ipsilateral, and 50% accurate (as good as chance) for those cases with 
HNV. The overall accuracy of He volumetry for the group of patients in this study 
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was (103/127) = 81%. 
N Mean Age Males Females 
LHA 42 35 22 20 
RHA 38 32 17 21 
LNV 27 39 11 16 
RNV 20 32 7 13 
Training set 152 25 87 65 
Table 2 - Description of patient and training population 
Our overaU mode l, formed by the union of the intensity and trace models for the left 
and right VOIs, was built using our training set of 152 healthy control subjects from 
the ICBM database. For each of the se models aU eigenvectors accounting for 99.7% 
of the variance of the neurologically healthy data set were chosen, for a total of 538 
eigenvectors. Normality of the eigencoordinates from the projected study data was 
confirmed for each PC using quantile plots and Shapiro-Wilke test (P > 0.05). 
In order to assess the classification accuracy of our automated methodology, we 
performed four experiments as foUows: 
• Experiment 1 - Classification (HA vs HNV): determine the classifier's ability at 
separating the HA vs HNV groups based solely on MR imaging data; 
• Experiment 2 - HA Lateralization (LHA vs RHA): de termine the classifier's 
ability at lateralizing the seizure focus within the hippocampal atrophy group; 
• Experiment 3 - HNV Lateralization (LNV vs RNV): determine the classifier's 
ability at lateralizing the seizure focus within the normal hippocampal volume group; 
and 
116 
• Experiment 4 - Lateralization (L vs R): de termine the c1assifier's ability at 
lateralizing the seizure focus irrespective of hippocampal volume. 
For each experiment a response curve was built of model accuracy vs total number 
of eigenvectors inc1uded in the classification process (see Figure 25). The best 
classification results following leave-one-out, forward stepwise linear discriminant 
analysis (P-to-enter < 0.0001) on the total number of eigenvectors included in the 
classification are reported in Table 3, with the resulting number of eigenvectors 
retained by the classifier to reach the best classification results and the 
corresponding Wilk's À statistics. Highlights of Figure 25 and Table 3 are 100% 
classification accuracy for Experiments 1,2 and 3, and 96% accuracy for 
Experiment 4. 
Expt GroupA Group B Total # Wilk's DF Accuracy 
# Classif. 
elgen. Eigen. 
1 HA (80) HNV (47) 10 4 0.029 4 100% 
2 LHA(42) RHA (38) 538 13 0.083 13 100% 
3 LNV (27) RNV (20) 8 5 0.078 5 100% 
4 L (69) R (58) 240 12 0.242 12 96% 
Table 3 - Classification results by experiments 
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Figure 25 - Experimental results 
(Left) Model response curves for the 4 classification experiments. The classifier was 
presented between 4 and 538 eigenvectors, for each classification experiment, with 
the accuracy generally increasing as variables were added. The optimal number of 
eigenvectors presented to the classifier, along with the number of eigenvectors 
retained by the classifier (P < 0.0001), are reported in Table 3.1t is important to note 
that the order with which the eigenvectors were presented to the classifier is not 
optimal for the task of separating TLE patients, but rather is optimal for the 
representation of the reference set data (decreasing eigenvalue). This explains why 
some of the curves are not monotonically increasing (e.g. L vs. R). (Right) Receiver 
Operating Characteristic (ROC) curve for the Left vs. Right seizure focus 
experiment (Experiment 4). Forward, stepwise analysis identified 12 significantly 
discriminant eigenvectors as shown in Table 3. We plotted sensitivity vs. 1-
specificity for Left seizure focus discrimination (blue curve) and Right seizure focus 
discrimination (green curve) for the 12 variable model. 
Discussion 
For many neurological diseases with specifie intensity and shape changes, as seen on 
MRI, the classical approach for computer-aided diagnosis remains volumetry of 
single structures, such as the HC, or parahippocampal gyrus (Bernasconi, 
Bernasconi et aL 2003), MR-based HC volumetry, while greatly beneficial, is not 
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sufficiently specific nor sensitive, especially in cases where the HC volume faUs 
within normal ranges. 
We are proposing a classification methodology that uses intensity and registration-
based shape features from a large, non-specifie VOL Our results indicate that these 
features are sufficient to adequately discriminate between different groups of 
subjects. In our study population, the accuracy of classification of patients into HA 
or HNV, the lateralization of the HA group into LHA and RHA, and of HNV into 
LNV and RNV, was 100%. We were also able to lateralize the seizure focus 
irrespective of HC volume with 96% accuracy. 
Methodological considerations 
The methodology is formulated to be simple and flexible, allowing a number of 
possible features to be used without extensive reengineering. We achieved 
substantial data reduction, starting from a model of 152 VOIs (152 X 2VOIs X 
360800 voxels = 1.1 X 107 points in MRI space) down to 538 eigencoordinate points 
in a predefined PC space. As the training set is composed of ICBM subjects that are 
separate from the test set subjects, there is no issue of overdetermination. Further, 
by using leave-one-out or jacknife linear discriminant analyses, we ensured that 
there was no overlearning in the classification stage. 
From the response curves of Figure 25 for each classification experiment an initial 
conclusion can be made, in that the optimal number of eigenvectors varies 
depending on the classification problem. This result is not surprising and means that 
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distinct covarying intensity and/or shape features characterize the different two 
groups under study. Assessment of the variations in intensity and shape embedded in 
the significant eigenvectors is beyond the scope of this paper, and will be performed, 
along with their clinical corre la te, in a separate communication. 
Using intensity features from MRI raises the question of calibration and 
normalization. Absolute intensities are rarely used in MRI, since they vary with 
machine calibration, shimming, and patient-induced variations. We have tried to 
limit those variations by (1) using the same scanner for every individual in the study; 
(2) ensuring that the same quality assurance procedures were followed for each 
acquisition; and (3) scanning the patients in random group order. Our approach has 
been to create a model eigenspace based on subjects from the ICBM database, in 
which we projected our cohorts of TLE patients. While such a space built from 
young, neurologically healthy individuals may not be optimal to represent the test 
population, it should be noted that our primary goal was to find an independent 
basis for a comparative evaluation of our study cohort and its subsequent 
classification, but not the best mathematical representation. This is demonstrated in 
Figure 25, especially for Experiment 4 (L vs R). If the space was optimal for 
representing the TLE patients one would expect a monotonous increase in accuracy 
as the number of eigenvectors presented to the classifier increased. However, such is 
not the case since we were presenting to the classifier eigenvectors ordered along 
their weight for a young, healthy population. This explains why, for example, in the 
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case Experiment 4, the accuracy of the classification does not monotonically 
increase, since quite obviously sorne of the eigenvectors that improve the 
classification are found in later reference space eigenvectors, that do not carry much 
eigenweight for normal, healthy subjects, but they do carry discriminatory 
information for TLE patients. 
Clinical considerations 
The prevalence of HA as reported in the lite rature for cohorts of TLE patients 
ranges from 50%(Ng, Tang et al. 2000) through 90%(Cascino 1995), with 
a "consensus range" emerging between 75%(Spencer, McCarthy et al. 1993) or 
76%(Jack, Theodore et al. 1995) to 85%(Cheon, Chang et al. 1998; Bemasconi, 
Bemasconi et al. 2003). HA prevalence in our cohort felliower than this accepted 
range at 63%, but this complicates, rather than simplifies, the task for the 
classification system, as there are less HA examples to leam from in the leave-one-
out analyses. Our first experiment was aimed at determining if HC atrophy was 
detectable with our methodology. By definition, HC volumetry determines atrophy 
with 100% accuracy. Our results show that we are able to differentiate between HA 
and HNV with the same accuracy. From a clinical point of view however, the 
advantage of the automated technique relies in its independence from manual 
intervention, outside of the one-time definition of the VOl in Talairach-like 
coordinates. HA is typically associated with ipsilateral seizure and therefore 
volumetry seems like a good indicator of lateralization. The accuracy of 
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lateralization in TLE patients with HC atrophy is at a minimum 80% (Bemasconi, 
Bemasconi et al. 2003) or 90% when including structures other th an the HC, such as 
the amygdala (Cendes, Andermann et al. 1993), entorhinal and parahippocampal 
formation (Bemasconi, Bemasconi et al. 2003), or combining with T2-weighted MRI 
hyperintensities in the medial temporal lobes (Kuzniecky, Suggs et al. 1991) or 
spectroscopie data (Li, Caramanos et al. 2000). Other authors report a maximum of 
98% (Spencer, McCarthy et al. 1993) or 100% in (Jack, Theodore et al. 1995) for 
lateralization via volumetry. In this cohort, since we selected individuals with atrophy 
ipsilateral to seizure focus, the accuracy of MRI-based volumetry was 100%. Our 
classification results achieved the same accuracy for lateralization of seÏzure focus in 
patients with HA, using 13 eigenvectors. 
Also by definition, the lateralization of seizure focus in patients with normal 
hippocampal volume cannot be done on the basis of HC volumetry and therefore is 
at best equal to chance (50%). In contrast, our methodology surpasses this result by 
achieving 100% lateralization accuracy with 5 eigenvectors. 
Finally, we attempted to lateralize seizure focus from the onset, that is without a 
priori separation of the groups based on hippocampal volume. The accuracy of HC 
volumetry in this instance can be derived by combining the consensus ranges of 
prevalence for HA, along with the lateralÏzation accuracy of HC volumetry in the 
presence of HA or HNV, that is [(75 - 85%) X (85% - 98%)] + [(50%) X (25% -
15% )]. Therefore, lateralization of seizure focus with volumetry alone should range 
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between 76% and 91 %, and as mentioned in this cohort is 81 %. Our results show an 
ability to lateralize seizure focus with 96% accuracy with 12 eigenvectors, but, 
contrary to volumetry, without the need for additional measurements or manual 
segmentation. The non-invasiveness of MR-based techniques makes them 
preferrable alternatives for the presurgical evaluation of patients with TLE if proven 
to be as accurate. We believe that the proposed methodology for automated analysis 
of Tlw MRIs has reached the level at which it needs to be evaluated further in 
prospective studies to determine its possible inclusion in routine clinical use. 
We chose intractable temporal lobe epilepsy (TLE) as a pathology of interest since 
its characteristics made it an ideal test case for our proposed methodology. Clearly, 
other neurological diseases that exhibit related morphological changes detectable via 
Tlw MRI intensity and shape may benefit from this approach. As an example, 
preliminary results for this methodology in the study of Alzheimer's dementia and 
Mild Cognitive Impairment are discussed in a separate communication (Duchesne, 
Pruessner et al. 2005). 
Conclusion 
The underlying assumption for this work is that there exists sufficient information in 
VOIs extracted from Tlw MRI global volumes to be used for the correct 
classification of our study subjects. Our results demonstrate that multidimensional 
spaces can be created from a PCA of extracted features of interest from training set 
123 
images, and that such a space forms an adequate basis for the discrimination 
between subject projections. Our results further indicate that LDA can classify 
groups using the selected features with a high degree of success. The proposed 
methodology does not rely on segmentation, requires no user input and is data-
driven. 
The ability to lateralize seizure focus in intractable TLE based solely on pre-
operative TlwMR imaging has great potential to improve CUITent diagnostic 
procedures. It is anticipated that such systems will gain widespread use in the next 
few years in a wide range of neurological diseases. 
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Chapter 5 
Prediction of outcome for TLE surgery 
Foreword 
Having demonstrated in the previous chapter that there were appearance 
differences in intensity and shape related to seizure focus localization, and that these 
differences could be used for pre-surgicallateralization, we turned our attention to 
the problem of predicting the long-term, post-surgical clinical status. 
The main objective of selective amygdala-hippocampectomy (SAH) performed in 
intractable TLE patients is one of seizure control; in the majority of cases, but not in 
aIl, this goal is achieved. Being able to predict for which patients the CUITent 
procedure would be most beneficial would significantly alter patient management. 
Our first attempt at predicting post-surgical clinical status at one year foIlow-up was 
to use the same technique as used in the previous chapter, that is a linear model of 
appearance principal components extracted from the MTL. The results we obtained 
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were inconclusive, and we could do no better th an chance. This was not entirely 
surprising, given the literature on the subject (see Chapter 2), which indicates that 
the extent of disease damage in extra-temporal are as is probably the most 
determinant predictor of outcome. We therefore decided to tum to the second, 
VBM-based methodology described in Chapter 3. 
Our primary goal in this article was to determine if there existed regions of grey and 
white matter concentration differences related to surgical outcome outside of the 
temporal lobe. At the same time, we wished to verify if these differences could be 
used for the purpose of predicting surgical outcome. Again, we hypothesized that 
they could be modeled linearly, or at least sufficiently weIl estimated to allow for the 
correct classification of patients into positive or negative outcome groups. The 
standard of comparison for this task was clinical evaluation of seizure control at one-
year follow-up. 
Our results indicate that our assumptions were correct. We found differences in GM 
and WM concentrations mostly outside of the hippocampal area, and outside of the 
MTL, that were indicative of post-surgical outcome. A model based on the age of 
seizure onset, duration of seizures, ipsi and contra-Iateral hippocampal volumes 
reached a 72.6% accuracy; this was increased to 78.9% when incorporating GM and 
WM concentration measures within these are as. 
126 
An early form of this work was printed as a conference proceeding(Duchesne, 
Bernasconi et al. 2004), before being submitted for publication in the journal 
NeuroSurgery. 
As the methodology has been extensively described in Chapter 3, the reader may 
choose to skip the Methods section of this chapter without loss of information. For 
the sake of brevity, keywords have not bee induded, and a li st of abbreviation can be 
found at the end of this thesis. 
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Abstract 
Background - For patients with intractable temporal lobe epilepsy (TLE), 
resection of the epileptogenic seizure tissue has been shown to be a beneficial 
approach, with the majority of patients experiencing seizure control (positive 
outcome) after surgery. Predicting intervention success however remains a difficult 
task. 
Objective - We wished to study pre-operative Tlw MRI of TLE patients who had 
undergone selective amygdala-hippocampectomy (SAR) as part of their surgical 
treatment, in order to predict clinical status at one year foIlow-up. 
Methods - We performed voxel-based morphometry (VBM) studies of gray and 
white matter (GM!WM) concentration changes by comparing patients with negative 
outcome to those with positive outcome to de termine regions of concentration 
differences related to the surgical result. A region of interest was defined as the 
union of aIl voxels above a threshold for significance. Its size, the average GM and 
WM concentration within it, were measured for each patient. A model was built by 
adding VBM-based measures to non-VBM data (age of onset, duration of epilepsy, 
ipsi- and contra-Iateral hippocampal volumes as measured on MRI). Multiple cross-
validation trials were used to assess the predictive ability of the model. 
Results - GM concentration changes were primarily located in the left fronto- and 
inferio-temporal region, while WM concentration changes were found in the left 
mid-temporal region. Predicting surgical outcome using non-VBM based measures 
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resulted in an accuracy of 72.6%, while adding VBM-based features improved the 
this predictive accuracy of future clinical status to 78.9%. 
Conclusion - This article demonstrates the idea that pre-operative MRI analysis 
can increase the accuracy of surgi cal outcome prediction for an individual patient, 
and therefore could be useful for patient selection in order to maximize surgical 
benefit. Of course, conventional or depth EEG remain critical tools for the 
understanding of the temporo-spatial pattern of the epileptic discharges; it is only 
proposed here that MRI can play a pote nt role in pre-surgical planning and 
evaluation. 
Introduction 
Predicting surgical outcome in the treatment of medial temporal lobe epilepsy 
(MTLE) remains an outstanding challenge. Since the advent of high-resolution 
neuroimaging, there have been numerous attempts at finding structural or functional 
markers that can be used for that purpose, but no completely reliable indicator has 
been found to date. 
Microscopically, the most commonly described findings in MTLE are neuronalloss 
and gliosis of the hippocampus (RC) and the parahippocampal (PRC) region 
(Falconer, Serafetinides et al. 1964). The central goal of surgery in MTLE has 
consisted in the removal of this affected tissue, in an attempt to remove the site of 
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seizure generation and thus achieve seizure control. As the understanding of the 
disease and image-guidance improved (Olivier, Alonso-Vanegas et al. 1996), MTLE 
surgery has moved from complete to partiallobectomy (anterior temporal 
lobectomy or ATL), to selective amygdalo-hippocampectomy (SAR) (Olivier 2000). 
The latter approach consists in the resection of the amygdala (AG) and HC complex, 
and often parts of the neighboring structures, such as the entorhinal cortex (EC). 
For most intractable MTLE patients, surgery is the best possible treatment choice 
(McLachlan 2001). Vickrey et al. (Vickrey, Hays et al. 1995) have assessed MTLE 
surgery success and demonstrated that surgery patients had greater de cline in 
average monthly seizure frequency and took fewer antiepileptic medications, when 
compared to patients that had not received surgery. 
For the purposes of this study, we will define surgical outcome, or postoperative 
seizure control (Jack, Sharbrough et al. 1992), as either positive (complete remission 
and disappearance of all seizures, corresponding to Engel Group 1) or negative (all 
levels of seizure recurrences, or Engel Groups II/III/IV)(Engel, Van Ness et al. 
1993). 
Surgical Outcome Prediction in MTLE 
While the majority of patients undergoing surgery have positive outcome, there 
remains a significant proportion (20-30%) where the procedure will not completely 
eliminate seizures (Antel, Li et al. 2002). It is difficult at present to determine a 
priori if the procedure will be successful. MTLE surgical outcome prediction has 
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been examined mainly in subjects undergoing ATL, and remains marginal when 
using neuropsychological testing (Sawrie, Martin et al. 1998), shows correlation to 
interictal EEG (Bautista, Cobbs et al. 1999), and appears successful (>90% 
accuracy) when using PET (Dupont, Semah et al. 2000) (Choi, Kim et al. 2003) or 
pathological assessment of the resected tissue (Berg, Walczak et al. 1998). 
Magnetic Resonance Imaging (MRI) has seen its use increase in the pre-surgieal 
evaluation of MTLE patients. HC neuronalloss found in surgieal specimens 
obtained from patients with pharmacologically intractable TLE has been shown to 
correlate with HC atrophy on volumetrie MRI (Cascino, Jack et al. 1991). MRI 
studies in MTLE have also shown volume reduction ipsilateral to the side of the 
seizure focus in the PHC region (Bernasconi, Bernasconi et al. 2003); there is also 
evidence for extra-temporal gray and white matter (GM, WM) reductions in 
epilepsy patients when compared to controls (Woermann, Free et al. 1999) (Keller, 
Wilke et al. 2004) (Bernasconi, Duchesne et al. 2004). Nearly 80% of MTLE cases 
exhibit lateralized HC atrophy (Bernasconi, Bernasconi et al. 2003), strongly 
correlated with an ipsilateral seizure focus. 
Surgie al outcome predietion via MRI has been attempted in ATL (Jack, Sharbrough 
et al. 1992) (Radhakrishnan, So et al. 1998) (Kobayashi, Lopes-Cendes et al. 2001) 
with an accuracy ranging from 62% to 96%(Gilliam, Faught et al. 2000). Fewer 
authors have attempted to predict surgieal outcome for SAH based on MRI. Abosch 
et al. (Abosch, Bernasconi et al. 2002) reviewed EEG, histopathological studies and 
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pre-operative MRI for 54 patients, half ofwhom had good post-operative seizure 
control (Engel Groups 1/11). Their main conclusion is that SAH outcome can be best 
predicted when patients exhibit clear unilateral TLE; there remains a subpopulation 
(nearly 50% of cases), however, that meets the criteria for TLE, but does not 
become free from seizure following SAH (Abosch, Bemasconi et al. 2002). Antel et 
al. (Antel, Li et al. 2002) have used a classifier based on MRI and MR spectroscopy, 
correctly predicting the surgi cal outcomes of 39 of 52 (75%) of patients who became 
seizure free and 21 of 29 (72%) of patients who did not. 
There remains a need therefore to increase the accuracy of non-invasive, pre-
operative surgical outcome prediction in SAH. 
Hypothesis and objectives of research 
Our research hypothesis is that there exist anatomical regions of the brain that are 
linked to post-surgical outcome, either inside or outside of the MTL, and who se 
image informative content has the potential to predict surgical outcome. 
Our goal is to demonstrate the usefulness of a new methodology, based on pre-
operative MRI, in the prediction of surgical outcome in a retrospective study of 
MTLE patients having undergone SAH. In the first part we will describe our 
attempt at identifying those regions by comparing pre-operative MRIs of positive 
outcome patients to those of negative outcome patients. In the second part we 
de scribe our methodology for predicting surgical outcome based on simple MR 
image features computed within the identified regions. 
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Methods 
Subjects 
The study population consisted of 39 patients with intractable, non-foreign tissue 
MTLE seen at the Montreal Neurological Institute for SAH. AlI patients gave 
written consent for our study, which was approved by our Institute Review Board. 
Lateralization of seizure focus in MTLE patients was determined by a 
comprehensive evaluation including prolonged video-electroencephalogram (EEG) 
telemetry. The EEG focus was defined as right or left if more than 70% of seizures 
were recorded from one side. 
Pre-operative T1-weighted (T1w) MRI 3D images were acquired on a 1.5T scanner 
(Philips Gyroscan, Best, Netherlands) using a fast gradient echo sequence (TR= 18 
ms, TE=lO ms, 1 NEX pulse sequence, flip angle= 30°, matrix sÏze=256 X 256, 
FOV=256mm, slice thickness=lmm). AlI global MRI data were processed to 
correct for intensity non-uniformity due to scanner variations (SIed, Zijdenbos et al. 
1998), linearly registered into stereotaxie space and resampled onto a 1mm isotropie 
grid (Collins and Evans 1997). Manual MRI volumetry of the HC (rater: N.B.), 
based on a previously published protocol (Bernasconi, Bernasconi et al. 2003), 
showed atrophy ipsilateral to the seizure focus in aIl patients. 
AlI SAH procedures were performed by the same surgeon (A.O.) with a 
standardized approach (Olivier 2000). Post-operative follow-up for a minimum of 12 
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months was used to consolidate patients in two outcome groups: seizure free 
(positive outcome, n=25) or not seizure free (negative outcome, n= 14). 
The clinical data collected consisted in lateralization of seizure focus, age of onset, 
duration of epilepsy, and outcome grouping, along with MR-based manually 
extracted ipsi- and contralateral HC volumes. 
Detection of GM/WM concentration differences related to surgical 
outcome 
Our primary objective was to determine regions of gray and white matter (GM / 
WM) atrophy related to MTLE surgical outcome. To this end we performed 
between-group voxel-based morphometry (VBM) (Ashburner and Friston 2000) 
studies. These are statistieal analyses of generalized linear model results performed 
on a voxel-by-voxel basis on combined cohorts of co-registered subject imaging data. 
In this case, we compared the GM and WM concentration maps of negative 
outcome to positive outcome patients. 
The GM!WM concentration maps were obtained after classification of T1w MRI 
volumes (Zijdenbos and Dawant 1994), linearly registered (Collins and Evans 1997) 
to a common reference target of 152 young healthy volunteers, the so-called MN! 
Brain or ICBM 152 average (Mazziotta, Toga et al. 1995). GM or WM 
concentration maps were blurred using an isotropie Gaussian kernel of lOmm full-
width at half-maximum, under the assumption that this spatial kernel size matched 
the expected changes (Ashburner and Friston 2000). In those smoothed 
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concentration maps, each voxel takes on a concentration value between (0,1) 
indicative of the presence or not of GM or WM in that voxel. T -statistics maps were 
obtained by estimating a generalized linear model at each voxel, with age of onset 
and duration as covariates. Significant clusters, above a threshold t-value and 
composed of a sufficiently large number of contiguous voxels ("cluster extent"), 
were obtained following the procedure developed by Worsley et al. (Worsley, 
Andermann et al. 1999) to correct for data nonuniformity. 
Prediction of surgical outcome 
Our hypothesis for predicting surgical outcome is that regions of differences in GM 
or WM concentration related to surgical outcome, which have been extracted in the 
previous step, can be exploited for classification purposes. We thus proceeded to 
define a global region of interest as the ensemble of aIl voxels ab ove the cluster 
statistical significance threshold in each of the four concentration difference maps 
(one each for the combination of increase/decrease in GM/WM concentrations). We 
measured the number of voxels within these regions of interest, along with the 
region's mean GM and WM concentration, on the patients' classified preoperative 
image, for a total of 8 VBM-based measurements. 
Ideally there would be twO groups of subjects, one to extract the global region of 
interest, and the second to test the classification. However, due to the limited 
number of patients (N = 39), we decided to proceed in a leave-one-out fashion 
where multiple VBM group comparison analyses were carried out, with each subject 
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removed in turn from the group; the concentration difference maps were therefore 
independently assessed from that subject. The global region of interest was 
calculated as defined above, and the number of voxels in the region, along with the 
mean GMJWM concentration within that region, was measured on the subject's own 
MR image. This approach was therefore repeated 39 times, in order to benefit from 
making comparisons statistically independent. 
To summarize, the 8 VBM measurements (average value and volumes for GMIWM 
increases/decreases in concentration) for each subject "left out" were measured on 
the regions defined by the VBM analyses of the remaining 38 subjects. When 
completed, we had age of onset, duration of seizures, ipsi and contra-Iateral 
hippocampal volumes and those 8 VBM-based values for each subject that can be 
used as input to the classifier. 
Classification was performed using linear discriminant analysis of the 
aforementioned VBM and non-VBM based measures to assess group membership, 
with prior probabilities set to 0.7 (positive) and 0.3 (negative) in accordance with 
data set frequencies. The final reported result consisted in the mean accuracy of 
multiple cross-validated trials (Figure 26). In each of those trials, the study data is 
randomly split in two groups: the first group is the training set and is used to 
estimate the classification functions; the second group is the test set, classified using 
the functions derived from the training set. This procedure is repeated multiple 
times and the average proportion of correct classifications of the test set is an 
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empirical measure for the success of the discrimination. The cross-validation 
experiments were completed using SYSTAT 10.2 (SSI, Richmond, CA) . 
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Figure 26 - Cross-validation trials 
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Cross validation trials proceed as follows. The study population is randomly split 
into a training and a test set, with the linear discriminant functions estimated on the 
training set. The test set is used to evaluate how good the classification is, and this 
process is repeated multiple times to get a good estimate of the overall accuracy for 
classification. 
Experiments 
Four experiments were run: 
1) Prediction of surgical outcome using non-VBM based measures (age of onset, 
duration, ipsi and contralateral HC volumes); 
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2) Prediction of surgical outcome using VBM-based measures only; 
3) Prediction of surgical outcome using age of onset, duration and VBM-based 
measures; and 
4) Prediction of surgical outcome using aIl non-VBM and VBM-based measures. 
Results 
There were no statistical differences in age of onset, duration of epilepsy, ipsilateral 
or contralateral hippocampal volumes between the positive and negative outcome 
groups (P > 0.05, DF = 37) (see 
Table 4). Box plots of age of onset, duration, ipsi and contra-Iateral volumes are 
shown in Figure 27. 
Outcome N Age of Duration Ipsilateral HC Contralateral 
onset volume HC volume 
(yrs)[SD] (yrs)[SD] (mnf) [SD] (mnf) [SD] 
Positive 25 10.3 [6.0] 21.0 [12.1] 2588.8 [417.9] 3665.2 [669.1] 
Negative 14 15.1[13.2] 24.1 [11.3] 2327.8 [449.3] 3333.4 [679.3] 
P (Neg. to Pos.) > 0.05 > 0.05 > 0.05 > 0.05 
Table 4 - Clinical data for positive and negative outcome groups 
There was an equal (N = 7) number of patients with left-sided seizure focus and 
ipsilateral He atrophy than right-sided patients in the negative outcome groups, 
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while there were 14left-sided and 11 right-sided patients in the positive outcome 
groups. Due to the limited number of patients in this study, the relationship between 
outcome and lateralization of seizure foeus was not investigated further. 
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Figure 27 - Patient data 
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(A) and (B) Box-plots of age of onset and duration of epilepsy for the negative 
(group -1) and positive (group 1) outcome patients. (C) and (D) Box-plots ofipsi-
and contra-lateral hippocampal volumes for the same patients. Experiment 1 
assessed the accuracy of individual prediction using these data in multiple cross-
validation trials. Specificity to positive outcome was 87%, sensitivity to negative 
outcome was 13.8%, resulting in a combined accuracy of 72.6%. 
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Figure 28 presents the results of between-group VBM analyses for GM and WM 
concentration differences, respectively, with aIl 14 negative outcome patients 
compared to aIl 25 positive outcome patients. AlI voxels displayed are above the 
cluster threshold for statistical significance (t= [-3.326,3.326] for decrease or 
increase in concentration respectively, P < 0.05, corrected for data nonisotropy and 
multiple comparisons). Even though many voxels reached peak significance, and 
many more were ab ove the cluster threshold, there were no clusters that reached 
significance, as none reached the constraint on their extent (number of contiguous 
voxels)(Worsley, Andermann et al. 1999); we will therefore report statistical trends. 
GM concentration decreases (negative relative to positive outcome patients) are 
detected primarily in the left fronto-temporal and left inferio-temporal regions, 
while concentration increases are found primarily in the basal forebrain region (see 
Discussion). Trends in WM concentration decreases (negative relative to positive 
outcome patients) are noted in the le ft mid-temporal are a, caudal to the 
hippocampus; an area of increased WM concentration in negative outcome patients 
relative to positive can be found in the right cingulate at the parietallevel. 
It should be restated at this point that our definition of regions of interest is the 
ensemble of voxels above the t-statistic cluster threshold for significance; we did not 
impose as a condition that a voxel belong to a significant cluster. This relaxed 
condition entails that voxels included are not significant using standard VBM criteria 
however, as seen below, they can be used for classification. 
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The mean number ofvoxels per region was 3640 [SD 1120] for GM decrease and 
973 [446] for GM increase, while the mean WM decrease region was 419 [215] voxels 
and the mean WM increase region was 2963 [959] voxels. Box plots of mean GM and 
WM concentration measures within the regions of interest are shown in Figure 29. 
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Figure 28 - VBM results related to surgical outcome 
GM concentration decreases (A) and increases (B) in the negative outcome group 
when compared to positive outcome group as determined by VBM, shown in glass 
brain view; WM concentration decreases and increases are shown in (C) and (D), 
respectively. Ali voxels are above the cluster threshold for statistical significance (t > 
1 3.361), but clusters are not significant as they do not meet the statistical extent 
criterium. GM concentration decreases are seen in the left fronto-temporal and left 
inferio-temporal regions, while increases are noticed in the basal forebrain region, 
likely due to misclassification due to poor contrast. Trends in WM concentration 
decreases are noted in the left mid-temporal area, caudal to the hippocampus; an 
area of increased WM concentration in negative outcome patients relative to positive 
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can be found in the right cingulate at the parietallevel. Note that this VBM was 
completed using aIl 39 subjects. Wh en extracting the VBM-based measures for each 
subject "left out", the VBM would only use the remaining 38 subjects. 
Given those data, Experiments 1 through 4 assessed the accuracy of individu al 
prediction using a model built either with non-VBM (Experiment 1: 4 variables, age 
of onset, duration, ipsi and contralateral HC volumes), or VBM measures 
(Experiment 2: 8 variables, number of voxels, GM/WM mean concentration in the 
increase/decrease regions of interest), or a combination of the two (Experiment 3: 10 
variables, age of onset, duration, 8 VBM-based measures; Experiment 4: 12 variables, 
age of onset, duration, ipsi and contralateral HC volumes, and 8 VBM-based 
measures), with fifteen cross-validation trials run in each experiment. The median 
number of subjects in the training sample and the test sample, the specificity for 
positive outcome and sensitivity to negative outcome, as weIl as the combined 
prediction accuracy, were recorded and are shown in 
Table 5. 
Expt Variables Median number 
of subjects SP SN Accuracy 
Training Test 
set set 
1 4 37 2 87% 13.8% 72.6% 
2 8 37 2 91.7% 25.0% 66.7% 
3 10 37 2 90.5% 50.0% 76.5% 
4 12 37 2 90.9% 58.3% 78.9% 
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Table 5 - Summary of results [Specificity (SP) to positive outcome, sensitivity (SN) 
to negative outcome, and mean accuracy] 
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Figure 29 - VBM-based measurements 
(A) and (B) Box-plots of GM area average decreases and in creas es in concentration 
values, respectively, for ail voxels belonging to the global region of interest, in 
individual subjects volumes; WM area average increases and decreases are shown in 
(C) and (D) respectively. In this figure group (-1) represents negative outcome while 
group (1) represents positive outcome. While the spread in the measures is large, 
there are sufficient differences between the distributions to increase the specificity to 
positive outcome to 90.9%, the sensitivity to negative outcome to 58.3%, and the 
combined accuracy to 78.9%, wh en adding these features to those of Fig. 2. 
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Discussion 
Hippocampal and extra-hippocampal involvment in MTLE 
A consensus exists on the importance of HC resection in MTLE surgery, especially 
in cases where there is concordance between HC atrophy assessed on MRI and focal 
epileptic discharges measured via EEG. In such unequivocal cases, outcome can be 
reliably predieted (Jack, Sharbrough et al. 1992; Bautista, Cobbs et al. 1999); 
discordant assessments are not as reliable. 
The situation outside of the HC is not as weIl defined. Bonilha et al. (Bonilha, 
Kobayashi et al. 2004) report that the extent of the AG and HC resection is clearly 
associated with surgical outcome, whereas pre-operative variables and interictal 
EEG abnormalities are not. They hypothesize that an incomplete resection of 
atrophie HC may explain most surgieal failures in patients with MTLE due to 
unilateral He sclerosis (Bonilha, Kobayashi et al. 2004). However, in the 
retrospective study by Abosch et al. (Abosch, Bemasconi et al. 2002) mentioned 
earlier, of 27 SAH patients, 13 of these subsequently having undergone either 
extension of the SAH (six cases) or a cortico-SAH (seven patients), showed that 
ne ar-total resection of me sial structures did not necessarily improve outcome. The 
authors conclude by stating that the majority of patients receiving suboptimal seizure 
control following SAH did not meet the criteria for unilateral MTLE, and are 
therefore unlikely to benefit from addition al resection of me sial structures. There 
remains a subpopulation, however, that meets the criteria for MTLE, but does not 
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become free from seizure following SAH. This is also supported by an analysis of the 
discharge patterns by Bautista et al. (Bautista, Cobbs et al. 1999), concluding that 
patients with focal interictal epileptiform discharges included in surgical resection 
have good surgical outcomes, while those with discharges extending beyond the area 
of resection experience poor surgical outcome. 
The importance of extra-hippocampal anatomy for the prediction of postoperative 
outcome has been shown in a (18)fluorodeoxyglucose (FDG) positron emission 
tomography (PET) study by Dupont et al. (Dupont, Semah et al. 2000), where they 
correctly predicted 2 -year prognosis in 100% of the patients using 4 regions: the 
temporal pole, the medial temporal region, the anterior part of the lateral temporal 
neocortex, and the basofrontal region. 
We have identified areas of GM and WM concentration differences that were 
related to surgical outcome in TLE patients having undergone SAH using a standard 
VBM approach. The fact that there exist regions of differences nearly reaching 
significance, regardless of the mixed nature of the groups (left and right seizure 
focus), is further indication of extra-hippocampal involvement in TLE. The basal 
forebrain differences are more than likely due to errors in the automated tissue 
classifier (Zijdenbos and Dawant 1994) due to decreased tissue contrast in this area. 
WM and GM concentration decreases however in the fronto-, inferio and mid-
temporal areas are indicative of possible increased pathological affect in these areas. 
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By including this extra-hippocampal information to the other non-VBM information 
(age of onset, duration of seizure, ipsi/contralateral He volume) we increase the 
accuracy of MR-based classifiers to 4 out of 5 patients (Experiment 4), primarily 
by increasing the sensitivity to negative surgical outcome. This accuracy is 
maintained even if we automate completely the image processing, that is without 
resorting to manu al segmentation of the hippocampus (Experiment 3). We 
hypothesize that our results reflect the case that patients with poor surgical outcome 
have more disease-driven damage in extra-hippocampal areas, including extra-
temporal are as. 
Methodological Considerations 
Automated techniques for surgical outcome prediction are by nature objective; the 
proposed methodology is also data-driven, requires no user intervention 
(Experiment 3 paradigm), and is based on a standard Tlw MR acquisition. 
We have been successful in identifying significant peaks and trend areas of GM and 
WM concentration differences using a standard VBM approach. Figure 28 displays 
the VBM results for the between-group differences for aIl subjects. Our 
classification technique relies on a leave-one-out approach for purposes of 
independence however, we do not feel that the exclusion of one individual from the 
group comparison significantly changes the regions of GM and WM concentration 
differences when compared to the whole-group results. These areas could be refined 
if we were to use other approaches which improve the accuracy of VBM, such as 
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modulation by the Jacobian determinant (Good, Johnsrude et al. 2001), flipping 
left/right depending on side of seizure focus, or restricting the search area for VBM 
by eliminating regions known not to be affected in epilepsy (e.g. cerebellum, 
brainstem ). 
A limitation of this study is the relatively small patient sample size. Great care was 
taken to avoid dependence and overlearning of the training set, by performing 
multiple leave-one-out VBM analyses and subsequent cross-validation trials for 
classification. A larger database th an currently available would allow the separation 
into subgroups based on seizure focus laterality and/or to consider the four main 
Engel (Engel, Van Ness et al. 1993) outcome classes separately. 
Conclusion 
In this work we have set the basis for surgi cal outcome prediction for temporal lobe 
epilepsy patients undergoing selective amygdala-hippocampectomy, based on voxel-
based morphometry analysis of pre-operative grey and white matter concentration 
maps. Regions of difference exist between positive and negative outcome patients, 
and can be used to predict surgi cal outcome with high accuracy using a completely 
automated methodology; the accuracy is increased marginally when including 
manual, expert-based volumetric information. 
MR-based preoperative planning, including seizure focus lateralization, is an 
established procedure. This article presents the idea that pre-operative MRI can be 
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used to increase the accuracy of surgical outcome prediction for an individual 
patient. Using MRI to predict outcome, without depending on additional minimally-
invasive (SPECT, PET) or invasive (surgically implanted EEG or sEEG) modalities, 
could reduce the significant resources and patient burden devoted to pre-surgical 
evaluation, while improving success. Of course, conventional and/or sEEG remain 
critical tools for the understanding of the temporo-spatial pattern of the epileptic 
discharges; it is only proposed here that MRI can play a potent role in pre-surgical 
planning and evaluation. 
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Chapter 6 
Differentiation of AD and MCI from 
normal aging 
Foreword 
We have already mentioned that the difficulties in early clinical detection of AD lie 
for the most part in the similarities between its initial manifestations and cognitive 
impairment due to normal aging (NA) processes (Chetelat and Baron 2003). In 
order to resolve this situation an objective classification technique is required. 
Having previously demonstrated that existing appearance differences in TLE could 
be used for classification, we wished to test whether or not the same process could 
be used in the identification of AD or MCI patients when compared to normal aging 
individuals. The aspect of the method being investigated here is robustness, not to 
noise but rather to a change in the signal: given a completely dissimilar disease, with 
a radically different pathological process, would the classification be successful? We 
thought that our methodology was just as relevant as in TLE, as there were many 
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reports in the literature of intensity (Freeborough and Fox 1998) and shape changes 
(Fox and Schott 2004), to cite but a few, occurring with time between AD, MCI and 
NA. Further, there was ample evidence that the earliest pathologieal deposition of 
Aj3 in the brain occurred in various structures within the MTL (Thal, Rub et al. 
2002), and therefore our large volume approach, rather than a structure-centrie one, 
seemed equally applicable. 
Our goal remained to perform this task in a cross-sectional fashion, departing from 
the usual research paradigm of longitudinal examination. While we expected a loss 
of sensitivity and/or specificity due to this strategy, we believed that the clinieal 
reality could still be enhanced by a technique that would be readily applicable for the 
treating physician. The standard of comparison for this task was a clinieal diagnosis 
of probable AD or MCI according to criteria from NINCDS-ADRDA for the 
former and Petersen et al. (Petersen, Doody et al. 2001) for the latter. 
Our results indicate that our methodology was indeed robust to a different 
pathological process. We found that the appearance-based approach was 92.6% 
accurate in separating a group of 20 normal aging individuals vs 17 AD and MCI 
patients. This was superior to the 82.1 % accuracy of a model composed of age, 
MMSE scores, hippocampal and amygdala volumetrie measurements. 
An early form of this work was published as a conference proceeding (Duchesne, 
Pruessner et al. 2005), before being submitted for publication in the journal 
Alzheimer's and Dementia. 
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After submission of this manuscript, we became aware of a fundamental flaw in the 
image acquisition. Whereas we believed a priori that the scans had been acquired at 
a single site due to blinding during initial analysis, it appeared that such was not the 
case as patients and controls were actually scanned in 3 different centers within the 
Munich area. This could have had a significant impact on the results. 
We have since rerun our analyses, including this element as a new variable. We are 
pleased to report in an addendum to this manuscript that the system was sufficiently 
robust to maintain an accuracy of 90.9%, while rejecting the institution as a 
discriminating variable. This would therefore indicate that the methodology could 
handie muiti-site data, an important consideration in clinicai research. 
As the methodology has been extensively described in Chapter 3, the reader may 
choose to skip the Methods section of this chapter without loss of information. For 
the sake of brevity, keywords have not bee included, and a list of abbreviation can be 
found at the end of this thesis. 
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Abstract 
Background - Neuropathological studies in AIzheimer's dementia (AD) have 
shown brain degeneration early in the disease course in the medial temporal lobes 
(MTL). 
Objective - We aimed at differentiating AD and mild cognitive impairment (MCI) 
from normal aging (NA) with > 90% accuracy using a recently developed 
automated classification technique based on analysis of MTL information from 
cross-sectional MR data. 
Metbods 
Subjects- 13 clinical AD and 4 MCI patients [age 68.0 (8.2), MMSE 20.2(5.0)] were 
compared together against 20 NA subjects [age 60.8 (8.6), MMSE 29.8(0.6)]. Tlw 
MRI data were acquired after informed consent on a 1.5T scanner. 
Analysis- AIl sc ans were corrected for intensity signal inhomogeneity, linearly 
registered in stereotaxie space and intensity normalized. Hippocampal (HC) and 
amygdala (AG) volumes were obtained by manual segmentation. Rectangular 
volumes of interest (VOl) were defined on the left and right MTL (80 X 52 X 60 
voxels), linearly and nonlinearly registered to a reference target image. The 
classification features were the normalized intensity and the trace of the J acobian of 
the nonlinear registration deformation fields. Normative spaces for group 
comparison were created from 152 normal young subjects using principal 
components analysis of their intensity and trace VOIs, and the scans from the NA 
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and MCI + AD cohort subjects were projected in these spaces. Forward stepwise 
linear discriminant analyses of the eigendata was used to classify the subjects in 
multiple cross-validation trials. 
Results - There were significant group differences between NA and AD+ MCI for 
age (P = 0.0138) as weIl as MMSE, HC and AG volumes (P < 0.0001). For 
classification using non-MR features (age, MMSE, left and right He and AG 
volumes) the mean accuracy was 82.1 %, sensitivity to AD+ MCI 81.2%, and 
specificity to NA of 85.9%. For classification using only MR features, the mean 
accuracy was 92.6%, mean sensitivity 78.2% and mean specificity 97.3%. 
Conclusion - Our results indicate that cross-sectional MR data can adequately 
discriminate NA from AD+ MCI, at an improved accuracy when compared to HC 
and AG volumetry. This single-scan, practical and objective method holds promise 
for AD or MCI patient management. 
Introduction 
Neuroimaging techniques, in particular structural or anatomical magne tic resonance 
imaging (MRI), allow the visualization and quantification of pathologically induced 
brain changes in the living subject; it then becomes possible to employ those metrics 
as surrogate measures of the state of the disease. These techniques can help to 
achieve earlier diagnosis, characterize the time-course of the illness and generally 
increase therapy efficacy. 
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Alzheimer's disease (AD) is a progressive neurodegenerative disorder associated 
with disruption of neuronal function and graduaI deterioration in cognition, function, 
and behavior (Khachaturian 1985) . The progression of AD is graduaI, and the 
average patient lives 8 to 10 years after onset of symptoms (Petre lIa, Coleman et al. 
2003). It is the most common cause of dementia in the elderly (65 years and older), 
responsible for 75% of all dementia cases (Group 2000; J. R. Petrella 2003). As the 
globallife expectancy rises and populations age, the prevalence of AD is expected to 
triple over the next 50 years (Carr, Goate et al. 1997); improving care while reducing 
the socio-economic impact of AD is therefore an important and necessary topic of 
research. 
The diagnosis of clinically probable AD can be made with high accuracy in living 
subjects only once the stage of dementia has been reached, and requires clinical, 
neuropsychological and imaging assessments (PetrelIa, Coleman et al. 2003). It can 
only be confirmed by postmortem histopathology. Neuropathological studies have 
shown however that brain degeneration occurs very early in the course of the disease, 
even before the first clinical signs, in certain regions such as the medial temporal 
lobe (MTL) (PetrelIa, Coleman et al. 2003) (Figure 30). The etiology can be 
summarized as neuronal dysfunction and eventualloss due to abnormal 
accumulation of beta-amyloid proteins. 
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Figure 30 - Tl w imaging in normal aging, MCI and AD 
Anatomical magnetic resonance imaging (MRI) enables us to visualize 
pathologically induced brain changes in the living subject and use those as surrogate 
measures of the state of the disease. In general, radiological assessment of cross-
section al MR images demonstrates typical enlargement of ventricular and sulcal 
spaces in Alzheimer's dementia patients (AD, bottom row) wh en compared to 
normal aging individuals (NA, top row), but it is easy to find individuals with similar 
characteristics across both groups. The radiological situation is even more complex 
in the assessment of Mild Cognitive Impairment (MCI, middle row), an at-risk 
group of progression to AD. This significant overlap between the cross-sectional 
MRI appearance of NA, MCI and AD makes differentiation challenging for even the 
best trained observers. 
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The difficulties in early clinical detection lie for the most part in the similarities 
between cognitive impairment due to normal aging (NA) processes and the initial 
manifestations of AD (Chetelat and Baron 2003). Beyond changes due to normal 
aging, but before AD, mild cognitive impairment (MCI) is a condition referring to 
patients with significant but isolated memory impairment relative to subjects of 
identical age (Petersen, Doody et al. 2001). MCI individuals are considered an at-
risk group for progression to AD, and therefore early prediction of progression to 
AD in those patients is an important research goal. 
Our general hypothesis is that cross-sectional, single-scan classification may be 
possible based on detectable Tl w MR signal intensity differences that would 
possibly be due to pathology-related microscopie changes, combined with 
macroscopic alterations in structure shape, measurable via registration-based 
metrics. These features would be extracted a large, non-specific Volume of Interest 
(VOl) centered on the MTL (see Figure 31). 
Our goal is to demonstrate that it is possible to differentiate NA subjects from AD 
and MCI patients with high accuracy based solely on cross-sectional MRI data using 
an automated classification technique. 
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Figure 31- Hypothesis for classification 
Histological data for AD shows that tangles and plaques start to accumulate 
primarily in the medial temporal lobe, and are ultimately responsible for neuronal 
dysfunction and eventualloss. The hypothesis for our methodology is that pathology 
related microscopie cellular changes such as those would eventually affect the Tl-
weighted MR signal on a macroscopic level. The resulting intensity and shape 
changes can be exploited for classification purposes, even though the tangles or 
plaques cannot be seen on Tl w MRI at that resolution. 
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Method 
Study group 
A total of 194 subjects from three different groups were included in this study. The 
reference group consisted in 152 young normal subjects from the International 
Consortium for Brain Mapping database (ICBM)(Mazziotta, Toga et al. 1995), 
whose scans were used to create the reference model. The study population 
consisted in 20 normal aging subjects (NA), 13 AD and 4 MCI patients. Our goal 
was to demonstrate the ability of our classification methodology to differentiate NA 
from MCI or AD using MRI and therefore, we merged the latter two groups into a 
single patient group with 17 subjects. 
The patients had clinical diagnosis of probable AD according to the NINCDS-
ADRDA (McKhann, Drachman et al. 1984), recruited from the Alzheimer 
Memorial Center, Ludwig Maximilian University (Munich, Germany). Further 
sociodemographic information on study subjects is shown in 
Table 6. Cognitive impairment in the AD patients was assessed using the Mini-
Mental State Examination (MMSE)(Folstein, Foistein et al. 1975). MCI was 
diagnosed according to the criteria by Petersen et al. (Petersen, Doody et al. 2001). 
MCI patients performed below the age-adjusted average in tests on memory 
impairment in the absence of global cognitive impairment and impaired activities of 
daily living. Normal aging subjects were free of memory complaints and scored 
within 1 standard deviation on aIl axes of the CERAD (Consortium to Establish a 
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Registry for Alzheimer's Disease) cognitive battery. Significant medical co-
morbidity in the AD/MCI patients and controls was excluded by medical history, 
physical and neurological examination, psychiatric evaluation, chest X-ray, ECG, 
EEG, brain MRI and laboratory tests (complete blood count, sedimentation rate, 
electrolytes, glucose, blood urea nitrogen, creatine, liver-associated enzymes, 
cholesterol, HDL, triglycerides, antinuclear antibodies, rheumatoid factor, VDRL, 
HI V, serum B12, folate, thyroid function tests and urine analysis). None of the 
AD/MCI patients had hypertension or diabetes. AlI subjects or the holders of their 
Durable Power of Attorney provided written informed consent for the study. The 
protocol was approved by the Ethical Review Board of the Faculty of Medicine, 
Ludwig Maximilian University (Munich, Germany). 
N Age MMSE HC volume AG volume 
(rIS) (mnf) (mnf) 
Left Right Left Right 
NA 20 60.8 (8.6) 29.8 (0.6) 3332 (570) 3144 (594) 970 (255) 986 (299) 
AD+MCI 17 68.0 (8.2) 20.2 (5.0) 2060 (638) 1996 (628) 602 (274) 549 (236) 
P 0.0138 • <0.0001· <0.0001· <0.0001· <0.0001· <0.0001· 
(NA vs AD+ MCI) 
Table 6 - Infonnation on NA, AD, MCI cohort 
Data acquisition and initial processing 
The reference ICBM subjects were scanned on a Philips Gyroscan 1.5T scanner 
(Best, Netherlands) using a Tlw fast gradient echo sequence (TR=18 ms, TE=lO 
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ms, flip angle=30°, matrix size=256 x 256, FOV=256 mm, slice thickness=1 mm, 
sagittal acquisition). MRI examinations for the study subjects were performed on a 
1.5T Siemens Magnetom Vision MRI Scanner (Siemens, Erlangen, Germany), with 
a volumetry volumetrie T1w sagittally oriented MRI sequence (TR=11.6ms, 
TE=4.9ms, resolution 0.94 x 0.94 x 1.2 mm" rectangular FOV for sagittal slices 256 
mm (SI) x 204 (AP) mm]. Initial MRI processing was identical for aIl subjects in the 
study. Following acquisition, intensity inhomogeneities due to scanner variations 
were corrected (SIed, Zijdenbos et al. 1998) and the mean grey-Ievel intensity was 
scaled to that of the standard reference for aIl subjects. Linear registration was used 
for global alignment into the same standard reference space (Collins, Neelin et al. 
1994), that corresponds to a voxel-by-voxel average of the 152 reference subjects 
previously registered in the Talairach-like stereotaxie space in the context of the 
ICBM project (Mazziotta, Toga et al. 1995). The data was finally resampled onto a 
1mni isotropic grid (Mazziotta, Toga et al. 1995). 
MRI-based hippocampi and amygdalae volumes 
MRI volumetry of le ft and right hippocampi and amygdalae was performed by one 
rater (J.c.P.) for the NA and AD+ MCI patients using a previously published 
proto col (Pruessner, Li et al. 2000). 
MRI-based multi-dimensional classification 
The classification method can be summarized as follows (see Figure 32). First, from 
pre-processed data (A) volumes of interest centered on the left and right MTL were 
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extracted using stereotaxic-like (Talairach and Tournoux 1988) coordinates (start 
coordinates x= [ + 2,57] for the left and right sides respectively, y= [-53] and z= [-52]). 
Each VOl thus measured 55 x 82 x 80 = 360800 voxels. The extent of the VOl 
captured the hippocampus and neighboring MTL structures, such as the entorhinal, 
perirhinal and parahippocampal gyri, irrespective of normal inter- and intra-
individual variability. To further reduce position al variations, which would propagate 
as unwanted noise in the morphometric modeling, a local affine transformation was 
applied to co-register the individual subject's VOl with the corresponding VOl of 
the reference target. 
The second step was to generate a normal, non-pathological eigenspace (B) from 
the ICBM reference group of young, normal control subjects (N = 152). This 
multidimensional eigenspace was created by uniting results from four distinct 
Principal Component analyses of (i) intensity images of the left and right VOIs (C); 
and (ii) a measure of local volume change for the left and (Worsley, Marrett et al. 
1996) right VOIs (D). The latter estimate was derived from the determinant of the 
Jacobian of the deformation field, obtained following non-linear registration of the 
subject volume to the reference image. 
Nonlinear registration attempts to match image features from a source volume to 
those of the reference image at a locallevel, typically in a hierarchical fashion, with 
the aim of reducing a specifie cost function. Whereas many nonlinear registration 
processes exist, the one chosen for this study was ANIMAL, developed by Collins et 
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al. (Collins and Evans). This algorithm attempts to match image grey-Ievel intensity 
features at a locallevel (voxel) in successive blurring steps, by maximizing the cross-
correlation function of voxel intensities between the source and reference images. 
The result is a dense deformation field, capturing the displacements required to 
align the subject VOl with that of the reference image. 
Figure 32 - Methodology 
The classification methodology used in this article can be broken down in the 
following steps. First, aIl images are pre-processed in an identical fashion, which 
includes signal inhomogeneity correction, global alignment to a standard stereotaxie 
space, and extraction of two volumes of interest, centered on the left and right 
medial temporal lobes, shown in (A). A local affine transformation is applied to the 
local VOl to improve the alignment with the reference volume, and the mean 
intensity of the VOl is scaled with respect to the mean intensity of the reference 
volume in (C). We also extract, for each of those volumes of interest, a measure of 
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shape variation in (D). Intensity and shape models for each VOl are buiIt using 
Principal Components Analysis in (B), in order to generate a reference space from a 
group of images of 152 young healthy volunteers. Our ultimate goal being to 
discriminate between groups A and B (NA vs AD+MCI), we process their images in 
a similar fashion and project the intensity and shape volumes in the 
multidimensional space of the reference group in (E). For classification, we exploit 
the differences in the projection eigencoordinates using crossvalidated, linear 
discriminant analyses in (F). 
The classification of NA and AD+ MCI subjects was accomplished by projecting 
their VOIs in the multidimensional reference eigenspace (E), and then by 
estimating the classification functions with forward stepwise linear discriminant 
analyses. The goal is not to find a feature space that optimally represents the two 
groups but rather to find a suitable basis for comparison, allowing for effective 
classification (Figure 33). 
The final reported result consisted in the mean accuracy of multiple cross-validated 
trials (Figure 34). In such designs, the study data is randomly split in two samples, 
the first (training set) to estimate the classification functions, used to classify the 
second sample (test set). The proportion of correct classification for the test set is an 
empirical measure for the success of the discrimination. 
Experiments 
There were two classification experiments performed: 
~ Experiment 1 was aimed at separating the NA and AD+ MCI groups on the basis 
of non-MR features (baseline age, MMSE, left and right AG and HC volumes); 
and 
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~ Experiment 2 was aimed at separating the NA and AD+MCI groups on the basis 
of MR features, extracted in the fashion described above. 
2 
Figure 33 - Cartoon-like representation of classification of patient groups 
The reference set is represented by the blue ellipse, aligned and centered with the 
first two principal components since the eigenspace originates from this data. Our 
goal however is to use the same space for the separation of NA individuals (green) 
from AD+MCI patients (orange and red). The goal is not to find the optimal space in 
which to represent the NA, AD or MCI subjects, but rather to have a common basis 
to compare populations. 
Results 
Subjects age, MMSE and volumetry 
There was a significant group difference for baseline age (DF=36, P=O.0138) when 
comparing the NA and AD+ MCI groups (Table 6). The average MMSE score in 
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the AD group was 18.7, which would qualify them as being "moderate" AD (Petrella, 
Coleman et al. 2003); the MCI group MMSE average was 25.5. When combined the 
AD+ MCI MM SE group average was 20.2, significantly different (DF=36, 
P<O.OOOl) from the NA group MMSE average of 29.4. 
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Figure 34 - Cross-validation trials 
The study population is randomly split into a training and a test set, with the linear 
discriminant functions estimated on the training set. The test set is used to evaluate 
how good the classification is, and this process is repeated multiple times to get a 
good estimate of the overall accuracy for classification. 
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There were significant volume differences between the two groups under study for 
aIl structures (Table 6): left He (DF=36, P<O.OOOl), right He (DF=36, P<O.OOOl), 
left AG (DF=36, P=0.0002), and right AG (DF=36, P<O.OOOl). 
Given those group differences, Experiment 1 was designed to assess the accuracy 
of individual classification using these 6 features (age, MMSE, left and right He, left 
and right AG volumes). Forward, stepwise linear discriminant analysis (P-to-enter = 
0.15) was used to select the discriminatory variables from the training set and 
compute the classification function for each trial of the test set. Fifteen cross-
validation trials were run, with a median of 30 subjects in the training sample and 7 
in the test sample. The mean accuracy for individual classification was 82.1 %, the 
mean sensitivity to AD+ Mel was 81.2%, and the mean specificity to NA 85.9%. 
The median number of variables retained by the forward, stepwise linear 
discriminant analysis was 1, with never more th an 2 variables retained by the mode!. 
More specificaIly, the left He volume was always chosen; in 9 trials out of 15, it was 
the only variable retained. In 5 trials, age was also significant, and in one trial, left 
AG volume. 
Experiment 2 was designed to assess the accuracy of individual classification using 
MR-based features. Our ove raIl MRI-based model, formed by the union of the 
intensity and trace principal components for the left and right VOIs, was built using 
our training set of 152 young control subjects. A total of 538 principal components 
were retained, accounting for 99.7% of the variance of the reference data set. 
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Fifteen cross-validation trials were ron, with a median of 32 subjects in the training 
sample and 5 in the test sample. Forward, stepwise linear discriminant analysis (P-
to-enter = 0.15) was used to select the discriminatory variables from the training set 
and compute the classification function for each trial of the test set. Normality of the 
eigencoordinates along those eigenvectors was confirmed using quantile plots and 
Shapiro-Wilke test (P > 0.05). The mean accuracy for individual classification was 
92.6%, the mean sensitivity to AD+ MCI was 78.2%, and the mean specificity for 
NA 97.3%. 
The median number of variables retained by the forward, stepwise process was 17. 
A plot of the NA vs AD+ MCI eigencoordinate data along the three most occurring 
discriminative eigenvectors is shown in Figure 6. AlI but two of the 7 most occurring 
eigenvectors throughout the trials (occurrence > 2) were shape eigenvectors. 
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Figure 35 - Patients data projected along most discriminant eigenvectors 
The NA (green) and AD+MCI (red) data is shown here plotted along the three most 
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discriminating eigenvectors in the multidimensional reference space of cross-
sectional MR intensity and shape information. One can estimate a plane that would 
optimally separate the two groups in one of the cross-validation trials. The resulting 
average discriminatory accuracy for 15 trials was 92.6%, with a mean sensitivity of 
78.2% and mean specificity of 97.3%. 
Discussion 
Our results indicate that the position information (eigencoordinates) of new data 
projected in a multidimensional normative domain is sufficient to adequately 
discriminate between normal aging individuals and AD or MCI patients. The mean 
accuracy of the technique, given the study population, was 92.6%, its mean 
sensitivity 78.2% and mean specificity 97.3%. 
Methodological implications 
ln order for automate d, quantitative neuroimaging methods to gain widespread 
acceptance in the scientific and clinical community, they must meet and exceed the 
lower bound on overall diagnosis accuracy set by current clinical performance, 
estimated at 78% in the case of AD (Weiner, Albert et al. 2005). Techniques must 
also be reproducible, practical, objective and sufficiently accurate to detect changes 
due to the pathology of interest. 
Accuracy - The identification of group membership based on MR features is on 
average 10% more accurate than if it were done with baseline age, MMSE and 
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manually segmented HC and AG volumes. It is also 15% more specifie. However, it 
has to be noted that the technique is less (7.7%) sensitive. 
The increased accuracy can readily be explained when one considers the 
informational value of the two approaches. In HC volumetry, between 3000 to 4000 
voxels are compressed in a single scalar measurement, expressed in maT, while in 
the methodology being propose d, more th an 4 X 300000 voxels are processed and 
expressed in terms of 538 principal components coordinates. Clearly, additional 
important information is embedded in MTL voxels, and is included in our analysis in 
the form of intensity and shape covariates. 
Reproducibility - Being a completely automated methodology, the technique 
presented in this article is therefore completely reproducible. Volumetry, on the 
other hand, shows intra (0.91-0.95) and inter-rater (0.83-0.91) variability, as 
demonstrated in a study on hippocampal segmentation by Pruessner et al (Pruessner, 
Li et al. 2000). This added variability in segmentation measurements - volumetrie 
noise - reduces the classification accuracy of any methodology. 
Practicality - It is important to note that the PCA technique as employed here 
requires no manual intervention other than the definition of the VOl, which is done 
once and based on Talairach coordinates on the reference image. This is a 
significant reduction of required resources when comparing such a technique to 
volumetry or other expert-based techniques that may require 2 hours per 
hippocampus for manual segmentation (Hogan, Mark et al. 2000). 
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Objectivity - The underlying assumption for this work is that there exists sufficient 
information in a chosen VOl from MRI to be used for the accurate determination of 
group membership in aIl subjects. As there is no further user interaction other than 
the delineation of the VOl, the process is completely data-driven and therefore 
objective. 
Clinical implications 
Use of cross-sectional MRI vs other imaging modalities for AD 
diagnosis 
For patients with AD or at an increased risk of developing AD (e.g. MCI) a number 
of approaches can be considered in order to aid the diagnosis, aIl with varying 
degrees of success. Neuropsychological screening tests are necessary to recognize 
and monitor these subjects, with an accuracy of 78 % (Weiner, Albert et al. 2005). 
Neuroimaging approaches must be considered, however disadvantages of techniques 
other than routine MRI preclude them from being widespread AD diagnosis-
enabling technologies. PET (Klunk, Engler et al. 2004) and SPECT (Kogure, 
Matsuda et al. 1999; Herholz 2003) offer sufficient specificity and sensitivity in the 
differential diagnosis of AD from other cortical and subcortical dementias and also 
offer prognostic value however, both modalities are minimaIly invasive procedures 
with radiation dose limitations and therefore cannot be repeatedly performed on a 
single patient for longitudinal studies nor used as a screening mechanism for large 
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populations. Other techniques such as fMRI (Johnson, Saykin et al. 2000), MR 
spectroscopy (Kantarci, Smith et al. 2002), MR diffusion tensor (Stahl, Dietrich et al. 
2003) and MR magnetization transfer (Kabani, SIed et al. 2002) show promise for 
the future, but they are difficult to implement in a clinical setting without a 
dedicated research group for technical support. Finally, as compared to MRI, CT 
images lack the detailed soft-tissue information necessary for detecting subtle 
structure changes associated with the disease, especially at an early stage, even 
though late-stage measures show promise(Frisoni, Rossi et al. 2002). 
Longitudinal analysis of MRI has been proposed to differentiate between aging, 
MCI, and AD (Fox and Freeborough 1997; Fox and Schott 2004) with high accuracy. 
However, by its very nature such a method implies a delay between sc ans before any 
assessment can be made. That delay, required to detect a change induced by the 
pathology in seriaI scans, reduces the window of opportunity for early treatment or 
optimal patient management. Cross-sectional analysis, on the other hand, by 
generating an immediate assessment, would allow for better patient management if 
shown to be sufficiently accurate. 
Automated classification vs expert-based volumetry 
Volumetry, that is volume measurement of a particular bounded structure of interest, 
is the primary indicator of structure integrity. Stereology, i.e. the technique of 
proper sampling based on the Cavalieri principle (Cavalieri 1635), has been the 
preferred approach to calculating volumes before the advent of high-resolution 
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images, where volumes can be reliably estimated directly from the (often isotropic) 
voxel count, slice thickness and pixel size. Cross-sectional measurements of the 
hippocampus have achieved classification accuracies between controls and AD 
patients of nearly 90%, and between individuals with MCI and AD patients near 
80%, with hippocampal volumes and/or deformation analysis (Csernansky, Wang et 
al. 2000; Pennanen, Kivipelto et al. 2004) Longitudinally-assessed MR-based atrophy 
rates of the hippocampus is also a reliable indicator of the state of the disease (Jack, 
Slomkowski et al. 2003) . 
While undeniably useful for understanding disease-driven changes in the chosen 
structure(s), volumetry relies on accurate segmentation, a process subject to 
inter/intra-rater variability (Pruessner, Li et al. 2000) as mentioned earlier. This 
variability is likely to increase in MCI and AD as boundaries shift due to atrophyand 
become less clearly delineated as intensity changes. This added variability in 
segmentation measurements, or volumetrie noise, will reduce the classification 
accuracy of any methodology based on such information. Finally, it requires expert 
knowledge, making it unsuitable for large-scale studies and may limit its availability 
in a clinical setting. 
Morphological findings 
From the results of Experiment 1, we can reasonably conclude that left HC volume 
is the main variable differentiating NA and MCI + AD groups, in line with other 
observations from different groups (Visser, Scheltens et al. 1999; Mungas, Reed et al. 
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2002; Thompson, Hayashi et al. 2004). Likewise, from Experiment 2, local volume 
changes are the strongest discriminators between our two groups since shape 
eigenvectors are mostly used in the classifier. This is also supported by the literature 
that shows different atrophy patterns between AD and NA (Fox and Schott 2004; 
Thompson, Hayashi et al. 2004). 
A more detailed assessment of the variations in intensity and shape embedded in the 
significant eigenvectors should yield important information regarding the 
pathophysiology of the disease, but is beyond the scope of this paper. This 
assessment should provide important clues to the on-going disease processes 
common across individuals and their implications on brain morphology. This task 
will be performed, and interpreted with their clinical correlates, in a separate 
communication. 
Conclusion 
We report results from a quantitative MRI technique that achieved the required 
sensitivity and specificity in the cohort studied by classifying AD+ MCI vs NA with 
92.1 % accuracy, 97.3% specificity and 78.2% sensitivity. The methodology does not 
rely on segmentation, requires no user input and is data-driven. Such a system stands 
to benefit patients and health care systems immediately. 
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Addendum 
Mter submission of this manuscript, we became aware of a fundamental flaw in data 
analysis due to blinding to subject data. Whereas we believed a priori that the scans 
had been acquired at a single site, it appeared that such was not the case as patients 
and controls were actually scanned in 3 different centers within the Munich area (see 
Table 7 for breakdown). We therefore needed to assess the impact on the results. 
Group 
NA 
MCI 
AD 
Site 1 
15 
o 
o 
Site 2 
5 
o 
4 
Table 7 - Acquisition sites 
Site 3 
o 
4 
9 
Leave-one-out classification based solely on acquisition sites separates individuals in 
our two groups (NA vs AD+ MCI) with 76% accuracy. 
Experiment 1 was rerun including acquisition site as a variable. Forward, stepwise 
linear discriminant analyses (P-to-enter = 0.15) were used in fifteen cross-validation 
trials, with a median of 33 subjects in the training sample and 4 in the test sample. 
The mean accuracy for individual classification was 83% (compared to 82.1 % 
previously), the mean sensitivity to AD+ MCI was 83.4% (compared to 81.2% 
previously), and the mean specificity to NA 79.6% (compared to 85.9% previously). 
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The median number of variables retained by the fOlward, stepwise linear 
discriminant analysis was 2, and in aIl trials, acquisition site was retained as a 
discriminant variable. 
Experiment 2 was repeated as weIl, including acquisition site along with MR 
features. Fifteen cross-validation trials were run in a similar fashion as Experiment 
1, with a median of 33 subjects in the training sample and 4 in the test sample. The 
mean accuracy for individual classification was 90.9% (compared to 92.6% 
previously), the mean sensitivity to AD+ MCI was 76.2% (compared to 78.2%), and 
the mean specificity for NA 97.3%, identical to the previous result. The median 
number of variables retained by the forward, stepwise process was 17, and in 14 out 
of 15 trials, acquisition site was not retained by the stepwise process; in the one trial 
where it was, it was of low rank. 
This would therefore indicate that our methodology is sufficiently robust to multi-
site differences in scanner hardware and acquisition variations. While more balanced 
and planned testing is required, this fortuitous discovery bodes weIl for the ability to 
handle multi-site data, an important consideration in clinical research. 
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Chapter 7 
Prediction of MCI progression to AD 
Foreword 
Outside of therapeutic research, one of the most important questions in the field of 
AD is to de termine who, within at-risk groups, and eventually the general population, 
will develop the disease. The study of the morphological differences between MCI 
patients that will progress to AD (decline in cognitive status towards dementia) vs. 
those that do not progress is still in its infancy, and no consensus has emerged yet 
regarding possible different appearance patterns between these patients. 
Longitudinal structural analysis does indicate a higher rate of atrophy in structures 
such as the hippocampus for progressors, however cross-sectional analysis is not 
equally sensitive (Chong and Sahadevan 2005). 
We confirmed in the last chapter that differences related to AD pathology could be 
estimated with a linear modeling approach of appearance principal components. 
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Given these, the dimensions that we sought to investigate in this last article were 
two-fold: on the one hand, extend this work to address the important issue of 
prediction of progression to AD in a cohort of MCI patients, and on the other, 
assess the system's robustness to noise and low resolution data. 
The cohort we investigated was part of a larger study on memory loss in the elderly, 
arguablyone of the few studies of this kind in the world with such long-term clinical 
follow-up. We selected 24 MCI patients from this study, 2/3 ofwhom progressed to 
AD within a mean time of 2.6 years, and the remaining patients remaining stable 
after a mean follow-up of 5.7 years. IncidentaIly, baseline neuropsychological testing 
proved insufficient for predicting progression to AD (Chertkow, Bocti et al. 2005). 
The MR data we used had Imm in-plane resolution but 5mm slice thickness. Even 
though we resampled that data to a Imm isotropie grid, the classification was 
essentially presented with 20% less information when compared to the three studies 
in previous chapters. We also realized that there were many movement artifacts, 
noise contributors to the images. Those artifacts were responsible for rejecting most 
(about 2/3) of the patients from the parent memory study. 
Using noisy, low resolution data served two objectives: by itself, it was a test of how 
much data was actually needed for the classifier, as weIl as giving an idea of its 
robustness. Secondly, it was also a real-world test, where the clinical reality dictates 
that acquisitions must be performed quickly, especially in aging subjects and even 
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more so in patients with dementia; if proven successful in this data set, it would bode 
weIl for its use outside of the research and into the clinic. 
The standards of inclusion and progression for patients in this study were based on 
extensive clinical diagnosis of MCI and probable AD according to criteria including 
Petersen et al. (Petersen, Doody et al. 2001), the Montreal Cognitive Assessment 
scale (Nasreddine, Phillips et al. 2005) and the NINCDS-ADRDA. 
We are pleased to report that the methodology was robust and highly successful to 
predict future clinical state in our cohort of MCI patients, with an accuracy of 82.6%. 
This essentially means that, given only baseline scans for these individuals, an 
automated analysis technique could predict progression to dementia on average 2.6 
years before the clinical diagnosis in four patients out of five. We also established 
that the main are as of signal difference were related to Tl w intensity in the right 
MTL, calling for future work in biological interpretation. 
An early form of this work was published as a conference abstract (Duchesne, De 
Sousa et al. 2005), before being submitted for publication in the journal Lancet 
NeuroJogy. 
As the methodology has been extensively described in Chapter 3, the reader may 
choose to skip the Methods section of this chapter without loss of information. For 
the sake of brevity, keywords have not been included, and a list of abbreviation can 
be found at the end of this thesis. 
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Abstract 
Background - Amnestic Mild Cognitive Impairment (MCI) individuals are known 
to be at risk for progression to Alzheimer's Dementia (AD). There is evidence that 
in those who will progress, measurable hippocampal and entorhinal cortex atrophy 
from MRI serves as a moderate, though labor-intensive, predictor. 
Objective - We aimed at predicting progression to AD in MCI patients using a 
recently developed MRI-based automated classification technique, which uses aIl 
MRI data within a 3D rectangular volume of interest, automatically positioned on 
the medial temporal lobes (MTL). 
Metbods 
Subjects-24 amnestic MCI patients gave informed consent to participate in this 
study, which was approved by our IRB. Mean follow-up after baseline 
neuropsychological testing and MRI was 5.7 (4.0) yrs. 16 patients progressed to AD 
after 2.6 (1.6) yrs [me an age 77.7, sd (5.1) yrs, MMSE 26.9 (2.4) at baseline], and 8 
remained non-demented at date oflatest follow-up [age 80.3 (6.3) yrs, MMSE 28.5 
(1.2) at baseline]. 
Analysis- Baseline Tl-weighted MRIs were acquired on a 1.5T scanner (5 mm 
slices), corrected for intensity inhomogeneity, linearly registered in stereotaxie space, 
resampled to a 1mm3 grid and intensity normalized. Rectangular volumes of interest 
(VOl) were defined on the left and right MTL (80 x 52 x 60 voxels). Each VOl was 
further linearly and non-linearly registered to a reference target image. 
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Multidimensional reference spaces were built using principal component analysis of 
(i) the normalized intensity and (ii) a shape metric, corresponding to local volume 
change, calculated via the trace of the Jacobian of the dense deformation field from 
nonlinear registration. This was do ne first for a reference set of 152 normal young 
subjects. Afterwards, scans from the study subjects were projected in these spaces to 
extract features for each data set. Forward stepwise linear discriminant analyses 
were used on the projection coordinates in multiple cross-validation trials to assess 
the classifier performance. 
Conclusion - Results of 15 cross-validation trials show an average sensitivity to 
progression to AD of 94% (15/16), average specificity to non-progression of 75% 
(6/8) and overall average accuracy of 88% (21/24). These results indicate that single-
scan MR data projected in multidimensional feature domains has the potential to 
adequately predict future clinical status of amnestic MCI patients. This practical, 
automatic, and objective method therefore holds promise for early AD detection as 
an aid to diagnosis and patient management. 
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Introduction 
Mild cognitive impairment is a term that describes elderly individuals with memory 
complaints and significant objective cognitive impairment relative to subjects of 
identical age (Flicker, Ferris et al. 1991; Petersen, Doody et al. 2001). Individuals 
with mild cognitive impairment are considered an at-risk group for progression to 
dementia (DeCarli 2003; Dubois and Albert 2004). For those individuals where 
memory loss is the predominant complaint, the term amnestic MCI (hereafter 
referred to simply as MCI) is now used. MCI strongly predicts progression to 
dementia due to Alzheimer's disease (AD)(Petersen 2004). AD is a progressive 
neurodegenerative disorder associated with disruption of neuronal function and 
graduai deterioration in cognition, function, and behavior (Khachaturian 1985). 
Early prediction of progression to AD in MCI patients is therefore an important 
research goal. 
The etiology of AD is not clearly known, but most researchers stress the abnormal 
accumulation of Ap and Tau proteins (Thal, Rub et al. 2000; Thal, Rub et al. 2002; 
Giannakopoulos, Herrmann et al. 2003) leading to neuronal dysfunction and 
eventual cellioss and abnormal cell death. Neuropathological studies in AD have 
shown in fact that abnormal accumulation of proteins and brain degeneration occurs 
very early in the course of the disease, even before the first clinical signs. 
Neurofibrillary tangles accumulate early on in certain regions such as the medial 
temporal lobe (MTL)(Cummings, Pike et al. 1996; Nagy, Hindley et al. 1999; Thal, 
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Rub et al. 2000; Thal, Rub et al. 2002; J. R. Petrella 2003; Petrella, Coleman et al. 
2003). Microscopicallya strong predictor of premortem cognitive dysfunction 
appears to be the relative area of entorhinal cortex occupied by beta-amyloid 
deposition (Cummings, Pike et al. 1996). Macroscopically, there is a growing body of 
evidence indicating that entorhinal cortex atrophy is a strong predictor of 
progression to AD in MCI individuals (Du, Schuff et al. 2003; deToledo-Morrell, 
Stoub et al. 2004; Pennanen, Kivipelto et al. 2004) 
To date the diagnosis of clinically probable AD can be made with high accuracy in 
living subjects only once the stage of dementia has been reached, and requires 
clinical, neuropsychological and imaging assessments (J. R. Petrella 2003); it can 
only be confirmed by postmortem histopathology (Risse, Raskind et al. 1990). 
For the detection of initial manifestations of AD in MCI patients a number of 
approaches are being proposed with varying degrees of success (Chertkow 2002; 
Chong and Sahadevan 2005). Clinical prediction and use of neuropsychological tests 
have been used to assess risk of progression in group studies, but have not yet 
proven their utility in individu al cases (Daly, Zaitchik et al. 2000). The accuracy of 
neuropsychological cognitive markers for AD is approximately 78 % (Weiner, Albert 
et al. 2005). CSF biomarkers reach high sensitivity and specificity, but have 
associated complications in clinical practice and might not be acceptable on a 
repeated basis (Blennow and HampeI2003). 
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Neuroimaging must be considered (Chetelat and Baron 2003) yet, disadvantages of 
techniques other th an routine anatomical MRI preclude them from being 
widespread AD prognosis-enabling technologies. Positron Emission Tomography 
(PET) (Klunk, Engler et al. 2004; Nordberg 2004) and Single Photon Emission 
Computer Tomography (SPECT) (Kogure, Matsuda et al. 1999; Herholz 2003) have 
been used with varying degrees of success in diagnosing and predicting AD but are 
expensive and not standardized. Furthermore, both modalities are minimally 
invasive procedures with radiation dose administration and associated cumulative 
limitations, and therefore cannot be repeatedly performed on a single patient for 
longitudinal studies nor used as a screening mechanism for large populations. 
Other techniques such as fMRI (Johnson, Saykin et al. 2000), MR spectroscopy 
(Kantarci, Jack et al. 2000), MR diffusion tensor (Stahl, Dietrich et al. 2003) and 
MR magnetization transfer (Kabani, SIed et al. 2002) imaging show promise for the 
future, but are aIl difficult to implement in a clinical setting without a dedicated and 
sophisticated research group for technical support. FinaIly, as compared to 
anatomical MRI, CT images lack the detailed soft-tissue information necessary for 
detecting subtle structure changes associated with the disease at a very early stage, 
even though late-stage AD measurements show promise (Frisoni, Rossi et al. 2002). 
Cross-sectional and longitudinal analysis of MRI for measurement of volumes and 
atrophy rates of the hippocampi (HC) and other structures have been proposed to 
differentiate between aging, MCI, and AD (Fox and Freeborough 1997; Jack, 
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Slomkowski et al. 2003; Fox and Schott 2004) . There is evidence that in those who 
will progress, measurable hippocampal and entorhinal cortex atrophy as 
demonstrable on T1-weighted (T1w) MRI, serve as a moderate, though labor-
intensive, predictor (Du, Schuff et al. 2001; Grundman, Sencakova et al. 2002; 
deToledo-Morrell, Stoub et al. 2004; Korf, Wahl und et al. 2004; Pennanen, Kivipelto 
et al. 2004). While undeniably useful for understanding disease-driven changes in 
the chosen structure ( s), volumetry relies on accurate segmentation, a time-
consuming process subject to inter/intra-rater variability (Pruessner, Li et al. 2000). 
More importantly perhaps, it requires expert knowledge, making it unsuitable for 
large-scale studies and this williimit its widespread availability in a clinical setting. 
Further, by its very nature longitudinal analysis implies a delay between sc ans before 
any assessment can be made. That delay, required to detect a change induced by the 
pathology in seriaI scans, reduces the window of opportunity for early treatment or 
optimal patient management. Cross-sectional analysis, on the other hand, by 
generating an immediate assessment using a single scan, may allow for better patient 
management if shown to be sufficiently accurate. 
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Our general hypothesis is that prediction of future clinical state may be possible 
based on Tl w MRI signal differences, detectable on cross-sectional or single-scan 
images. These would possibly be due to pathology-related microscopie and 
macroscopie changes or alterations in structure shape, measured via intensity and 
shape-based features and forming a measure of the appearance of an image. 
Moving away from structure-centric approaches, appearance features extracted from 
a large, non-specific Volumes of Interest (VOl) centered on the MTL of the subject 
(see Figure 36) can be compared to multiple MR images of reference, and training 
and test groups are used to build a model for prediction. 
The overall technique, called appearance-based classification (ABC), was applied 
successfully in the lateralization of the seizure focus in temporal lobe epilepsy 
(Duchesne, Bernasconi et al. 2006). 
Figure 36 - Intensity and shape features within the volume of interest 
(Left) Sagittal whole-brain view for subjeet with hippoeampal atrophy. (Middle) 
Closer view of the Volume of Interest (VOl), as defined in stereotaxie spaee on the 
left medial temporal lobe. (Right) Identieal view trough the traee VOl for the same 
subject. Green voxels do not move. From green to white (maximum) via yellows and 
reds indieate increase or expansion. From green to black (minimum), via blues and 
purples indicate decrease or contraction. The direction of movement is defmed as 
the deformation that the subject's VOl seen in (A) must accomplish in order to align 
with the corresponding VOl extracted from the reference volume. 
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Our goal is to demonstrate the ability of this novel MRI-based automated 
classification technique in predicting progression to AD in a cohort of MCI patients. 
Metbods 
Subjects and neuropsychological evaluation 
The McGill University Study of Mild Memory Loss in the Elderly has followed a set 
of 89 amnestic MCI (with or without other cognitive domain problems) over 12 years. 
AlI subjects had presented to their family physician with complaints (from the 
individuals themselves or their families) of memory loss, and were referred for 
further evaluation. AlI were assessed by a neurologist or geriatrician skilled in 
assessment of memory-impaired elderly individuals, and were judged as also able to 
meet the criteria for Mild Cognitive Impairment (MCI) defined in the working 
group of Winblad and colleagues (Winblad, Palmer et al. 2004) as weIl as Petersen 
in his original operational definition of MCI (Petersen, Smith et al. 1995; Petersen, 
Smith et al. 1999). AlI had a history of memory decline in the last 1-4 years reported 
by the patient, caregiver (usually the spouse), or both, of a sufficient degree to bring 
them to medical attention. AlI subjects were documented to have objective memory 
impairment on a standardized mental status exam. Deficits in other cognitive areas 
(outside of short term memory) were judged as minimal and not sufficient to imply a 
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clinical diagnosis of dementia. In aIl cases, there was supporting objective evidence 
on clinical mental status evaluation as weIl as formaI neuropsychological testing. 
The subjects did not meet the NINCDS-ADRDA criteria for the diagnosis of 
probable AD or the DSM-3 criteria for dementia, due to the lack of significant 
associated other cognitive deficits or to the lack of impairment of daily functioning 
(McKhann, Drachman et al. 1984) ((APA) 1994) . AlI were classified according to 
the Washington University clinical dementia rating (CDR) scale and met the 
criteria for "0.5" on that scale as described above (Hughes, Berg et al. 1982). There 
was no evidence on clinical evaluation of systemic or other neurological disease 
sufficient to interfere with cognitive function. CT and/or MRI excluded structural 
brain disease, and blood work was done including CBC, routine chemistry, thyroid 
function, serum B12, folate, and VDRL. AlI subjects scored less than 4 on the 
Hachinski ischemic sc ale (Hachinski, Iliff et al. 1975). The Mini-mental status exam 
(MMSE) (Foistein, Foistein et al. 1975) was carried out by the clinician as a global 
assessment too1. 
Subjects received standardized clinical, mental status, neuropsychological, 
and cognitive evaluation. AlI subjects underwent neuropsychological evaluation 
which included the Logical Memory 1 and II components of the Weschler Memory 
Scale (Wechsler 1987), the RA VLT (Rey Auditory Verbal Learning Test), the 
FOME (Fuld Object Memory Examination), the Knopman and Ryberg test of 
verbal memory (Knopman and Ryberg 1989). A shortened version of the Boston 
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Naming test (Kaplan, Goodglass et al. 1978), letter and category fluency , tests of 
block design (Wechsler 1981) and clock drawing (Freedman and Leach 1994) as 
weIl as the digit symbol and digit span sub-tests of the W AIS- R verbal intelligence 
scale (Wechsler 1981) were also administered. Depression was excluded via the 
Yesavage Geriatrie Depression Scale (Geriatrie Depression scale > 15) (Yesavage, 
Brink et al. 1983). 
The diagnosis of amnestic MCI in our cohort was supported by a 
neuropsychological evaluation establishing that a) there was memory performance at 
least 1 s.d. below the mean on one of the RA VLT (Rey Auditory Verbal Learning 
Test), the FOME (Fuld Object Memory Examination), or the Logical Memory 
(paragraph recaIl) subtest of the Wechsler Memory Scale - Revised. 
The subjects were followed at 12-month intervals with both clinical assessment and 
repeat neuropsychological examination. At each visit, the clinical diagnosis was re-
evaluated by the multi-disciplinary team headed by a neurologist or a geriatrician. 
The presence or not of clinical dementia was assessed. AlI subjects were followed 
for a minimum of 24 months unless death intervened. 
Differences between subjects who declined and those who did not were assessed by 
t-test. Outcome data were analyzed by analysis of variance, using both outcomes of 
de cline documented on MMSE, and clinical diagnosis of dementia, as outcome 
variables. Correlations of the presence of clinical features with outcome were 
assessed using Chi-square analyses. 
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AlI subjects provided written informed consent for the study and the MeGill 
University Review Board approved the protocol. Readers should note that detailed 
results from this neuropsychological data have been presented in a separate 
communication (Chertkow, Bocti et al. 2005). 
MRI acquisition and initial processing 
MRI data for aIl subjects were acquired between 1993 and 1998 on a 1.5T GE Signa 
5 scanner (GE Healthcare, Milwaukee, WI) using a 3D sequence (TR=300ms, 
TE=4.2ms, FA=90, sagittal acquisition with 256 (SI) x 256 (AP) 0.86 mm pixels, 5 
mm slice thickness) at the Montreal General Hospital. 
Following acquisition, intensity inhomogeneities due to scanner variations were 
corrected (SIed, Zijdenbos et al. 1998). Grey-Ievel intensities were then commonly 
scaled across subjects. Affine (9 degrees of freedom or DF) linear registration was 
used for global alignment into a standard reference space (Collins, Neelin et al. 
1994). The data was finally resampled onto a 1m~ isotropic grid (Mazziotta, Toga 
et al. 1995). The reference image used for the linear registration and resampling was 
the International Consortium for Brain Mapping (ICBM) T1w target, known as 
icbm152, a voxel-by-voxel average of the 152 normal subjects previously registered in 
the Talairach-like stereotaxie space in the context of the ICBM project (Mazziotta, 
Toga et al. 1995). 
193 
MRI-based classification of subjects 
The classification method used to predict future clinical state of the subject can be 
summarized as follows (Duchesne, Bemasconi et al. 2005). First, from pre-processed 
data, volumes of interest (VOl) centered on the left and right MTL were extracted 
using stereotaxie coordinates (st art coordinates in Talairach space: x=[ +2,57] for 
the left and right sides respectively, y=[-53] and z=[-52]). Each VOl measured 55 x 
82 x 80 = 360800 voxels. The extent of the VOl captured the hippocampus and 
neighboring MTL structures, such as the entorhinal, perirhinal and 
parahippocampal gyri, irrespective of normal inter- and intra-individual variability. 
To further reduce positional variations, which would propagate as unwanted noise in 
the morphometric modeling, a local affine transformation (12 DF) was applied to 
co-register the individu al subject's VOl with the corresponding VOl of the reference 
target. 
The second step was to generate a normal, non-pathological eigenspace from the 
ICBM reference group of young, normal control subjects (N = 152). This 
multidimensional eigenspace was created by uniting results from four distinct 
Principal Component (PC) analyses of (i) intensity images of the left and right VOIs; 
and (ii) a shape me tric, corresponding to a measure of local volume change for the 
left and right VOIs. The latter estimate was derived from the trace of the Jacobian 
of the deformation field, obtained following non-linear registration of the subject 
volume to the reference image. The classification of P vs NP groups of MCI patients 
194 
was accomplished by projecting the MRI VOIs from these subjects, processed in a 
similar fashion, in the multidimensional reference eigenspace; and then by 
estimating classification functions on the projection coordinates with forward 
stepwise linear discriminant analyses. The goal was not to find a feature space that 
optimally represented the two groups but rather to find a suitable basis for 
comparison, allowing for effective classification by deriving prognostic information 
correlated to a particular distribution of coordinates along a PC (see Figure 37). 
1'C2 
MCI • Non-progre •• ors 
(NP) 
Linear discriminant functiOn 
NP 
MCI·Progressors 
(P) 
J'Cl 
1'C2 
Figure 37 - Cartoon-like representation of classification of patient groups 
(Top) The reference set is represented by the green ellipse, aligned and centered 
with the first two principal components sin ce the eigenspace originates from this 
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data. Our goal however is to use the same space for the separation of MCI 
progressors (red) from non-progressors (pink). (Bottom) The eigendistance between 
centers of the two populations can be expressed back in terms of image intensity and 
shape variations; these in turn can help with the biological interpretation of the 
results (see Figure 39). 
The final reported results consist in the mean accuracy of multiple cross-validated 
trials. In each of these trials, the study data was randomly split in two groups: the 
first group was the training set and was used to estimate the classification functions; 
the second group was the test set, classified using the functions derived from the 
training set. This procedure was repeated multiple times and the average proportion 
of correct classifications of the test set was used as an empirical measure for the 
success of the discrimination. The cross-validation experiments were completed 
using SYSTAT 10.2 (SSI, Richmond, CA). 
Experiments 
There were two classification experiments performed: 
~ Experiment 1 was aimed at separating P and NP groups on the basis of two non-
MR features, baseline age and MMSE; and 
~ Experiment 2 was aimed at separating P and NP groups on the basis of MR 
features, extracted in the fashion described above. 
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Results 
Demographies 
With the design of this longitudinal study, subjects were followed until they 
progressed to dementia, and then dropped from the cohort. 
AlI subjects showed neuropsychological deficits in the memory domain greater th an 
1.5 standard deviation on age-matched tests. While clinically mild, these were at 
times equivalent or greater than the degree of memory loss. 
In both P and NP subgroups, between 1/2 and 2/3 of subjects had additional domain 
deficits. There were aIl combinations of isolated memory as weIl as non-memory 
deficits accompanying the memory loss. The multiple patterns were encountered 
both in progressors as weIl as non-progressors. Chi square analysis of aIl 
combinations failed to find significant differences in the distribution of 
neuropsychological profiles, in any set of groupings. As mentioned previously, 
detailed results of the full subject cohort have been presented in a separate 
communication (Chertkow, Bocti et al. 2005). 
Only 24 subjects out of the larger group of 89 had baseline MRI that could be 
recovered, and therefore form the sub-group investigated in this study. Other images 
were either lost in digital format due to backward hardware and software 
incompatibilities, or discarded due to the presence of extensive motion artifacts. 
Sixteen of the se 24 subjects progressed to AD on average in 2.6 (std dey 1.6) yrs 
after an initial baseline visit (Group P), while the remaining eight subjects have 
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clearly not progressed during the foIlow-up period (Group NP, mean follow-up 5.7 
(std dev 4.0) yrs). 
Age and MMSE of the progressors and non-progressors is shown in Table 8. There 
was a significant group difference for baseline age (DF=22, P=0.0358) when 
comparing the P [mean age 78.5, sd (5.3) yrs] vs NP groups [72.0 (6.8) yrs]. The 
average MMSE score in the progressor group was 26.5 (2.3) at baseline scan, 
significantly different (DF=22, P=O.Olll) from the non-progressor group MMSE 
average of 28.5 (1.2) at baseline scan. 
Progressors (P) 
Non-progressors (NP) 
P (PvsNP) 
N 
16 
8 
Age 
(yrs) 
78.5 (5.3) 
MMSE 
26.5 (2.3) 
72.0 (6.8) 28.5 (1.2) 
0.0138 * <0.0001* 
Conversion 
(yrs) 
2.6 (1.6) 
Table 8 - Demographie and MMSE information on study subjeets 
Given the age and MMSE group differences, Experiment 1 was designed ta assess 
the accuracy of individual classification using these 2 features. For aIl cross-
validation trials a model using bath features was used to compute the classification 
function tram the training set and apply it to the test set. Fifteen trials were ron, 
with a median of 23 subjects in the training sample and 1 in the test sample. The 
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mean accuracy for individual classification was 63%, the mean sensitivity for 
progression 59%, and the mean specificity for non-progression 57%. 
Experiment 2 was designed to assess the accuracy of individual classification using 
MR-based features. Our overall MRI-based model, formed by the union of the 
intensity and shape principal components for the left and right VOIs, was built using 
our reference set of 152 young control subjects. A total of 538 principal components 
were retained, accounting for 99.7% of the variance of the reference data set. 
Fifteen cross-validation trials were run, with a median of 23 subjects in the training 
sample and 1 in the test sample. Forward, stepwise linear discriminant analysis (P-
to-enter = 0.15) was used to select the discriminatory variables from the training set 
and compute the classification function for each trial of the test set. Normality of the 
eigencoordinates along those eigenvectors was confirmed using quantile plots and 
Shapiro-Wilke test (P > 0.05). 
The mean accuracy for individual classification was 88% (21/24), the mean 
sensitivity for progression 94% (15/16), and the mean specificity for non-progression 
75% (6/8). The median number of variables retained by the forward, stepwise 
process was 10, with the three most occurring discriminating eigenvectors describing 
covariances in right MTL intensity (see Figure 38). 
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Figure 38 - Patients data plotted along most discriminat eigenvectors 
The NP (green) and P (red) patients data are shown here plotted along the three 
most discriminating eigenvectors in the multidimensional reference space of cross-
section al MR intensity and shape information. One can estimate a plane that would 
optimally separate the two groups in one of the cross-validation trials. The resulting 
average discriminatory accuracy for 15 trials was 86%, on average 2.6 years before 
clinical diagnosis. Mean sensitivity for progression was 84.6% and mean specificity 
83%. 
Discussion 
Our resuIts indicate that the position information (eigencoordinates) of new data 
projected in a multidimensional reference domain has the potential to adequately 
predict progression of MCI to AD, on average 2.6 yrs before a clinical diagnosis is 
made. The mean accuracy of the technique, given the study population, was 86%, its 
mean sensitivity to progression 84.6% and mean specificity 83%. 
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The ability to predict progression in MCI has been explored in terms of clinical, 
neuropsychological and biological parameters (Bozoki, Giordani et al. 2001; 
Chertkow 2002). Although promising, none of the se to date have produced a simple, 
reliable, and inexpensive predictive measure. 
This reinforces the notion that additional information must be collected at baseline 
and follow-up, using other independent or orthogonal biomarker(s) such as 
neuroimaging. We have already discussed the limitations of functional and 
longitudinal structural imaging; we will focus our attention in this section to 
available structural techniques that are applicable to cross-sectional MR data. 
Volumetry of the HC and surrounding structures is the most-often used approach in 
research and clinical practice. It has been shown to suffer from significant intra 
(0.91-0.95) and inter-rater (0.83-0.91) variability in a hippocampal segmentation 
study in normal controls by Pruessner et al. (Pruessner, Li et al. 2000). This 
variability is likely to increase in MCI and AD as boundaries shift due to atrophy and 
become less clearly delineated as intensity changes. This added variability in 
segmentation measurements, or volume tric noise, will reduce the classification 
accuracy of any methodology based on such information. 
By contrast, the technique presented in this article is completely automated and 
therefore completely reproducible. Further, it is important to note that the 
technique requires no manu al intervention other th an the definition of the VOl, 
which is do ne once and based on stereotaxie coordinates on the reference image. 
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This is a significant reduction of required resources when comparing to volumetry or 
other expert-based techniques that may require 90-120 minutes per hippocampus for 
manual segmentation. This independence from user interaction also ensures that the 
process remains objective. 
One might wonder if this classification procedure is overdetermined when using 
many eigencoordinates for classification, and may risk over-Iearning of the data, the 
independence of the reference group from the training set and the independence of 
the training set from the test set in the multiple trials both ensure that such will not 
be the case. In such a setting, the cross-validation procedure makes the most of the 
limited data (24 subjects). 
The increased accuracy of this method when compared to single-scan volumetry can 
readily be explained when one considers the difference in information al value of the 
approaches. Wherease the CUITent technique uses 4 X 300000 voxels, processed and 
expressed in terms of 538 principal components coordinates, HC volumetry 
compresses 3000 to 4000 voxels in a single scalar measurement, expressed in mnf. 
Clearly, additional important information is embedded in voxels outside of HC but 
within the MTL, included in our analysis in the form of intensity and shape 
covanances. 
Other cross-sectional structural imaging techniques have been suggested for the 
differentiation of AD from normal aging and/or MCI. Cortical thickness, known to 
be affected in AD (Shefer 1973; Duyckaerts, Hauw et al. 1985), can be estimated via 
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automated analysis of in vivo MRI. Its successful application to AD research has so 
far been limited to the differentiation of normal aging from AD (Lerch, Pruessner et 
al. 2005); it has not yet been applied to the successful prediction of MCI progression 
to AD. In order to detect cortical thickness changes, high-resolution scans are 
required (at least with Imm isotropie acquisition); conversely, the technique 
proposed in this article is shown to be accurate even when using low resolution MRI 
(slice thickness 5mm). 
Assessment of the covariations in intensity and shape embedded in the most 
discriminating principal components should yield important information regarding 
the pathophysiology of the disease. To this effect we have imaged the three most 
discriminating eigenvectors by expressing the difference between centers of the 
progressing and non-progressing groups in the image domain, along each of these 
principal components. While there were on average 10 discriminating functions for 
our validation trials, we chose to image the first three most discriminating principal 
components for the sake of clarity. The resulting image (see Figure 39) shows 
covarying areas of maximal difference between the groups that drive the 
classification. 
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(A) (B) 
Figure 39 - Areas of discriminating intensity covariances in right medial temporal 
lobe 
Eigendistance (see Figure 37) between centers of the two populations along the three 
most discriminating PCs of Figure 38 have been expressed back in the image domain 
(PC55 in blue, PC96 in red and PC64 in green). Ail three eigenvectors were 
modeling intensity variations in the right MTL. Our results therefore suggest that 
the degree of pathological impact in the right MTL is indicative of future 
progression to AD. 
Of primary interest is the fact that aIl three PCS were modeling intensity variations 
in the right MTL. This does not imply that intensity changes are not apparent in the 
left MTL but rather, that they do not have strong discriminating power in separating 
progressors vs non-progressors. Accepting our hypothesis that pathology-related 
microscopic changes affect the Tlw signal, this finding would imply that the main 
difference between the two groups is therefore related to the degree of disease 
spread in the right MTL. A second possible conclusion is that discriminative 
intensity variations will occur before discriminative shape changes. The latter is 
supported by the fact that the degree of atrophy of MTL structures is smaIler in MCI 
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than in AD patients, when compared to normal controls (Pennanen, Kivipelto et al. 
2004; Thompson, Hayashi et al. 2004). 
Differences in gray and white matter in the right MTL have also been reported in 
the literature since such intensity changes are reflected in decreases in gray matter 
concentrations. VBM studies have shown patterns of differences primarily in the 
right MTL when looking at MCI vs AD (Karas, Scheltens et al. 2004; Pennanen, 
Testa et al. 2005) as weIl as, and more importantly, in progressor vs non-progressor 
MCI patients (Chetelat, Landeau et al. 2005). 
As mentioned, discriminative changes in shape should follow those in intensity, and 
indeed there have been reports of the discriminatory ability of shape measures in 
AD, MCI and normal aging differentiation studies (Csernansky, Wang et al. 2000; 
Duchesne, Pruessner et al. 2005) but not within an MCI population as it relates to 
cognitive dec1ine. 
Chetelat and colleagues report regions of significant greater GM loss in converters 
relative to non-converters in the hippocampal area, inferior and middle temporal 
gyrus, posterior cingulate, and precuneus (Chetelat, Landeau et al. 2005). This 
pattern is echoed by areas of intensity covariances shown in Figure 39. Areas of 
difference between the two groups are primarily located in the HC, PHC and medial 
occipito-temporal gyrus. It is not c1ear if the se intensity differences are indicative of 
GM or WM atrophy, as this cannot be determined by this methodology; more 
analysis is therefore required. 
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Overall, we speculate that the se intensity differences result from advanced extra-
cellular plaque formation, neurofibrillary tangles accumulation and other 
pathological processes in the progressors. 
Conclusion 
We report results from a MRI analysis technique that achieved high sensitivity and 
specificity in predicting MCI progression or non-progression to AD with 86% 
accuracy in the cohort studied on average 2.6 years before clinical diagnosis. We 
found that right MTL intensity changes were most discriminative between the two 
groups. The importance of the right MTL in the prognosis of MCI and early 
detection of AD is therefore supported. Clinically, this methodology, which does not 
rely on segmentation and requires no user input, holds promise for the development 
of an inexpensive, reliable and safe biomarker to be used in predicting progression in 
MCI individuals. 
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Chapter 8 
General Discussion and Conclusion 
General discussion 
The purpose of this the sis was to develop and validate novel, automated image 
processing techniques that would answer important clinical problems in neurological 
diseases. Two methods have been proposed: one based on the appearance (intensity 
and shape features), and a second, on grey and white matter voxel-wise 
characteristics. Both methods were designed to be volume-centric, data-drive n, and 
cross-sectional. 
Chapter 4 was instrumental in presenting the ABC methodology and its application 
to the difficult task of lateralization of seizure focus in temporal lobe epilepsy. While 
MRI is not a sensitive tool for measuring the temporo-spatial pattern of seizure 
onset, it is fit for the task of assessing its impact on the morphology within the 
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medial temporal lobe. This, in tum, seems sufficient for resolving the clinical 
problem of lateralization. 
The ABC technique was as accurate as expert-based volumetry of the hippocampus 
in separating patients with or without hippocampal atrophy (127/127), as weIl as 
lateralizing seizure focus in subjects with hippocampal atrophy (80/80). It also 
achieved perle ct accuracy (47/47) at determining the seizure focus in patients 
without hippocampal atrophy, weIl above volumetry (equal to chance) in this respect. 
Finally, it achieved 96% accuracy in lateralizing seizure focus when given no a priori 
information about hippocampal volume; this is a major improvement over the 81 % 
accuracy for expert-based volumetry in the same cohort. These results suggest that 
MRI analysis could replicate the gold standard measurement (clinical evaluation, 
extensive video-EEG monitoring, and in sorne cases surgically implanted EEG), 
while offering considerable reductions in time, resources, and patient discomfort. 
In Chapter 5 the second, VBM-based methodology was used to increase our ability 
at predicting the future clinical status of patients undergoing SAH, from three to 
four out of five patients when added to the clinical information available (age of 
onset, duration of epilepsy, contra and ipsi lateral hippocampal volumes). It also 
fared better in specificity (90.5% vs. 75%), slightly better in accuracy (78.9% vs. 
74.1 %), but poorer for sensitivity (50% vs. 72%) than a similar study conducted by 
Antel et al. (Antel, Li et al. 2002) using MRI and MRS imaging. Contrary to the 
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latter, the VBC method relies on standard T1w imaging, whereas MRS demands 
significant expertise and long acquisition times. 
This study also underlined the fact that there appears to be extra-hippocampal GM 
and WM differences between patients with negative vs positive outcome; this finding 
should be further explored. It would imply that sorne of the candidates undergoing 
SAH have more extensive pathology-related damage; in these cases, more extensive 
pre-surgical evaluation would be required and possibly the resection target modified 
to suit their particular condition. 
Chapter 6 was key in assessing the robustness of the method to a change in the signal 
brought about by the application to a completely different pathology. The ABC 
methodology was proven to be accurate in differentiating AD and MCI from normal 
aging individuals, on the basis of a single MR scan, with a mean accuracy for 
individual classification of 90.9%, mean sensitivity to AD+ MCI of 76.2% and mean 
specificity for NA of 97.3%. This is to be compared to the ability of hippocampai and 
amygdala volumetry at the same task, with a mean accuracy of 82.1 %, mean 
sensitivity to AD+ MCI 81.2%, and mean specificity to NA of 85.9% within that 
cohort. 
This has immediate clinicai implications for memory clinics; for exampIe, the high 
specificity of this MRI -based technique could offer a reliable and objective mean of 
reducing the number of faise positives, given inconclusive neuropsychologicai 
assessments. It aiso enlarges the scope of the technique potentially for other 
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neurological diseases, as these results add further credence to support our 
hypothesis that intensity and shape changes can be used for discriminative tasks. 
The surprising find that ABC seems also robust to signal differences due to 
acquisition hardware bodes well for the future application of this technology to 
multi-site data, which is routinely done in large scale clinical studies and 
pharmaceutical trials. 
Chapter 7 demonstrated that the ABC technique with MR data could be a potent 
imaging biomarker, by accurately predicting future clinical state in a cohort of MCI 
patients. The search for such a biomarker is at the center of MCI research in a wide 
variety of areas: neuropsychology, proteomics and genomics, and neuroimaging; 
results such as those confirm the ability of MRI measurements to act as a surrogate 
indicators for the disease. 
Further, the resulting evidence from the experiments in that manuscript 
demonstrates that the right MTL holds the key information to differentiate or 
predict future clinical status, and will also be use fuI for the design of new techniques 
or analysis of other structural and functional data. 
Finally, this study highlighted the fact that the ABC methodology is robust to noise 
(from movement artifacts) and reduced information found in clinical thick-slice data. 
Sorne would imply that this essentially indicates that a structure-centric approach 
could be used rather than the generic volume of interest. This claim is not 
necessarily true. First, the accuracy of HC and AG volumetry was lower than the 
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VOI-centered ABC approach, and by aIl accounts those are privileged structures in 
AD research. Second, a priori knowledge of the pathophysiological processes of the 
disease are required in order to select the structurees) of interest within the 
convoluted brain morphology. The ABC methodology requires no such preliminary 
exploratory work. On the other hand, a sensitivity analysis to a change in VOl 
parameters should be completed; while its extent may remain the same, different 
sampling schemes could be investigated. 
Future work 
ln fact, there are probably more open questions to be answered now that the 
techniques have proven successful than at the start of this thesis. 
The location of the VOl should be reexamined. One practical consideration when 
selecting the left or the right MTL was the available memory to perform the 
necessary computations. The constant upgrading of hardware capabilities make even 
larger, less specifie VOIs possible, which could potentially encompass most sub-
cortical structures. 
The extension or relocation of the VOl is directly linked to the application. There 
are a number of other neurological disorders in which intensity and/or shape 
differences exists, and therefore that could benefit from the ABC technique: 
schizophrenia and depression are but two examples. One attempt is currently under 
way for the study of movement disorders, with a VOl centered on the thamalus and 
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basal ganglia. One could argue that a single model should be done for the whole 
brain; while possible, the extensive, normal cortical variability may mask out the 
potential pathological signal. 
ln any case, the technique should also be tested using a VOl located in a brain 
region where the a priori hypothesis shows that the pathological effect is nuIl or 
extremely limited (e.g. occipital lobe in AD); this would be an interesting 
confirmatory experience to validate the sensitivity of the method. 
Further sensitivity analysis of the ABC methodology would include the different 
parameters of registration (see Robbins et al. (Robbins, Evans et al. 2004» and 
intensity normalization. Likewise, the effect of Gaussian blurring kemel size, as weIl 
as parameters involved in the tissue classification, should be exhaustively verified in 
further studies using the VBC methodology. 
The same technique is not only sc al able in terms of the size of the feature vector, but 
also to its content. So far the applications have been mono-modality. Clearly, other 
imaging (T2, PD, PET, SPECT) and/or other descriptors of the images (texture 
vectors) can be incorporated in the modeling and used for discrimination. 
Modeling itself could be revisited. The underlying assumption in both methodologies 
was that linear models (of intensity and shape covariances, or large scale GM or 
WM differences) would be sufficient for the discrimination task. It is to be expected 
that many nonlinear processes result from the pathology; accounting for those 
nonlinearities using other modeling techniques (nonlinear PCA, for example) could 
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potentially reduce even further the discriminatory space. 
Most of the experiments in these manuscripts confronted MR analysis against other 
clinically oriented variables. Reality dictates that aIl available information should be 
combined in order to maximize the bene fit to the patient. Of course, this was done 
purposefully within these articles to single out the increase in classification or 
prediction accuracy that could be attributed solely to the MR-based methodologies. 
In the future, all available information should be combined in a proper statistical 
framework to maximize the accuracy of the classifier. It is likely that other 
approaches, e.g. volumetry, redundantly explain sorne aspects of the underlying 
pathological process, such as local volume change. In such cases, a stepwise process 
would reject the redundant features and select only the most discriminating one. 
Careful retrospective analysis of the discriminant variables would yield the 
appropriate cocktail of measurements commensurate to the task at hand. 
The road ahead for research is therefore centered on converting these 
methodologies to nonlinear modeling; to combine clinical variables with MRI 
information; and to extend the analysis to multi-modality data. As a first step, this 
could entail using co-registered T2 and PD images, and if possible PET imaging (e.g. 
PIB compound in AD) or inter-ictal SPECT (e.g. Technetium-99m HMPAO in 
TLE). It remains that many centers will not have access to such resources, lacking 
the facilities or the expertise and may have only access to simple MR sequences. 
One development goal should be therefore to tie together the methodologies set 
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forth in this thesis into an easy-to-use package, in order for users to incorporate 
them easily into current clinical practice. 
Finally, much work remains in the biological interpretation of the discriminative 
intensity and shape information embedded in the eigenvectors. This step is necessary, 
it is realized, for acceptance of the methodologies in the wider clinical community. 
As an example, the corroboration of findings on Tlw MRI - or other MR sequences 
- with functional data, such as PET images with PIB, would serve to bridge the gap 
between intensity differences seen on MRI in MCI progressors vs non-progressors 
and the microscropic pathological advances in A~ load. 
Conclusion 
The goal of this thesis was to present the development and validation of two novel 
methodologies for automated analysis of MRI, to be used as aid to diagnosis in 
clinically relevant neurological problems. The four studies presented have shown 
that these techniques can lateralize the seizure focus and predict surgical outcome in 
temporal lobe epilepsy, differentiate AD and MCI from normal aging, and predict 
future clinical status for MCI patients. The potential for future studies and 
development seems clear, and should aid clinicians in making important diagnostic 
decisions regarding patient management and care. 
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Gray Matter 
Hippocampal normal volume 
Hippocampus 
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Left seizure focus with Hippocampal Atrophy 
Left seizure focus with Normal HC Volume 
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